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II. Structure of Thesis
The thesis herein is structured into two major parts: preliminary pages and substantive chapters. 
The preliminary pages are made up of the title page, declaration of originality of work, Table of 
contents, and finally, a summary of findings. The summary comes in English and Deutsch.
There are 5 substantive chapters divided into one introductory chapter called Introduction, three 
result chapters, numbered consecutively as Chapters 2 through 4 and made up of two publications 
and a manuscript. Chapter 5 is the discussion chapter. The reader should note that because each 
publication/manuscript has a detailed discussion, the discussion as presented in Chapter 5 is 
rather an overview of findings, possible implications and suggestions for further research.
Chapter 1, the introductory chapter is a synopsis of current state of the art and chronicles a wide 
variety of aspects considered relevant to the current study. It introduces the reader to the problem 
of Animal African Trypanosomosis (AAT) and Human African Trypanosomosis (HAT), the 
involvement of sialic acid (Sia) and trans-sialidases (TS) in trypanosomiasis. More emphasis is 
placed on trans-sialidases from African trypanosomes but due to the inescapable fact that more is 
known about the American T. cruzi TS (TcTS), a large number of references are made to TcTS. 
Chapter 2/Publication 1 is on T. congolense trans-sialidase 1 (TconTS1) variants, the group with 
the largest gene members in this organism. Cloning, sequencing and biochemical attributes of two 
variants have been reported and compared with TcTS.
Chapter 3/Publication 2 deals with the remaining TconTS genes of TconTS2, TconTS3 and 
TconTS4. The model blood glycoprotein fetuin has been used as donor in presence and absence 
of acceptor disaccharide lactose to further asses the sialidase and trans-sialidase activities of 
these genes. While this chapter reports also on the cloning and sequences of TS gens from T. 
brucei (TbTS), no enzymatic activities of the TbTS are reported here. Instead, data is mined for 
another African AAT-causing parasite, T. vivax and phylogenetic analysis employed using full 
lengths (open reading frames, ORFs), catalytic and lectin domains separately to delineate TS 
orthologues among these group of organisms.
Chapter 4/Manuscript characterises the activities of TconTS genes on a complex and biologically 
relevant substrate, mammalian serum glycoconjugates.
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III. Summary
The work compiled here aimed at biochemically characterising trans-sialidase (TS) genes from 
Trypanosoma congolense, the most prevalent causative agent of animal African trypanosomiasis, 
also called nagana. Using published partial TS sequences as starting queries, database at the 
Welcome Trust Sanger Institute (WTSI) was queried and TS1 genes identified. This is a multi-copy 
gene group comprising 11 members. Members were cloned and recombinant protein expressed in 
fibroblasts and purified proteins assayed for enzyme activities (Publication 1/Chapter 1). All TS1 
variants were found to be active TS enzymes, transferring Sia from donor fetuin to the lactose 
acceptor substrate and could resialylate asialofetuin up to 50%. Use of synthetic substrates 
revealed poor specific activities.
Further searches on WTSI using TconTS1 gene variants as queries revealed 3 other TS genes, 
TconTS2, TconTS3 and TconTS4, all conserving the critical amino acids required in activity. A 
further 3 distantly related genes, this latter group is presumed inactive due to lack of conservation 
of critical amino acids (Publication 2/Chapter 3). TS/sialidase ratios confirmed the former  to be 
active trans-sialidases but with differing specific activities. A mouse monoclonal antibody raised 
from native proteins probably containing other TconTS and not only TconTS1 reacted with both 
TconTS1 and TconTS2, two of the proteins with the highest specific activities. Incidentally, the 
epitope for the antibody is localised on the lectin domain (LD) in both enzymes. Phylogenetic 
analysis using the LD grouped TconTS1 and TconTS2 together while the use of catalytic domain 
(CD) grouped them separately. This suggests a possible role for the LD in enzyme activities and 
hence pathology of nagana.
To gain knowledge on the role of TS in pathogenesis of nagana, blood glycoconjugates were 
employed as substrates and activities of TS gene characterised (Manuscript/Chapter 4). All 
TconTS proteins transferred Sia from serum-bound glycoconjugates to lactose. In absence of 
lactose, TconTS1 and TconTS2 released free Sia from the serum-glycoconjugates, possibly 
explaining the high amounts of free Sia observed in blood and serum of animals suffering nagana. 
TconTS3 showed an unidentified product peak in presence of serum-bound Sia and lactose, while  
3 unidentified signals probably representing serum-glycoconjugates inherent in serum were  
altered by TconTS2. Collectively, the above indicate the possibility of  acceptor and donor 
preferences and show that expressing more than one TS gene at a time could be beneficial to the 
parasite.
Since TS genes are expressed in two different hosts systems; the Glossina insect vector and the 
mammalian hosts with different pH systems, pH optima for the enzymes was studied. TconTS2 
exhibited a wide pH optima that would make it active in both host systems.
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IV. Zusammenfassung
Die hier vorgelegte Arbeit befasst sich mit der biochemischen Charakterisierung von Trans-
sialidase (TS)-Genen aus Trypanosoma congolense, dem Hauptverursacher der Afrikanischen 
Trypanosimiasis, auch bekannt als Nagana. Unter Verwendung von bereits veröffentlichten 
Teilsequenzen der TS, konnten TS1-Gene aus der Datenbank des Welcome Trust Sanger Institute 
(WTSI) identifiziert werden. Dabei handelt es sich um eine „Multi-Copy“-Genefamilie, die 11 
Mitglieder umfasst, die alle durch Klonierung als rekombinante Proteine in Fibroblasten exprimiert 
und deren spezifische Enzymaktivitäten gemessen wurden (Veröffentlichung 1/ Kapitel 1). Es 
konnte gezeigt werden, dass alle TS1 Varianten Enzymaktivität besitzen und in der Lage sind 
sowohl Sialinsäure vom Akzeptorsubstrat Fetuin auf das Donorsubstrat Laktose zu übertragen, als 
auch desialyliertes Fetuin wieder bis zu 50% zu resialylieren. Der Einsatz von synthetischen 
Substraten ergab nur geringe spezifische Enzymaktivitäten.
Zusätzliche Recherchen in der WTSI Datenbank mit Hilfe der TconTS1 Genvarianten als 
Grundlage, führten zu 3 weiteren nahen TS verwandten Genen, die hier als TconTS2, TconTS3 
und TconTS4 bezeichnet werden und 3 entfernter verwandten Genen. Letztere scheinen inaktive 
TS Formen zu sein, da sie die für einen Transfer/Hydrolyse konservierten, essentiellen 
Aminosäuren nicht enthalten (Veröffentlichung 2/ Kapitel 3). Das Verhältnis von Transfer- zu 
Sialidase-Aktivität der drei nahe verwandten TS Gene bestätigt diese als aktive Trans-sialidasen, 
jedoch mit unterschiedlichen spezifischen Enzymaktivitäten. Ein gegen TconTS gerichteter, 
monoklonaler Antikörper zeigt deutliche Kreuzreaktivität mit TconTS1 und TconTS2, die beiden 
Proteine mit den höchsten spezifischen Aktivitäten. Interessanterweise ist das Epitop dieses 
Antikörpers jeweils in der Lektin-Domäne (LD) der TSs lokalisiert. Phylogenetische Analysen über 
die LD zeigen die gemeinsame Gruppierung von TconTS1 und TconTS2, wo hingegen die der 
katalytischen Domäne (CD) beide voneinander separiert. Diese Befunde könnten auf eine 
mögliche Rolle der LD in Hinsicht auf die spezifische Enzymaktivität und damit auch auf deren 
Rolle in der  Pathologie der Nagana hinweisen. 
Um weitere Erkenntnisse bezüglich der Rolle der TS in Krankheitsverlauf der Nagana zu 
gewinnen, wurden Glykokonjugate aus dem Blut als potentielle Substrate eingesetzt und die 
Aktivitäten der TS Gene charakterisiert (Manuskript/ Kapitel 4). Alle TconTS Proteine transferieren 
Sia von  Glykokonjugaten aus dem Blutserum auf Laktose. In Abwesenheit von Laktose konnte 
eine erhöhte Freisetzung von Sialinsäure aus den Glykokonjugaten durch TconTS1 und TconTS2 
nachgewiesen werden, die möglicherweise eine Erklärung für die hohen  Konzentrationen an freier 
Sialinsäure im Blut und Serum von mit Nagana infizierten Tieren ist. Mit TconTS3 erhält man  ein 
bisher noch nicht identifiziertes Produkt in Anwesenheit von serumgebundener Sialinsäure und 
Laktose, während 3 bisher nicht identifizierte Signale in Serum-Proben, die möglicherweise Serum-
Glycokonjugate repräsentieren, von TconTS2 verändert werden. Zusammenfassend zeigen die 
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genannten Ergebnisse eine potentielle Akzeptor- sowie Donor-Substrat Präferenz und deuten 
darauf hin, dass die gleichzeitige Expression verschiedener TS Gene ein entscheidender Vorteil für 
den Parasit  sein könnte.
Da Trans-sialidasen in zwei verschiedenen Wirtsystemen exprimiert werden; im Insektenvektor 
Glossina und in Säugern als Wirt, welche sich durch unterschiedliche pH-‚Systeme auszeichnen, 
wurden auch Untersuchungen zum pH-Optimum der Trans-sialidasen realisiert. Dabei zeigte 
TconTS2 ein Optimum über einem breiten pH-Bereich, was ein Hinweis auf dessen Aktivität im 
Wirtsystem darstellt.
v
V. Abbreviations 
AAT Animal African Trypanosomosis
ABC ATP-binding cassette transporter
a-HT atypical infections of humans
AQPs Aquaglyceroporins
ATP Adenosine triphosphate
Å angstrom
BSF Blood stream forms
CD catalytic domain
CMAH cytidine mononucleotide actyl hydrolase
CMPH Cytidine 5'-momphosphate-N-acetylneuaminic acid hydrolase
DA Diamidine
DANA 2-deoy-2,3-didehygro-N-acatylneuraminic acid
DNA Deoxyribonucleic acid
EMBL European Molecular Biology Laboratory
EST Expressed sequence tags
EtBr Ethidium bromide
Gal Galactose
G2 gap 2 (a stage in cell division cycle)
GARP Glycine-Alanine Rich protein
HAT Human African Trypanosomiasis
ISM isomethimidium chloride
KDN 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid
LD lectin domain
ManNAc N-acetyl-D-mannosamine
mRNA messenger RNA
MUNANA methylumbelliferyl N-acetylneuraminic acid
Neu neuraminic acid
NeuB sialic acid synthetase neuB
NeuC sialic acid synthetase neuC
Neu5Ac N-acetylneuraminic acid 
Neu5Gc N-glycolylneuraminic acid 
NMR Nuclear magnetic resonance
MRPs multi-drug resistance proteins
ORF Open reading frame
RBC red blood cells
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SAPA shed acute phase antigen
Sia Sialic acid
Sias Sialic acids (a set of sialic acid molecules)
SPR surface plasmon resonance
STD Saturation Transfer Difference
TconTS T. congolense trans-sialidase
TbTS T. brucei trans-sialidase
TcTS T. cruzi trans-sialidase
TevTS T. evansi trans-sialidase
TLF Trypanolytic lysis factor
TrSA T. rangeli sialidase
TS trans-sialidase
TvivTS T. vivax trans-sialidase
UDP-GlcNAc Uridine 5'-diphosphate-N-acetylglucosamine
USD United States dollars
VSG variant surface glycoprotein
WHO/TDR World Health Organisation/Tropical Disease Research
WSTI Welcome Sanger Trust Institute
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1.1.Trypanosomes
Trypanosomes are protozoans of the order kinetoplastida. This group of organisms infects millions 
of humans and animals and includes two genera, Leishmania and the digenetic flagellates, 
Trypanosoma. Members of the genus Trypanosoma are responsible for several neglected tropical 
diseases, both in man and his animals. However, only two cause significant human diseases on 
the African continent. These two, both subspecies of Trypanosoma brucei, are T. b. gambiense and
T. b. rhodesiense responsible for the Human African Trypanosomiasis (HAT), also known as 
sleeping sickness. Another human infective Trypanosoma, T. cruzi, the etiological agent of 
Chagas’ disease is responsible for the American trypanosomiasis. This condition afflicts millions of 
people in central and southern America and kills a reported 15, 000 yearly (Murcia et al. 2013).
The causative agent of HAT, T. brucei is further divided into two subspecies based on molecular 
typing. These are T. brucei gambiense, which causes a chronic form of sleeping sickness in West 
and Central Africa and T. brucei rhodesiense responsible for the acute form of the disease in 
Eastern and Southern Africa. The human-infective sub-species are considered to have arisen from 
the animal pathogen T. brucei that have acquired the ability to infect humans by resisting the 
trypanolytic lysis factor, TLF (Pays and Vanhollebeke 2008). A subspecies of T. brucei, T. brucei 
brucei, is not pathogenic to humans but instead infects ruminants and other animals, in addition to t 
other species, Trypanosoma congolense and T. vivax. Together, these Trypanosoma parasites are 
the causative agents of the Animal African Trypanosomiasis (AAT), widely known as nagana. 
Clinical signs of nagana are weight loss, anaemia and immunosuppression. Another pathogenic 
species e.g. T. simiae, is also present on the African continent. In common with the human 
parasites, the animal parasites are cyclically transmitted by haematophagous dipteran tsetse flies, 
Glossina species. Though humans have an innate protection against the animals infective species 
conferred on them by the trypanolytic lysis factor Apolipoprotein L-1 (apoL-1), present in human 
serum (Vanhamme et al. 2003), cases of a-typical infections of humans (a-HT) by the animal 
trypanosomes have been reported (Truc et al. 2013).
Traditionally, trypanosomes have been classified on the basis of site of development in the tsetse 
vector. This has given rise to four subgenera comprising (i). Trypanozoon e.g. T. brucei with midgut 
and salivary glands as sites of development, (ii). Nannomonas e.g. Trypanosoma congolense with 
midgut and proboscis as sites for development (iii). Duttonella where members develop in the 
proboscis and cibarium, an example include T. vivax (iv). Pcynomonas where members develop in 
the midgut, salivary glands and the proboscis. An example here is T. suis. This classification is not 
without problems and suggestions have been made on resolving them (Gibson 2007). Advances in 
molecular identification tools and phylogenetic analysis (Majiwa et al. 1993, McNamara, 
Mohammed and Gibson 1994, Solano et al. 1999, Desquesnes et al. 2001, Desquesnes, Ravel 
and Cuny 2002, Geysen, Delespaux and Geerts 2003, Malele et al. 2003, Hamilton et al. 2008, 
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Adams et al. 2010b, Silbermayr et al. 2013) have  lead to discovery of new trypanosomes. 
Advances in these methods portends great impact on understanding the diversity, distribution and 
biology, e.g host ranges of these trypanosomes, genetic exchange (Duffy et al. 2009, Morrison et 
al. 2009, Holzmuller et al. 2010) and species delineation for example, T. godfreyi (reviewed in 
Adams, Hamilton and Gibson 2010).
Tsetse flies are exclusive to Africa in a distribution that stretches between 14o North and 29o South 
of the equator (Krafsur 2009). About 30 extant taxa of these insects have been reported (Leak 
1998). Apart from T. evansi, with a much wider distribution found in Africa, the Americas, Asia, 
Middle and Far East and even Europe (Gutierrez et al. 2010), the exclusiveness of tsetse to Africa 
explains the restriction of diseases caused by T. brucei brucei, and T. congolense within sub-
Sahara Africa, resulting in losses of several billion dollars annually (Steverding 2008). T. evansi is 
the causative agent of the animal trypanosomiasis known as surra. In contrast to the other animal 
trypanosomes, this species has different vectors and is mechanically transmitted by biting flies of 
the genera Tabanus and Stomoxys. Its wider occurrence is attributed to the total adaptation to 
mechanical mode of transmission (Stephen, 1986) and to the transport of cattle from Africa in the 
19th century (Jones and Davila 2001).
On the other hand, T. cruzi, the etiological agent of Chagas’ disease is transmitted by bugs of the 
family Reduvidae (order Hemiptera). Although molecular typing of T. cruzi has identified two 
lineages (Fernandes et al. 1998), only one lineage, the type 2 is responsible for Chagas’ disease. 
T. cruzi has been studied more than the African counterparts (reviewed in Dc-Rubin and 
Schenkman 2012). The prospect of several common aspects of biology between these parasites 
(transmitted by insect vectors, common aspects of basic biochemistry) would have occasioned that 
knowledge gained on one species could be applied in the understanding of the other. Contrary to 
these expectations, profound differences at the level of host-parasite interactions have greatly 
reduced this prospect. 
1.2. Life cycle of T. congolense
It was assumed that the major differential attribute in the life cycles of T. congolense (Nanomonas) 
and its relative T. brucei (Trypanozoon) in Glossina vector was in the final destination of the 
metacyclics (reviewed in Hoare 1972). The complex life cycle of this organism was understood in 
terms of bloodstream form (BSF) parasites proliferating in the mammalian blood and getting 
ingested by tsetse while feeding. This follows establishment of infection in the midgut of vector 
accompanied by several changes in form and migrating anteriorly through the foregut to the 
proboscis for transmission into the mammalian host (see an illustration of the classical life cycle of 
T. congolense in Figure 1). While T. congolense metacyclics are found in the proboscis, those of T. 
brucei are located in the salivary glands, giving rise to the subgenera classification of these two 
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tsetse transmitted species. T. brucei is more studied among the African trypanosomes and the 
assumption that T. congolense shared similar aspects of the vector stage life with T. brucei led to a 
wide gap between knowledge of life cycles of these species as that of T. brucei continuously 
increased over the years from studies on the differentiation of bloodstream forms (Roditi, 
Carrington and Turner 1987, Tetley et al. 1987, Acosta-Serrano et al. 2001, Urwyler et al. 2007), 
cell cycle studies (Hutchinson et al. 2007) and genetic exchange and meiosis (Zampetti-Bosseler 
et al. 1986, Peacock et al. 2012). Generally, both species develop from blood stream forms into 
metacyclics by establishing infection in the ectoperitrophic space of the midgut where they 
subsequently invade the proventiculus in the mid gut, accompanied by loss of variant surface 
glycoprotein (VSG) forms. 
Figure 1. Life cycle of Trypanosoma congolense. Note that differences exist in the tsetse as regards sites of 
development when compared to other nagana-causing African trypanosomes as T. brucei develops in the 
salivary glands after midgut establishment while T. vivax does not require a midgut establishment (modified 
version from http://www.dpd.cdc.gov/dpdx???????? ??????????????????????????????
The VSG is replaced by procyclins, a collection of GPI-anchored glycoproteins (Pearson 2001) 
encoded by a small number of genes and hence limited potential for variation as the major surface 
protein in T. brucei (Butikofer et al. 1997, Acosta-Serrano et al. 1999), but the major surface coat in
T. congolense is carbohydrate (Utz et al. 2006). 
Recently, Peacock et al. (2012) using a combination of cell biology and microscopy clearly 
elucidated significant differences existing between transitional stages in the foregut and the 
mouthparts. In T. congolense, the proventricular trypomastigotes constitute a morphologically 
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discrete population that passes through the proventricular membrane to the foregut lumen before 
migrating to the proboscis. In the proboscis, it develops into epimastigotes and attaches via the 
flagella to the chitinous lining of the proboscis and cibarium as was previously described by 
Jefferies, Helfrich and Molyneux (1987). According to Thevenaz and Hecker (1980), the 
epimastigotes finally proliferates in the cibarium into the infective metacyclics that are already 
preadapted with VSG replacing the carbohydrate coat for life in the mammalian blood stream.
In T. brucei, an arrest occurs during G2 life cycle stage with a 4 N DNA content. The arrested stage 
divides asymmetrically into short and long epimastigotes. Both of these forms are found in the 
foregut (Gluenz et al. 2008) with the short form finally migrating anteriorly to colonise the salivary 
glands. Peacock et al. (2012) showed that there is a contrast between T. brucei and T. congolense. 
The asymmetric division in the former is achieved by the kinetoplasts migrating round the nucleus 
towards the anterior, resulting in the formation of 2 daughter epimastigote cells when the nucleus 
divides. In T. congolense, while there is migration of the kinetoplast around the nucleus to the 
anterior, an elongation of the posterior end occurs. This process in T. congolense could be 
accomplished with or without cell division. The resultant long epimastigotes (about 30 ?m) 
becomes reduced in size (ca. 13 ?m) forming the infective metacyclics. Successful completion of 
this life cycle depends on several factors mostly inherent in the biology of fly vector, trypanosome 
and blood meal and have been reviewed by Dyer et al. (2013). 
1.3. Sialic acids and Trans-sialidase in nagana
1.3.1. Sialic acids
Sialic acids (Sia) sugars and the multi gene protein family trans-sialidases play key roles in 
nagana. Sia is a monosaccharide family of 9-carbon backbone that incorporate a carboxy 
functional group. The carboxyl group confers upon them the negative charge and acidity. There are 
presently over 60 known members of this special class of compounds (Kamerling and Gerwig 
2006). Sia are restricted in their distribution as they occur in the deuterostomes and some bacteria. 
Except for the report by (Shah et al. 2003) that provides evidence for the occurrence of Sia in plant 
cells, plants are generally considered lacking Sia (Zeleny et al. 2006). Certain features make these 
compounds unique; in vertebrates, the glycan chains of vertebrates’ glycoconjugates are 
composed mostly of 5-carbon and 6-carbon sugars. Others include their being subject to a 
remarkable number of modifications as well as occupation of the terminal end of glycan chains. 
Their synthesis is by condensation of a neutral 6C unit with the 3C molecule, pyruvate (see 
Section 1.3.1.1 for the de novo pathway of Sia biosynthesis). Finally, while all other vertebrates’ 
monosaccharides are activated in form of uridine or guanidine dinucleotides, Sia are activated as 
cytidine mononucleotides, a high-energy donor sugar (Angata and Varki 2002).
Originally defined as derivatives of neuraminic acid (5-amino-3, 5-dideoxy-D-glycero-D-galacto-2-
5
nonulosonic acid, (Neu), the definition of Sia was expanded upon discovery of 3-deoxy-D-glycero-
D-galacto-2-nonulosonic acid (KDN). KDN has a hydroxyl group at position 5 of the 9-carbon 
backbone instead of the amino group. These two compounds are very similar in structure, 
occurrence and biosynthetic pathways (Angata & Varki, 2002). All other currently recognised Sia 
are biosynthetic derivatives of either N-acetylneuraminic acid (Neu5Ac) or KDN. Though highly 
diversified, the most common Sia in mammals are Neu5Ac and Neu5Gc, the latter resulting from 
an addition of oxygen atom to the N-acetyl group at C5 of the precursor CMP-Neu5Ac, forming N-
glycolylneuraminic acid (Neu5Gc). This reaction that forms Neu5Gc is catalysed by CMP-Neu5Ac 
hydroxylase (CMPH). Although among the most common Sia, second only to Neu5Ac in mammals, 
birds, reptiles, amphibians and fish, and the predominant Sia in man’s closest relatives, the great 
Apes, it is hardly found in humans, except in foetuses, brain and tumour cells, thus indicating a 
possible dietary uptake (Varki 2001, Sprenger and Duncan 2012). The structural gene, cytidine 
mononucleotide acetyl hydroxylase gene, CMAH responsible for modifying Neu5Ac is inactive in 
humans due to a mutation that results in deletion of exon 6 of the CMAH (Varki, 2001). 
In addition to the N-acetyl and N-glycolyl classes of Sia and and leading to the large diversity in 
this group of compounds are common modifications of the the ring or exocyclichydroxyls. These 
include one to three acetyl groups that could be added to the hydroxyl of C4 in the sugar ring, or to 
C7, C8 and C9 hydroxyls of the glycerol side chain. Sia may also be modified with lactyl, sulfhydryl, 
or methyl groups, although this is less usual a modification rather than acetylation (Vimr et al. 
2004). Further variety of Sia is increased by intra or intermolecular lactamization involving the 
carboxylate at C1 and intermolecular lactamization between C1 and C5 in the case of Neu (Angata 
& Varki, 2002).
More than 20% of Sia bound to glycoproteins of human RBC may be forms other than Neu5Ac, the 
predominant Sia in humans, including Neu (Bulai et al. 2003). Neu is considered to be derived via 
enzymatic deacetylation (Manzi, Diaz and Varki 1990). No clear idea exists as to why Sia exhibit 
such a wide and vivid structural variation. However, Angata & Varki (2002) argue that specific 
recognition of endogenous lectins and evasion of pathogens with Sia recognising lectins, are the 
driving forces within and outside respectively, and are probably at the heart of this diversification. 
Yet it is difficult to say to what extent any of these forces acting alone could drive the process of 
structural variation of the Sia. Put differently, the complex variability of Sia modifications has been 
suggested as being brought about by the struggle between pathogens and hosts’ cells (Gagneux 
et al. 2001),a classical illustration of evolutionary pressure. The result is the modification of 
pathogen recognition determinant, Sia by the hosts’ cells in order to avoid infection on the one 
hand. On the other, it leads to pathogens constantly evolving new binding specificities to overcome 
this hindrance and ensure survival. 
By the very nature of their position as terminal sugars on animal glycans, Sia equally play 
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important roles in masking recognition sites. For instance, pathogenic organism like viruses, e.g. 
Influenza virus A, B and C and bacteria make use of Sia containing glycoconjugates to gain 
attachment to the surfaces of hosts’ cells (Kelm and Schauer 1997). In eukaryotes, Sia have 
evolved to mediate a wide and diverse range of cell-cell and cell-molecule interactions. This 
include glycoconjugates and cell membrane stabilisation, mediation of cell-cell regulation and 
acting as chemical messengers, regulating transmembrane receptor function, affects membrane 
transport, control of the half-lives of circulating glycoproteins and cells and contributes to perm-
selectivity of the glomerular endothelium and slit diaphragm (Schauer 2000). Taken together, the 
relative importance of these complex molecules in the life function of higher organisms could be 
appreciated. This was amply demonstrated by early death of transgenic mouse mutants with 
homozygous defect in Sia biosynthesis (Schwarzkopf et al. 2002).
1.3.1.1. Sia synthesis and/or acquisition by organisms
According to Vimr and Lichtensteiger (2002), pathogenic organisms that modify their surfaces with 
Sia do this to avoid the host’s immune system by masquerading as ‘self’. They also do this to 
subvert the host’s innate immune system. It is envisaged that the biological advantages of cell 
surface sialylation in the host-pathogen or host-commensal interactions to the pathogen or 
commensal are enormous and due to this, these organisms have evolved, at least four known 
strategies to sialylate cell surfaces. These strategies include (i) de novo synthesis (ii) donor 
scavenging (iii) trans-sialidase and (iv) precursor scavenging (note: precursor scavenging is not 
discussed here).
The de novo Sia biosynthetic pathway was first discovered in Escherichia coli K1, where Sia are 
the repeating subunits of the capsular polysaccharide. The first step in the de novo Sia synthesis 
involves the conversion of the common cell precursor, UDP-GlcNAc to ManNAc by NeuC. NeuC 
catalyses the formation of a 2-acetamidoglucal intermediate by an elimination reaction. This is 
followed by irreversible epimerisation of this intermediate to ManNAc, as occurs in the mammalian 
system (Chou et al. 2003). Although slight variations exist within microorganisms (for e.g. between 
E. coli and the group B meningococci) in terms of NeuC orthologue, in either case, free ManNAc is 
produced as the obligate substrate for the following condensation reaction between ManNAc and 
phosphoenolpyruvate catalysed by NeuB (Vann et al. 1997). A detailed review of this process is 
provided by Vimr et al. (2004). In mammals however, the UDP-GlcNAc epimerase is a homologue 
of NeuC and that the mammalian orthologue of NeuB uses ManNAc-6-P instead of free ManNAc in 
the condensation reaction with phosphoenolpyruvate (Ringenberg, Lichtensteiger and Vimr 2001). 
The free Sia synthesised is activated by CMP-Sia synthetase, NeuA to produce the obligate donor 
of Sia for prokaryotic and eukaryotic sialyltransferases.
Donor scavenging is the second strategy of cell surface sialylation, only found in the sexually 
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transmitted bacteria, Neisseria gonorrhoea. The bacterium that causes gonorrhoea in man lacks 
the neuABC genes, yet it is capable of sialylating its cell surface (Vimr et al. 2004). This is 
accomplishes by an extracellular, membrane bound sialyltransferase which by virtue of its location 
has access to CMP-Sia which are present in small amounts as normal secretions of the host. 
1.3.2. Trans-sialidases
Trypansomes express a unique form of glycosyltransferase called trans-sialidase (TS) which it 
uses to acquire Sia. It was first described in the blood stream form of the American trypanosome, 
T. cruzi (Schenkman et al. 1991) and has been implicated in pathogenicity of the parasites. In the 
African trypanosomes, TS was shown to enhance survival and establishment of infections in T. 
brucei in the tsetse vector (Nagamune et al. 2004). TS was initially thought to be expressed only in 
the polycyclic forms in African trypanosomes (Pontes de Carvalho et al. 1993, Engstler, Schauer 
and Brun 1995). Recent evidences have shown that it plays a role in anaemia in animals suffering 
Trypanosoma congolense infections (Nok and Balogun 2003, Coustou et al. 2012) and T. vivax 
infections (Guegan et al. 2013). TS has therefore been established as virulent factors in 
trypanosomiasis. The enzyme accomplishes this by desialylation of erythrocytes leading to their 
clearance from the circulating system (Coustou et al. 2012, Guegan et al. 2013). A homology 
model of TconTS is presented as Figure 4b in Chapter 2.
TS is a modified version of the typical sialidases and catalyses the transfer of the Sia moiety from a 
donor conjugate to an acceptor substrate. The acceptor substrate must present a ?-galactoside or 
N-acetylgalactosamine as the terminal monosaccharide forming a new ?2,3-glycosidic linkage 
(Schenkman et al. 1991). Unlike the typical sialylytransferases, it does not require monosaccharide 
donors in form of cytidine-5?-monophosphate activated Sia and is highly specific for ?2,3-linked 
sialoglycoconjugate, though ?2-6 linked Sia can also be transferred (Tiralongo et al. 2003b). This 
trans-sialylation is highly efficient and differs significantly from the irreversible transfer catalysed by 
known CMP-Sia dependent sialyltransferases. They also act as typical sialidases in absence of an 
appropriate acceptor by hydrolysing glycosidically linked Sia (Schenkman et al. 1991). In this 
respect, TS is similar to viral, bacterial and even mammalian sialidases.
1.3.2.1. Expression and diversity in the Trypanosoma spp
Trans sialidase occur in Trypanosoma spp., as a multigene family in the genomes. T. cruzi, has the 
highest number of 1430 genes (Cazzulo and Frasch 1992, De Pablos and Osuna 2012), with 
members encoding for proteins of different sizes ranging from 60 to more than 200 kDa (Cazzulo 
and Frasch 1992, Colli 1993, Frasch 2000). Out of these large number, only 12 encodes 
enzymatically active T. cruzi trans-sialidase (TcTS) proteins while 725 encodes for inactive gene 
products and 693 are pseudogenes (Kim et al. 2005). The key element that differentiates an active 
TcTS from an inactive one is a single amino acid exchange, Tyr342-His (Frasch 2000). The 
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situation in terms of gene numbers seems more simplified in African trypanosomes, where the TS 
and TS-like gene families are much smaller. This is illustrated by the presence of 9 TS gene 
members (TbTS) identified in T. brucei (Montagna et al. 2002, Montagna, Donelson and Frasch 
2006, Nakatani et al. 2011). In T. congolense (TconTS), at least 17 TS-like genes have been 
identified (Tiralongo et al. 2003a, Tiralongo et al. 2003b, Koliwer-Brandl et al. 2011, Coustou et al. 
2012, Gbem et al. 2013). The TconTS genes have been classified into at least four different active 
groups as TconTS1, TconTS2, TconTS3, TconTS4 and the inactive TconTS-like genes (Gbem et al. 
2013). The largest group, TconTS1, has 11 closely related members that share over 95% 
sequence identity and all are active (Koliwer-Brandl et al. 2011). 
The key element mediating the functions of given TS has been ascribed to the N-terminal catalytic 
domain (CD) harbouring the active site with characteristic conserved amino acids (Cremona et al. 
1995, Buschiazzo, Campetella and Frasch 1997, Buschiazzo et al. 2000, Buschiazzo et al. 2002, 
Montagna et al. 2002, (Amaya et al. 2004, (Montagna et al. 2006). Members of TconTS-like genes 
lack these critical amino acids and are considered inactive. A recent study (Gbem et al. 2013) 
pointed to the possibility of the lectin domain (LD), at the C-terminus of these enzymes playing 
hitherto an unknown contribution in activity. More is however required to make conclusive 
statements on the role the lectin domain plays in TS activity.
T. vivax was thought to harbour genes expressing only sialidase activity without the corresponding 
transfer activity (Engstler et al. 1995). Phylogenetic analysis on the WTSI shot-gun sequences 
using trans-sialidase genes revealed the presence of 6 trans-sialidase gene like sequences 
(Jackson, et al. 2013) with most conserving the critical amino acids required for trans-sialidase 
activities. Guegan et al. (2013) found at least 3 TS/SA genes, TvivTS1, TvivTS3 and TvivTS5 to be 
involved in the animal pathogenicity of T. vivax infections. It is possible that other trypanosomes 
express TS genes as well, but which are yet to be studied. Phylogenetic analysis of the 
Trypanosoma genus using TS genes (Jackson et al. 2013, Guegan et al. 2013, Gbem et al. 2013) 
showed shared orthologues between T. congolese and T. brucei. In addition, while these two 
African trypanosomes were more closely related, T. vivax clustered separately away, an indication 
of a more distant evolution exemplified by a different biology in the tsetse vector. 
1.3.2.2. Trans-sialidase structure
Much of what is known about TS structure and mode of action are from studies using TcTS. 
Structurally, TcTS is an oligomer formed by heterogeneous subunits varying from 120-240kDa. 
These subunits are composed of an amino terminal domain containing a putative catalytic site and 
a carboxy-terminal domain made up of variable numbers of tandem repeats. The primary structure 
of TcTS contains a catalytic domain of 380 amino acids on the N-terminal region. This portion 
shares 30% identity with some known bacterial sialidases with most of the amino acid residues in 
the active site conserved (Cremona et al. 1995, Chuenkova and Pereira 1995; Buschiazzo et al. 
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2000). The catalytic domain is linked by by a long ?-helical segment of 23 amino acid residues to 
the lectin-like domain, made up of 260 amino acid residues (Buschiazzo et al. 2000). The lectin 
domain in natural TcTS is immediately followed by a repetitive, highly antigenic 12 amino acid 
residue motif known as shed acute phase antigen, SAPA (Buscaglia et al. 1999). SAPA is known to 
increase the half-life of TS in the blood (Buscaglia et al. 1999) and has also been speculated to 
serve as a decoy by TS to evade the host immune system (Frasch 1994). (Campetella et al. 1994) 
showed a recombinant TcTS without SAPA showing enzymatic activity, demonstrating that it is not 
required for the transfer reaction. Structural motifs have been found in trans-sialidase, e.g, Asp 
boxes, FRIP region but these have no direct effect on activity except protein structure (Monti et al. 
2010).
T. rangeli a non-human pathogenic close relative of T. cruzi expresses a sialidase, TrSA that 
shares 70% amino acids identity with TcTS without SAPA and it is strictly a hydrolase (Buschiazzo 
et al. 2000). Crystallographic along with mutagenesis studies helped illustrate a protein structure 
with a globular core that folds into two distinct structural domains with amino acids involved in 
transfer reactions identified (Buschiazzo et al. 2000, Buschiazzo et al. Amaya et al. 2004, Paris et 
al. 2005). The N-terminal domain (residues 1-372) displays a canonical ‘?-propeller’ topology that 
harbours the active centre core, similar to viral and bacterial sialidases. The C-terminal domain 
typically shows the characteristic ?-barrel topology of plant lectins (Buschiazzo et al. 2000) and is 
referred to as the lectin-like domain. Using modelling studies, Tiralongo et al. (2003a) and (Koliwer-
Brandl et al. 2011) provided evidence that the TconTS folds in a similar way like the TcTS (see the 
modelled structure of TconTS in Chapter 2). 
It was determined that in TcTS, Tyr120 was essential in binding Sia from donor substrate. Other 
critical amino acids are the arginine triad of Arg35, 245 and 314. This triad is essential in binding 
the COOH-group of Sia. Glu230 is required for stabilising the tree arginine residues. Asp59 and 
Asp96 are involved in proton transfer during catalysis, resulting in the formation of the transient 
oxocarbenium ion. Tyr342 was found to maintain contact with the oxocarbenium ion at C2 of Sia 
(Buschiazzo et al. 2000, Watts et al. 2003). A proline residue, P283 has also been found to be 
necessary as it influences the position of Trp312 in the active cleft. A combination of energy 
analysis and molecular dynamics (Demir and Roitberg, 2009, Mictchell et al. 2013), computational 
modelling, surface plasmon resonance (SPR) and nuclear magnetic resonance (NMR) 
spectroscopy (Buschiazzo et a. 2002, Haselhorst et al. 2004, Todeschini et al. 2004, Blume et al. 
2007,) have been used to gain up to date insight in the catalytic mechanism of TS enzymes. The 
sequence of events that occur in trans-sialylation are presented in mechanistic basis of TS reaction 
(see Section 1.3.2.5).
1.3.2.3. Conserved amino acids in TS catalytic pocket of African Trypanosomes
Molecular approaches have led to defining primary amino acid sequences in both T. rangeli and 
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several pathogenic trypanosomes. Primary amino acid sequences have been used to identify 
orthologues between different trypanosomes (Coustou et al. 2012, Gbem et al. 2013, Guegan et al. 
2013, Jackson et al. 2013). However, the absence of data on both hydrolysis and transfer activities 
that could be used to make meaningful comparison among trypanosomes have made it difficult to 
derive detailed inferences. Gbem et al. (2013) reported on the biochemical activities of TconTS1, 
TconTS2 and TconTS3 enzymes. In combination with specific activities reported for TconTS1 
variants (Koliwer-Brandl et al. 2011), comparisons could be made for at least TconTS gene 
products. Comparison on the basis of amino acid conservations in the catalytic pocket did not give 
a clear indication of specific activities in between TconTS genes, as critical amino acids were 
mostly conserved, yet specific activities varied.
1.3.2.4. Mechanistic basis of trans-sialylation and hydrolysis
Knowledge of enzyme catalysis by TS has been gained mainly from studies on the TcTS. The 
double displacement reaction mechanism for retaining glycosidases has been proven to hold for 
trans-sialidases (Watts et al. 2003; Amaya et al. 2004), but with a fundamental difference. In most 
of the known retaining glycoside hydrolases, a negatively charged nucleophile directly attacks the 
anomeric carbon to generate the covalent intermediate, while a neighbouring residue; for example, 
tyrosine stabilises the negative charge in the free enzyme. However, as Sia acids bear carboxylate 
groups adjacent to the anomeric centre, it is most likely that unfavourable electrostatic attractions 
will arise if the invariant Glu230 located in the active cleft of TSs were to directly function as a 
nucleophile (Watts et al. 2003). Computational analysis revealed that a long-lived covalent 
intermediate is formed in in trans-sialidase reactions with the Tyr342/Glu230 couple been invoked 
to relay charge from the more distant or remote glutamate by tyrosine. This makes the phenolic 
oxygen of tyrosine transiently achieve appreciable negative ion character at the transition state and 
the repulsive effects are therefore avoided. It means there must be substrate binding to the 
enzyme holo form before any transfer reaction is possible.
Comparing crystallographic structures of TcTS and TrSA show the active cleft of the former to be 
narrower and and more hydrophobic as opposed to the latter. The exclusion of water from the 
trans-sialidase was suggested to possibly favour trans-sialylation reaction over hydrolysis 
(Buschiazzo et al. 2002). (Demir and Roitberg 2009) used molecular dynamics calculations and 
confirmed the presence of Trp312 in the catalytic pocket of TcTS, making the above assertion 
possible as flexibility in the apo form is ensured due to the loop motion of Trp312. Combining 
several techniques including X-ray crystallographic studies, atom substitution at certain positions of 
the Sia moiety, mass spectroscopy, kinetic isotope effects and enzyme kinetics, detailed 
sequences of events that occur in the trans-sialidase substrate catalysis have been elucidated. 
These events include the formation of enzyme-substrate complex (Michaelis complex), formation 
of a covalent glycosyl enzyme intermediate, sugar distortion, nucleophilic charge relay and 
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acid/base catalysis.
Buschiazzo et al. (2002), Haselhorst et al. (2004) and Blume et al. (2007) showed via surface 
plasmon resonance (SPR) and NMR spectroscopy that the Sia binding modulates the asialoglycon 
binding. In other words, the acceptor aglycon would not bind until Sia binds. By retarding bond 
cleavage events in the enzyme-substrate complex through the introduction of a fluorine atom at C3 
of the substrate, Amaya et al. (2004) showed the complete nature of enzyme-substrate formation in 
the trans-sialidase catalytic activity. Two different substrates, sialyl-lactose (TcTS-SL complex) and 
methylumbelliferyl neuraminic acid, MUNANA (TcTS-MUNANA complex) showed the aglycon 
moiety occupies the same binding pocket in the enzyme-substrate complexes and makes strong 
stacking interactions with Trp312 and Try119. This has been further confirmed by Mitchell et al. 
(2010) using molecular dynamics simulations, showing that Trp 312 plays a dual role in making the 
flexibility of the active cleft possible. The stacking interactions of Trp312 with Tyr119 helps orients 
the substrates for sialylation and once the Sia is delivered, Trp312 via its lever-like action akin to 
molecular shovel, releases the donor from the active site and loads up the acceptor. Therefore, the 
donor moiety occupies the same site as its acceptor lactose in the reaction ternary complex. This 
supports the double displacement reaction mechanism.
Conformational changes are necessary for trans-sialylation reaction (Smith and Eichinger 1997). 
These changes are caused by the Sia binding in the active pocket leading to distortion in the 
packing of TS. The carboxyl group of Sia makes a number of hydrogen bonding interactions with 
the Arg triad. The interaction of the N atom in the N-acetyl group with Asp96 causes its movement 
about 0.8Å from its original position in the native TS binding pocket, with slight movement 
physically locking the acetamide group in position. This plasticity is necessary for trans-sialalylation 
reaction and is distinctly absent in hydrolysis. However, this flexibility is much reduced once 
sialoside ligand is bound.
There is also the interaction with Arg53 and Asp96 by the O4 of Sia, which leads to a further 
stabilisation of the locked positions of Asp96 and acetamide group. There is a single hydrogen 
bond interaction with the glycerol side chain of Sia with the terminal hydroxyl of Tyr120, priming the 
catalytic nucleophilic attack on the anomeric carbon of Sia. Kinetic isotope effects studies (Yang, 
Schenkman and Horenstein., 2000), Pierdominici-Sottile, Horenstein and Roitberg., (2011) and 
later confirmed by (Watts et al. 2003 and Amaya et al. 2004) suggested the formation of the next 
stable species along the reaction coordinate being the glycosyl enzyme intermediate. A covalent 
bond of about 1.42Å is formed between the oxygen atom of Tyr342 side chain and the anomeric 
carbon of Sia.The intermediate stabilised by stronger interaction of the glycerol group in the sialyl-
trans sialidase reactants as well as the relaxation of the sugar ring conformation offering greater 
stabilisation of the intermediate relative to ground states (Amaya et al. 2004). This stabilisation 
increases the life of the glycosyl-enzyme intermediate long enough to allow trans-glycosylation 
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which requires more time than the usual hydrolysis reaction. 
It has been observed that the Sia ring in complex with TS adopts a distorted B2,5 conformation. 
This distortion arises from the slight displacement of O4 that forms a hydrogen bonding interaction 
with Asp96. This distortion however places the anomeric carbon in a suitable position for in-line 
attack by the nucleophile (Tyr342) with minimal hindrance from the 1.3 diaxial repulsion and 
satisfies the stereo-electronic requirements for an incipient oxocarbenium ion (Amaya et al. 2004). 
Formation of the covalent intermediate is accompanied by a change in the conformation of the 
sugar ring. The sugar ring now relaxes into an undistorted 2C5 chair conformation with a ? linkage 
to the enzymatic nucleophile.
Saturation transfer difference (STD)- NMR (Blume et al. 2007) using pNP-Neu5Ac has allowed 
comparisons of the rate of hydrolysis with that of transfer by TcTS. TcTS is capable of transferring 
Sia from non-natural donors e.g. p-nitrophenyl and 4-methylumbelliferyl ?-sialosides. The rate of 
transfer is however slower for the artificial substrates. Paris et al. (2001) and Haselhorst et al. 
(2004) showed that the rate of Sia transfer from MUNANA to lactose is only about 0.6 compared to 
that of hydrolysis while that of hydrolysis is about twice more than that of sialyl-lactose. TconTS 
enzymes however show poor or no hydrolysis on MMNANA (manuscript from S. Kelm's 
laboratory). While the molecular events surrounding the differences in the reactions of TcTS with 
MMNANA and sialyl-lactose on one hand and the difference between TconTS on the other are not 
clear, it buttresses the subtle difference that exist between TSs from the two Trypanosoma spp and 
warrants further studies.
Equally, if the elements and events in the catalytic pocket were the only determinants of trans-
sialylation and hydrolysis reactions, TconTS enzymes would have exhibited close to same 
magnitude of activity, if similar substrates were to be used. Studies with the four active TconTS 
enzymes (Tiralongo et al. 2003a, Koliwer-Brandl et al. 2011, Gbem et al. 2013) showed different 
specific activities for these enzymes. This points to other elements, possibly from the lectin domain 
being involved in catalysis (Gbem et al. 2013). It will be interesting to see how much is contributed 
towards activity by the other factors inherent in TS genes. Knowledge gained in this area will be 
significant in designing inhibitors for the various TS enzymes.
1.3.2.5. Substrates for Trans-sialidase
Substrate specificities have been extensively studied for the American T. cruzi TS (reviewed in 
Schauer and Kamerling 2011). This is because TS was first discovered in this organism and 
research on the ethiologic agent of Chagas' diseases is by far more advanced than what obtains 
for the Trypanosoma species causing nagana. Substrates specificities are discussed here only in 
terms of the African trypanosomes.
(Engstler, Reuter and Schauer 1993) showed a variety of sialo-glycoconjugates as excellent 
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donors for T. brucei procyclic stage-derived TS. Serum glycoconjugates, human and bovine 
erythrocytes all served as substrates from which Sia was transferred. Acceptors of the transferred 
Sia were terminal ?-galactose residues from oligosaccharides and glycoconjugates, all resulting in 
the formation of ?2-3 linkages in the new products. Neu5Ac(?2-3)Gal(?1-4)Glc, Neu5Ac(?2-
3)Gal(?1-4)Glc-ol as well as fetuin served as “good” donors when lactose was used as an 
acceptor. MU-Neu5Ac was equally reported as a good donor. MU-Neu5Ac has also been reported 
as a donor of Sia when T. congolense procyclic stage TS was used (Tiralongo et al. 2003a, 
Schrader et al. 2003). Equally for T. congolense, it was reported that both Neu5Ac(?2-3)Gal(?1-
4)Glc and Neu5Gc(?2-3)Gal(?1-4)Glc served as excellent donors with similar relative Sia transfer 
rates but bovine brain ganglioside, collocalia mucin and bovine submandibular gland were not 
utilised (Engstler et al. 1995). These substrates were followed by fetuin and MU-Neu5Ac and that 
T. congolense preferentially linked Sia to (?2-3)Gal?1- structures. Like T. brucei, T. congolense 
shows minimal utilisation of ?2-6 and ?2-8 structures (Engstler et al. 2003, Schrader et al. 2003, 
Tiralongo et al. 2003a) and in addition, Tiralongo et al. (2003a) found out that even though TconTS 
uses ?2-6 structures as donors, only products with ?2-3 linkages are formed. Sialylated milk 
products acted as donors for the T. congolense procyclic TS which generally was found to favour 
terminal Gal(?1-4)GalNAc over Gal(?1-3)GalNAc sequences (Tiralongo et al. 2003a).
Koliwer-Brandl et al. (2011) found very low transfer activities for two variants of TconTS1; 
TconTS1b (EMBL:HE583284) and TconTS1e-1 (EMBL:HE583287) when using MU-Neu5Ac and 
Neu5Ac-pNP, another synthetic donor. This is in direct contrast to the earlier reports (Engstler et al. 
1993, Tiralongo et al. 2003a, Schrader et al. 2003). This discrepancy possibly arises from the fact 
that previous assays all made use of proteins from polycyclic T. congolese forms and those 
purifications most likely contained additional TS forms as well as GARP. At least the purification by 
Tiralongo et al. (2003a) has been shown to contain GARP in addition to other TconTS forms 
(Koliwer-Brandl et al. 2011, Gbem et al. 2013).
1.3.2.6. Inhibitors of Trans-sialidase
Due to the scourge of the American and African trypanosomiasis, several targets within the 
parasites have been sought for in order to design inhibitors in a bid to cure infections and disrupt 
their transmission cycle (Neres, Bryce and Douglas 2008) set out a list of criteria that should be 
considered before any rational drug design strategy could be embarked upon. These include 
aspects of parasite biochemistry that makes a strong basis for scientific intervention, if the parasite 
posses within its arsenal other alternatives that it could possibly employ to thwart such a scientific 
attack, if such a selected target is specific to the parasite and not common to both parasite and 
host, positive effects, if parasite is knocked out using means such as antibodies, gene knockout, 
siRNAs, previously known drugs analogous with similar effects and if mode of inhibition would 
affect the parasite significantly. On a holistic basis, TS presents an attractive target and inhibitors of
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these enzymes have generally been considered and pursued over other approaches in the fight 
against trypanosomes. This is more important especially as approaches like gene knockouts 
appear problematic due to multiple gene members.
It has been observed that classical sialidase inhibitors like 2-deoxy-2,3-didehydro-N-
acetylneuraminic acid (Neu2en5Ac), also called DANA, 4-amino-2-deoxy-2,3-didehydro-N-
acetylneuraminic acid (4-amino-Neu2en5Ac), 4-guanidino-Neu2en5Ac and N-(4-nitrophenyl) 
oxamic acid are not effective on TcTS (Paris et al. 2005, Neres, 2006). 2,3-Difluorosialic acid 
(Watts et al. 2003) inhibited wild-type TcTS in a time dependent manner as confirmed from kinetics 
studies. However, the wild type TcTS rapidly recovered activity by transglycosylation upon removal 
of excess inhibitor and incubation with lactosides. A derivative of Neu5Ac, 2,3-difluoro-Neu5Ac 
incorporating an aromatic ring at C9 was used in a bid to confer specificity. 20 mM concentration 
was found to inhibit TcTS by forming covalent intermediates with the enzymes (Buchini, 
Buschiazzo and Withers 2008). Hydrophobic interactions between the phenyl ring of Tyr119 was 
found to prevents lactoside binding in the catalytic pocket by 3-fluorosialyl fluoride. Other 
compounds designed to mimic Sia but contained phopsphonate instead of carboxylate group while 
inhibiting classical sialidases in a competitive manner did not inhibit trans-sialidases from T. cruzi 
and T. brucei (Engstler et al. 1994). (Streicher and Busse 2006) experimented with 
cyclohexenephosphonate monoakyl esters and found them to be weakly inhibitive.
Sia donor and acceptor analogues have also been considered and efficacies tested. These have 
been extensively reviewed (Neres et al. 2008, Schauer and Kimerling, 2011). The principle 
underlining this approach is for such substrates to occupy the Sia binding site of the donor 
substrate or target the acceptor site. For example, modification of the ganglioside GM3, though a 
substrate for trans-sialidase at either C4 or C8 results in reasonable inhibition of TcTS with 
inhibition concentrations ranging between 10–100 ?M (Vandekerckhove et al. 1992). Several of 
such substrates have been reported, for e.g. by (Agusti et al. 2007). 
Lactitol, a lactose derivative was found to out compete lactose as a Sia acceptor, preventing 
lactose sialylation as well as the sialylation of N-acetyl-lactosamine and 4-metylumbelliferyl-?-D-
galactopyranoside (Agusti et al. 2004). It was found that lactitol prevented sialylation of T. cruzi 
mucins in mM concentrations and reduced infections of mammalian cells up to 27% but without 
inhibiting TcTS enzymatic activity of. Instead, it acted as a preferential Sia acceptor (Agusti et al. 
2004). 
From the foregoing, it is obvious that a potent inhibitor of TS is yet to be found. Recently, 
(Buschiazzo et al. 2012) reported on an effective mouse monoclonal antibody (mAb13G9) with 
high affinity and specificity for TcTS. The mAb was shown to prevent both immune system and 
haematological abnormalities caused by T. cruzi infections. In T. congolense, Coustou et al. (2012) 
vaccinated mice with the TconTS-Like 2 gene and reported protection when challenged with T. 
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congolense parasites, illustrating the promise of vaccination using TS.
1.3.2.7. Drug transport and resistance in Trypanosoma spp
Drug and cross-resistance have become a huge problem in both AAT and HAT treatment. In AAT, 
three major drugs have been in use for the past 50 yrs. These are diminazene aceturate (DA), 
homidium chloride, both having prophylaxis and therapeutic properties and isometamidium chloride 
(ISM) which shows only therapeutic properties. It was reported over 10 years ago that about 35 
million doses of these drugs are used within the 37 African countries where trypanosomiasis is 
endemic (Diarra et al. 1998). It is therefore not surprising that across Africa, drug resistance have 
been reported for both the AAT and HAT (Geerts et al. 2001). Veterinary resistances to these drugs 
have been reported in 17 African countries (Delespaux et al. 2008). Drug resistance is equally a 
problem in HAT (see reviews by (Alsford et al. 2012), (Baker et al. 2013), (Kennedy 2013). Cross-
resistance has arisen due to long-term usage due to non-availability of new drugs among other 
factors. In order to come out with answers to this problem, research focused on mode of actions 
and mechanisms involved in this phenomenon.
Mitochondrial membrane potential (Werbovetz 2006) and binding to nuclear and kinetoplastid DNA 
(Carter and Fairlamb 1993) both aid the accumulation of diamidines in trypanosomes, but it is the 
presence of specific transporters in the plasma membrane that leads to the accumulation of 
trypanocides in the parasites (de Koning and Jarvis 2001). The purine transporter 2, P2, 
responsible for transport of adenine and adenosine has been implicated in reduced melarsoprol (a 
drug for human treatment but regularly used for animal treatment) uptake and cross-resistance to 
both melamine based arsenicals and diamidines. Both are imported into the cell via the same 
transporter, P2. In T. brucei, P2 is encoded by TbTA1 (Maser et al. 1999) as TbTA1 gene deletion 
and loss of mutation have been described in drug resistant strains (Mäser et al. 1999, Stewart et 
al. 2010). These same mutations were found in field isolates of T. brucei species in which 
treatment with melarsoprol failed (Matovu et al. 2001, Nerima et al. 2007). Another proof of the 
involvement of the P2 transporter in the cross-resistance came from the finding that tbat1-null 
trypanosomes lost the adenine sensitive component of adenine and melarsoprol import (Geiser et 
al. 2005), (Matovu et al. 2003). There is overwhelming evidence to support that DA is exclusively 
taken up by P2/TbAT1 transporter. Deletion of this gene or loss in the activity of its gene product 
results in high levels of resistance (de Koning 2001).
It was found that 50% pentamidine flux (pentamine is meant for human treatment but farmers 
equally employ it for animal treatment) is mediated by the same P2 transporter (de Koning and 
Jarvis 2001). The realisation of this low sensitivity and net uptake made it clear that other 
transporters must be involved in the cross-resistance phenotype. This led to the identification of the 
high affinity pentamidine transporter, HAPT1 (Bridges et al. 2007). Melarsoprol was shown to be a 
substrate for HAPT1 and loss of HAPT1 activity in Tbat1 null cells led to increased resistance to 
pentamidine and melarsoprol (Bridges et al. 2007), (Teka et al. 2011)
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The ATP binding cassette (ABC) class of transporters have been implicated in resistance 
mechanisms (Baker et al. 2013). Changes that occur in the net accumulation of drugs, as as well 
as the energy-dependent expulsion or extrusion of drugs, prodrugs or active metabolites have 
been associated with the ABC transporters. Two of these transporters, the P-gylcoprotein and the 
multi-drug resistance associated proteins, MRPs have been shown to be involved in cases of drug 
resistance in Plasmodium and Leishmania (Klokouzas et al. 2003), protozoan relatives of 
trypanosomes. In T. brucei, the efflux of the trypanothione, Mel T was observed when MRP A was 
over expressed in that organism (Shahi et al. 2002). 
Of recent, RNAi experiments led to the identification of a new class of transporters involved in drug 
resistance (Baker et al. 2012). The T. brucei genome encodes three classes of aquaglyceroporins 
(AQPs), AQP 1-3. The aquaglyceroporin 2, AQP2 restricted to the flagellar pocket has been found 
to mediate melarsoprol-pentamidine cross-resistivity in trypanosomes. Mutations affecting AQP2 
have been linked to clinal resistance (Baker et al. 2013). However, the specific details underlining 
its involvement are yet to be understood. 
1.4. Aims 
The work presented here aimed to biochemically characterise trans-sialidase genes and their 
products from the African trypanosome, T. congolense. This is the most prevalent causative agent 
of nagana. A detailed understanding of gene variations, number of gene copies, substrates 
specificities and enzyme kinetics would fill the knowledge gaps and engender new approaches in 
the fight against the veterinary trypanosomosis. HAT and a-HT may equally benefit from these 
finding. Therefore, we aimed to clone, express, purify and employ different substrates to 
biochemically characterise TS gene products from this organism. In order to have a basis for 
comparison, we looked at enzyme activities on a single but relevant glycoprotein, fetuin, We then 
looked at enzymatic activities on blood glycoconjugates. We made use of data obtained from 
databases in order to compare TS genes from other trypanosomes to ascertain the occurrence of 
or lack or orthologues among these genes.
Trans-sialidase represents an attractive target in the new direction as it is critical in the life cycle of 
the organism, both in the insect vector as well as in the mammalian host. Moreover, TS enzymes 
are not expressed by the mammalian host. It was thought that TS in African trypanosomes was 
only expressed in the procyclic insect forms (Engstler et al. 1993, 1995) where it plays a major role 
in the establishment of infection (Nagamune et al. 2004). The possible biotechnological application 
of the enzyme was a major attraction for investigating the enzymes from African trypanosomes 
(Tiralongo et al. 2003a). New evidences have pointed to the presence of these enzymes in the 
blood stream from of the parasites (Gbem et al. 2013) and as virulent factors in trypanosomosis 
(Nok and Balogun, 2003, Coustou et al. 2012, Guegan et al. 2013). With this findings, the 
attractiveness of TS as a therapeutic target in African trypanosomes has been greatly enhanced.
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Abstract
Background: Animal African trypanosomiasis, sleeping sickness in humans and Nagana in cattle, is a resurgent
disease in Africa caused by Trypanosoma parasites. Trans-sialidases expressed by trypanosomes play an important
role in the infection cycle of insects and mammals. Whereas trans-sialidases of other trypanosomes like the
American T. cruzi are well investigated, relatively little research has been done on these enzymes of T. congolense.
Results: Based on a partial sequence and an open reading frame in the WTSI database, DNA sequences encoding
for eleven T. congolense trans-sialidase 1 variants with 96.3% overall amino acid identity were amplified. Trans-
sialidase 1 variants were expressed as recombinant proteins, isolated and assayed for trans-sialylation activity. The
purified proteins produced a2,3-sialyllactose from lactose by desialylating fetuin, clearly demonstrating their trans-
sialidase activity. Using an HPLC-based assay, substrate specificities and kinetic parameters of two variants were
characterized in detail indicating differences in substrate specificities for lactose, fetuin and synthetic substrates.
Both enzymes were able to sialylate asialofetuin to an extent, which was sufficient to reconstitute binding sites for
Siglec-4. A mass spectrometric analysis of the sialylation pattern of glycopeptides from fetuin revealed clear but
generally similar changes in the sialylation pattern of the N-glycans on fetuin catalyzed by the trans-sialidases
investigated.
Conclusions: The identification and characterization of a trans-sialidase gene family of the African parasite T.
congolense has opened new perspectives for investigating the biological role of these enzymes in Nagana and
sleeping sickness. Based on this study it will be interesting to address the expression pattern of these genes and
their activities in the different stages of the parasite in its infection cycle. Furthermore, these trans-sialidases have
the biotechnological potential to be used for enzymatic modification of sialylated glycoconjugates.
Background
Animal African trypanosomiasis, called sleeping sickness
in humans and Nagana in cattle, is a resurgent disease
in Africa. Nagana is caused by Trypanosoma congolense
(T. congolense), Trypanosoma vivax (T. vivax) and Try-
panosoma brucei (T. brucei) subspecies. Most research
on African trypanosomes has focused on T. brucei,
whereas only few studies have been done with other
African trypanosomes including T. congolense. In wild
animals, these parasites cause relatively mild infections
while in domestic animals they cause a severe, often
fatal disease. Because of Nagana, stock farming is very
difficult within the tsetse belt of Africa [1].
Although of crucial importance for their survival,
cyclical transmission and hence pathogenicity of trypa-
nosomes, trypanosomes lack the biochemical metabolic
machinery synthesizing sialic acids (Sia), but use a
unique enzyme, trans-sialidase (TS) to transfer Sia onto
the parasites surface molecules from the environment.
Structurally TS belong to the family of sialidases (SA).
In contrast to the usual sialyltransferases, TS does not
utilize CMP-activated Sia as monosaccharide donors,
but catalyzes the transfer of carbohydrate-linked Sia to
another glycan forming a new a2,3-glycosidic linkage to
galactose or N-acetylgalactosamine.
Whereas more detailed studies exist on the role of TS
in the pathogenicity of T. cruzi, the etiologic agent of
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Chagas diseases in South America, where TS was first
discovered [2], the current knowledge about the corre-
sponding enzymes in the African trypanosomes is very
limited. Of all the African trypanosomes, only T. brucei
full length TS genes have been cloned and studied [3].
Sialylation of parasite surfaces is believed to protect the
parasites from the action of glycolytic enzymes as well
as from immunocompetent substances present in the
tsetse gut and blood meal respectively, as well as influ-
encing the interaction of parasites with the gut epithelial
cells [4-6]. In the African trypanosomes where TS is
thought to be expressed only in the procyclic insect
stages [5,7], TS has been shown to increase the survival,
maturation and hence establishment of the parasites in
the vector midgut [8].
Two TS forms, named TS-form 1 and TS-form 2,
have been purified from procyclic T. congolense cultures
[6]. Interestingly, glutamic acid and alanine-rich protein
(GARP) was co-purified with TS-form 1, suggesting that
GARP may be a natural substrate for TS-form 1. Inter-
estingly, TS-form 1 had significantly less SA activity and
higher TS activity, whereas SA activity was predomi-
nately found in preparations of TS-form 2. An anti-T.
congolense TS antibody (mAb 7/23) was developed using
TS form 1 as antigen. This antibody is specific for T.
congolense TS recognizing TS-form 1 and TS-form 2,
but does not bind to T. brucei TS. Peptides micro
sequencing revealed the amino acid sequence
VVDPTVVAK in TS-form 1. Subsequently, fragments of
two TS genes (TS1 and TS2) were sequenced, sharing
about 50% sequence identity [9]. TS1 encoded this pep-
tide sequence, whereas in TS2 this sequence ended in
VVK. These data strongly suggested that the gene pro-
duct of TS1 has been present in TS-form 1. Neverthe-
less, it has remained unclear whether only TS1 and/or
TS2 gene products were present in TS-form 1 and TS-
form 2 preparations. Due to the fact that the monoclo-
nal antibody mAb 7/23 bound both TS preparations, it
is quite possible that TS-form 2 contained at least some
amounts of TS1 gene product, which might have been
responsible for the TS activity of this preparation.
Here, we report the cloning of eleven trans-sialidase
TS1 variants from T. congolense and their recombinant
expression in CHOLec1 cells. Furthermore, the enzymatic
properties of two of these recombinant TS1 variants
were compared with TS from T. cruzi.
Results
Diversity of TS1 genes and structural model
Based on the partial sequence of TS1 [GenBank:
AJ535487.1] [9], an open reading frame in the Welcome
Trust Sanger Institute (WTSI) database was identified.
The full-length translation product consists of 750
amino acids extending the partial sequence of TS1 by
153 amino acids at the N-terminus and by 84 amino
acids at the C-terminus. It contains a 16 amino acids N-
terminal signal peptide and a catalytic domain (residues
17-467), which is connected through a long a helix
(residues 468-491) to a lectin domain (residues 492-732)
followed by a potential C-terminal GPI-anchor attach-
ment site (residues 733-750, identified by big-PI predic-
tor [10]). Furthermore, nine potential N-glycosylation
sites were identified (Figure 1).
T. congolense TS1 shares about 57% sequence identity
with T. brucei TS [EMBL: AAG32055.1] and 48% with
T. cruzi TS [EMBL: BAA09334.1] (Figure 2). The T.
brucei TS has a prolonged N-terminus of approx. 90
amino acids, which is conserved in T. congolense TS1
sharing 50% amino acids, but is absent in T. cruzi TS.
The catalytic domain of both African proteins has 60%
and the lectin domain 43% sequence similarities. T. con-
golense TS1, like T. brucei TS and T. rangeli SA, has no
C-terminal SAPA domain typical for T. cruzi TS [11].
Almost all amino acid residues reported to be required
for TS activity are identical in TS1 with the exception of
A325 (corresponding to P231 in T. cruzi TS) [11], R127,
G344-Q346 and Y408 (corresponding to Y248 and
W312, respectively in T. cruzi TS) [12] (Figure 2).
To produce recombinant protein for enzyme charac-
terization, the DNA encoding amino acids 17-732 was
amplified using genomic T. congolense DNA as a tem-
plate and inserted into a mammalian expression vector
as described in Methods. 13 clones were picked from
two independent cloning experiments and sequenced.
Interestingly, not all the 13 clones had identical
sequences and eleven different sequences were obtained
(TS1a through TS1j), exhibiting an overall amino acid
identity of 96.3%. A more detailed search of the WTSI
database using these sequences as queries confirmed the
presence of these TS1 genes in the T. congolense gen-
ome database. As shown in Figure 3, changes are not
evenly distributed over the protein sequences. Eight
were found in the lectin domain and 17 in the catalytic
domain, some close to the predicted active site as
shown in Figure 4A.
For a better understanding of how these differences
may affect TS function, we calculated a model structure
(Figure 4) for TS1 e-1 by homology modeling based on
the crystal structure of T. cruzi TS [12], which was com-
plexed with the Sia derivative 3-fluoro-5-N-acetyl-9-ben-
zamido-2,9-dideoxy-neuraminic acid. The superimposed
structures of T. cruzi TS and the T. congolense TS1 e-1
model had a root mean square deviation (RMSD) of
0.685 Å over 594 aligned residues.
In Figure 4A, amino acids of the active site are high-
lighted. Most of the amino acids reported to be relevant
for TS activity are identical in all T. congolense TS1 var-
iants (white labels). However, differences to T. cruzi TS
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were identified at three positions (yellow labels in Figure
4A). (I) At position 325 all T. congolense TS1 variants
have an alanine, like in T. brucei TS, replacing a proline
occurring in T. cruzi TS (P231); (II) Y408 of all T. con-
golense TS1 variants corresponds to a tryptophan in T.
cruzi TS (W321) and T. brucei TS; (III) the group of
G342, G343 and Q344 replaces a tyrosine (Y248) in T.
cruzi TS. In addition, near the catalytic site at position
407 (red label) in T. congolense TS1 variants, a serine or
valine occurs instead of arginine (R311) in T. cruzi TS.
Interestingly, similar differences occur also in T. brucei
TS (Figure 2). Since these amino acids are close to the
active site, they could influence the acceptor binding
specificity. The arginine at position 144 (blue label) is
conserved in all TS, with the exception of T. congolense
TS1g, where it is a cysteine.
In Figure 4B the amino acid positions are highlighted,
which have different side chains in TS1a-TS1j (Figure
3). It should be noted that these are all on the same
side of the protein as the catalytic site. Striking is a clus-
ter of amino acid variations in the lectin domain (posi-
tion 599 to 602 and 643) suggesting that these changes
may influence substrate binding of larger substrate
molecules, such as glycoproteins.
Characterization of T. congolense TS1 enzyme activity
All eleven TS1 gene products (TS1a-TS1j) were
expressed as recombinant proteins and were recognized
by the anti- T. congolense TS antibody (mAb 7/23) [6]
(data not shown). For all TS1 variants similar robust TS
activity could be determined, except for TS1g. This var-
iant, which carries cysteine instead of arginine at posi-
tion 144, had only very low TS activity. However, in
contrast to the other variants, TS1g released free Sia
from fetuin at about 50% of the transfer to lactose. Two
of the T. congolense TS1 variants, TS1b and TS1 e-1,
were further characterized. They differ in eleven of the
total 25 positions with amino acid variations listed in
Figure 3, three in the catalytic domain and eight in the
lectin domain.
The donor substrates fetuin 3’SL or pNP-Neu5Ac and
the acceptor substrates lactose, galactose or Gal-MU
were employed to determine sialidase and trans-sialidase
activities. For this purpose, a new assay was established
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T P D G V L Y C L H E Q N I D E V Y S L H L V R L V D E L K S I K S T A L V W K A Q D E L
L L G N C L P G D K Y D P G C D G I P T A G L A G L L V G P L T E K T W P D A Y R C V N
A A T S G A V S T A E G V R L D V G G G G H V V W P V S E Q G Q D Q R Y Y F T N S E F T
L A V T V R F D E M P Q G E L P L L G F V N R E G K V K K I L K V S L S G V E W L L A Y G
N E Y N S T A A E P L D V N E S H Q V V L A L H D G I V S L H V D G G N T T A T V S V R
V A S P A E L L N I H H L F V G T P V D G G A K E H A N I T V S N V L V Y N R P L R G V
E L L G L F A N R G R I R V P G S D N G V L S G G C L S L C Y L L L L V H V L M F
1 10 20 30 40 50 60 70 80 90 100 110 120 130
140 150 160 170 180 190 200 210 220 230 240 250 260
270 280 290 300 310 320 330 340 350 360 370 380 390
400 410 420 430 440 450 460 470 480 490 500 510 520 530
540 550 560 570 580 590 600 610 620 630 640 650 660
670 680 690 700 710 720 730 740 750 760 770 780 790
800 810 820 830 840 850 860 870 880 890 900 910 920 930
940 950 960 970 980 990 1,000 1,010 1,020 1,030 1,040 1,050 1,060
1,070 1,080 1,090 1,100 1,110 1,120 1,130 1,140 1,150 1,160 1,170 1,180 1,190
1,200 1,210 1,220 1,230 1,240 1,250 1,260 1,270 1,280 1,290 1,300 1,310 1,320 1,330
1,340 1,350 1,360 1,370 1,380 1,390 1,400 1,410 1,420 1,430 1,440 1,450 1,460
1,470 1,480 1,490 1,500 1,510 1,520 1,530 1,540 1,550 1,560 1,570 1,580 1,590
1,600 1,610 1,620 1,630 1,640 1,650 1,660 1,670 1,680 1,690 1,700 1,710 1,720
1,730 1,740 1,750 1,760 1,770 1,780 1,790 1,800 1,810 1,820 1,830 1,840 1,850 1,860
1,870 1,880 1,890 1,900 1,910 1,920 1,930 1,940 1,950 1,960 1,970 1,980 1,990
2,000 2,010 2,020 2,030 2,040 2,050 2,060 2,070 2,080 2,090 2,100 2,110 2,120
2,130 2,140 2,150 2,160 2,170 2,180 2,190 2,200 2,210 2,220 2,230 2,240 2,250
Figure 1 Primary sequence of TS1a. The full length coding domain sequence [EMBL: HE583283] with corresponding amino acid translations is
shown. The recombinant protein was generated without the N-terminal signal peptide and without the C-terminal region predicted to be
replaced by a GPI anchor in the native protein (framed boxes). Predicted N-glycosylation sites are highlighted by light grey boxes.
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                             1       10        20        30        40        50
                          60        70        80        90        100       110
                          120       130       140       150       160       170
T. congolense TS1e   --------MWPVNCYALLALVVAGQCCDHMHATAAVGTTHQALLWGSKWALRNKTTPKDG
       T. cruzi TS   ------------------------------------------------------------
      T. brucei TS   -MEELHQQMHMPISRLLLIFTAVCHCCALTSKAAGKGTTREAFLSGGSWALRKKLSEKDG
     T. rangeli SA   ------------------------------------------------------------
T. congolense TS1e   EVWWSNPQPGWKEVYDDEWEEWFMEQEGPTGVNGVRGEWYRRMTDGYILVGGPKLNSPDM
       T. cruzi TS   ---------------------------ASLAPGSSRVELFKRQSSKVPFEK---------
      T. brucei TS   EVWWWQDGPNWKDKYDKEWERWFKEEKGPWGGSEKRSEWFARMTGGYITLGKTKILSSAI
     T. rangeli SA   ----------------------------MLAPGSSRVELFKRQSSKVPFEK---------
T. congolense TS1e   NSTGTTMRTVHSYRIPSIVEVGGVLMCVGDARYITSTDYFFTDTVAAYSTDGGRTWKREV
       T. cruzi TS   -DGKVTERVVHSFRLPALVNVDGVMVAIADARYETSFDNSLIDTVAKYSVDDGETWETQI
      T. brucei TS   EGSDKVERTVHSFRIPSFVEVDGVLMGIGDARYLTSTDYFFTDTVAKYSADGGKTWKTEA
     T. rangeli SA   -DGKVTERVVHSFRLPALVNVDGVMVAIADARYETSNDNSLIDTVAKYSVDDGETWETQI
T. congolense TS1e   IIPNGRVDAHYSRVVDPTVVAKGNNIYVLVGRYNVTRGYWHNKNNRAGVADWEPFVYKGT
       T. cruzi TS   AIKNSRA-SSVSRVVDPTVIVKGNKLYVLVGSYNSSRSYWT---SHGDARDWDILLAVGE
      T. brucei TS   IIENGRVDPTYSRVVDPTVVAKADSVFVLVARYNVTKGYWHNENNAAGIADWEPFVYKGV
     T. rangeli SA   AIKNSRA-SSVSRVVDPTVIVKGNKLYVLVGSYNSSRSYWT---SHGDARDWDILLAVGE
T. congolense TS1e   VNVGTKDNATDVSISW-ERTALKSLYNFPVSGSPGTQFLGGAGGGVVTSNGTIVLPVQAR
       T. cruzi TS   VTKSTAGGKITASIKWGSPVSLKEFFPAEMEGMHTNQFLGGAGVAIVASNGNLVYPVQVT
      T. brucei TS   VTKGADGKTSDVRISW-TKTPLKPLYDFTVAGSKGTQFIGGAGNGVVTLNGTILFPVQAR
     T. rangeli SA   VTKSTAGGKITASIKWGSPVSLKEFFPAEMEGMHTNQFLGGAGVAIVASNGNLVYPVQVT
T. congolense TS1e   NKANRVVSMILYSADDGKSWHFGKGEAGVGTSEAALTEWDGKLLISARSDGG-----QGY
       T. cruzi TS   NKKKQVFSKIFYSEDEGKTWKFGKGRSAFGCSEPVALEWEGKLIINTRVD-------YRR
      T. brucei TS   NEDNAVVSMVMYSVDDGVSWHFARGETALLTSEASLTEWNGKLLMSARTDTSGVNVEGGF
     T. rangeli SA   NKKKQVFSKIFYSEDEGKTWKFGKGRSAFGCSEPVALEWEGKLIINTRVD-------YRR
T. congolense TS1e   RMIFESSDLGATWKEMLNSISRVIGNSPGRSGP-------GSSSGFITVTVEGVPVMLLT
       T. cruzi TS   RLVYESSDMGNTWLEAVGTLSRVWGPSPKSNQP-------GSQSSFTAVTIEGMRVMLFT
      T. brucei TS   RKVLESSNLGATWEESLGTISRVIGNSPDRTKPSPTANYPGSSGALITVTLGDVPVMLIT
     T. rangeli SA   RLVYESSDMGNSWLEAVGTLSRVWG-------PSPKSNQPGSQSSFTAVTIEGMRVMLFT
T. congolense TS1e   HPKNFKGSYYRDRLQMWMTDGNRMWHVGQVSEGDDNSAYSSLLYTPDGVLYCLHEQNIDE
       T. cruzi TS   HPLNFKGRWLRDRLNLWLTDNQRIYNVGQVSIGDENSAYSSVLYK-DDKLYCLHEINSNE
      T. brucei TS   HPKNTKGAWSRDRLQLWMTDGNRMWLVGQISEGDDNSAYSSLLLARDGLLYCLHEQNIDE
     T. rangeli SA   HPLNFKGRWLRDRLNLWLTDNQRIYNVGQVSIGDENSAYSSVLYK-DDKLYCLHEINSNE
T. congolense TS1e   VYSLHLVRLVDELKSIKSTALVWKAQDELLLGNCLPGD----KYDPGC-DGIPTAGLAGL
       T. cruzi TS   VYSLVFARLVGELRIIKSVLQSWKNWDSHLSSICTPADPAASSSERGCGPAVTTVGLVGF
      T. brucei TS   VYSLHLVHLVDELEKVNATVRKWKAQDALLAGLCSSSR---KKNDPTCS-GVPTDGLVGL
     T. rangeli SA   VYSLVFARLVGELRIIKSVLQSWKNWDSHLSSICTPADPAASSSERGCGPAVTTVGLVGF
T. congolense TS1e   LVGPLTEKTWPDAYRCVNAATSGAVSTAEGVRLDVGGGGHVVWPVSEQGQDQRYYFTNSE
       T. cruzi TS   LSHSATKTEWEDAYRCVNASTANAERVPNGLKF-AGVGGGALWPVSQQGQNQRYHFANHA
      T. brucei TS   LAGPVGASVWADVYDCVNASISDGVKVSEGVQLGGKRNSPLLWPVSEQGQDQRYYFANTH
     T. rangeli SA   LSHSATKTEWEDAYRCVNASTANAERVPNGLKFA-GVGGGALWPVSQQGQNQRYRFANHA
T. congolense TS1e   FTLAVTVRFDEMPHGELPLLGFVNRKDQVKKILKVSLSG-VEWLLAYGNEYNSTAAEPLN
       T. cruzi TS   FTLVASVTIHEVPKGASPLLGASLDSSGGKKLLGLSYDKRHQWQPIYGSTPVTPT-GSWE
      T. brucei TS   FTLLATVRFAGEPKAEAPLMGFSNAEGKTSETLSLTVGGK-KWVLTYGSVRKEGPTTSMD
     T. rangeli SA   FTVVASVTIHEVPSVASPLLGASLDSSGGKKLLGLSYDERHQWQPIYGSTPVTPTGSWE-
T. congolense TS1e   VNESHQVVLTLHDGIVSLHVDGGNMTATVSVRVASPAELLNIHHLFVGTPVDGGAKEHAN
       T. cruzi TS   MGKRYHVVLTMANKIGSVYIDGEPLEGSGQ-TVVPDERTPDISHFYVGGYKRSGMPTDSR
      T. brucei TS   WNQTHQIALTLRDGKVDAHANGELIIKEVSVGASESSAHLHLSHFFIGAPVNDSGEGGNN
     T. rangeli SA   MGKRYHVVLTMANKIGSEYIDGEPLEGSGQ-TVVPDERTPDISHFYVGGYKRSDMPTISH
T. congolense TS1e   ITVSNVLVYNRPLRGVELLGLFANRGRIRVPGSDNSVLSGGCLSLCYLLLLVHVLMF-
       T. cruzi TS   VTVNNVLLYNRQLNAEEIRTLFLSQDLIGTEAHMD-----------------------
      T. brucei TS   VIVRNVLLYNRKLDEDELQVLYSNREKIQPVVSAVGIPEGMSAPRLCCLLILMYVLAI
     T. rangeli SA   VTVNNVLLYNRQLNAEEIRTLFLSQDLIGTEAHMDSSSDTSA----------------
                          180       190       200       210       220       230
                          240       250       260       270       280       290
  400       410       420       430        440      450
  460       470       480       490           500        510
  520       530       540       550       560       570
  580       590       600       610        620       630
  640       650       660       670       680       690
  700       710       720       730       740       750 
                          300       310       320       330       340
350       360       370              380       390
Figure 2 Primary sequence alignment of trypanosomal trans-sialidases. The amino acid sequence of T. congolense [EMBL: HE583287] TS1 e-
1 was aligned with T. cruzi TS [EMBL: BAA09334.1, PDB: 3B69], T. brucei TS [EMBL: AAG32055.1] and T. rangeli SA [EMBL: AAC95493.1] based on a
structural alignment of T. congolense TS1 e-1 with T. cruzi TS generated with Yasara during homology modeling. Amino acids, which have been
proposed to be relevant for enzymatic activity are marked with black frames if conserved or with black frames and light grey background if not
conserved. Positions with variations occurring in T. congolense TS1 or T. brucei TS [3] are highlighted by dark grey boxes.
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as described under Methods, using HPAEC-PAD to
quantify sialylated oligosaccharide products with the
detection limit of 20 pmol 3’SL corresponding to 0.5
μM in the reaction mixture. In standard assays, 50 μL
TS reactions were set up with 50 ng TS1b or TS1 e-1,
100 μg fetuin (approx. 600 μM bound Sia) as donor sub-
strate and 100 nmol acceptor substrate (2 mM e. g. lac-
tose or galactose). Under these conditions, linear
product formation was obtained for up to 2500 pmol
corresponding to 50 μM 3’SL (Figure 5).
If lactose is used as a donor substrate under standard
conditions, 3’SL concentration increases linearly for
about 30 minutes before the reaction velocity started to
decrease (Figure 5A). It should be noted that lactose
was sialylated almost twice as fast by TS1b than by TS1
e-1. In contrast to lactose, galactose was sialylated at the
same rate by both enzymes, but at about 20-fold lower
velocity than lactose.
Different specific activities were obtained for T. congo-
lense TS1b, TS1 e-1 and T. cruzi TS (Figure 6). The
reaction velocity was linearly dependent on the amount
of TS as long as the concentration of the product 3’SL
was below 50 μM. Under standard conditions 50 μM
3’SL was produced in 30 minutes with 50 ng TS. If 200
ng TS or more were used, product formation was inde-
pendent of the amount of TS, probably due to the
increased use of 3’SL as a donor substrate in the reverse
reaction, finally leading to an equilibrium between lac-
tose, 3’SL, sialylated and desialylated glycans on fetuin.
This equilibrium apparently was reached in 30 minutes
with 500 ng TS (266 ± 4 μM 3’SL for T. cruzi TS, 194
± 6 μM 3’SL for TS1b and 165 ± 7 μM 3’SL for TS1 e-
1). After 20 h incubation, 50 ng TS was sufficient to
reach the equilibrium. Independent of the amount of
enzyme used, for all three TS applied similar final con-
centrations of 3’SL were obtained after 20 h incubation
(Table 1).
The HPAEC-PAD method used allowed not only
determining the TS, but also SA activity, since free Sia
and 3’ SL could be quantified from the same chromato-
gram. In standard reactions (50 ng TS, 30 min incuba-
tion time) no SA activity could be detected, both in the
presence or absence of lactose as an acceptor substrate.
This suggests that these TS1 variants usually need an
acceptor substrate like lactose to cleave Sia from a
donor substrate. However, after 20 h incubation, free Sia
was detected. The quantity of Sia released was depen-
dent on the amount of TS used (Table 1). Besides stan-
dard TS reactions with fetuin as donor and lactose as
acceptor substrate, TS reactions with 2 mM 3’SL as
donor and 2 mg/mL ASF as acceptor substrate were
performed. In these reactions, free Sia was detected after
short reaction times and after incubation for 24 h, 0.5-1
mM free Sia were produced (data not shown).
position TS1a TS1b TS1c TS1d TS1e TS1e' TS1f TS1g TS1h TS1i TS1j
79 E K E E E E E E E E E
89 G T G G G G G G A G G
96 K K T T T T K K K K T
144 R R R R R R R C R R R
170 R R R S R R S R R R R
215 K K R Q K K Q K K Q Q
217 N N D D N N D N N D D
218 R R K E R R E R R E E
220 G G A G G G A G G G G
221 V V I V V V I V V V V
293 K K K K K K K K K K N
338 A A A A A A T A A A A
375 G G K G G G P K K K S
377 S S N S S S S N N N S
404 L L L L F L L L L L L
407 S S S V S S S S S S S
409 Y Y Y S Y Y Y Y Y Y Y
588 Q Q Q Q H H H Q R R R
599 R R R R R R R H H R R
600 E E E E K K K K K K K
601 G G G G D D D G G G G
602 K K K K Q Q Q K K K K
633 D D D D N N N N L D D
643 A A A A T T T T A A A
658 T T T T M M M T T M T
Catalytic domain
Lectin domain
Figure 3 Amino acid variations found in T. congolense TS1a-
TS1j. TS1a [EMBL: HE583283], TS1b [EMBL: HE583284], TS1c [EMBL:
HE583285], TS1d [EMBL: HE583286], TS1 e-1 [EMBL: HE583287] , TS1
e-2 [EMBL: HE583288], TS1f [EMBL: HE583289], TS1g [EMBL:
HE583290], TS1h [EMBL: HE583291], TS1i [EMBL: HE583292], TS1j
[EMBL: HE583293]. Differences in amino acids are highlighted (light
grey: conservative; dark grey: modest; black: drastic change).
Figure 4 Homology model of T. congolense TS1. The crystal
structure of T. cruzi TS [12] in complex with 3-fluoro-5-N-acetyl-9-
benzamido-2,9-dideoxy-neuraminic acid was used as template to
calculate a model structure for T. congolense TS1 e-1. Only the
Neu5Ac part (orange) of the ligand in the binding site of the
complex is illustrated. (A) Conserved amino acids of the active site
are labeled in white. Amino acids at positions reported to be
important for ligand binding in T. cruzi TS [12], which are not
conserved in T. congolense are labeled in yellow. The red labeled
position 407 is a serine or valine in T. congolense TS1 forms. R144,
which is exchanged to a cysteine in TS1g, is labeled in blue. (B)
Green clouds mark positions at which different amino acids occur in
other T. congolense TS1 forms.
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For kinetic experiments, assays were incubated for 30
minutes using 50 ng TS, since under these conditions
3’SL production was linear for all three TS. To deter-
mine the kinetic parameters for the acceptor substrates
lactose (Figure 7A) or Gal-MU (Figure 7C), 100 μg
fetuin (600 μM bound Sia) was used as donor substrate.
The lowest KM for lactose was found for T. cruzi TS
with 327 μM compared to 1683 μM for TS1b and 727
μM for TS1 e-1 (Table 2). Furthermore, T. cruzi TS was
able to produce twice more 3’SL than TS1b and fourfold
more than TS1 e-1 under these conditions.
To determine the kinetic parameters for the donor
substrate fetuin (Figure 7B), 2 mM lactose was used as
acceptor substrate. Both T. congolense TS1 had similar
vmax-values, whereas the vmax for T. cruzi TS was about
fivefold higher. Different to the KM of lactose, the lowest
KM for fetuin was exhibited by TS1b with 359 μM,
which is about fivefold lower compared to TS1 e-1 with
1617 μM and about 12-fold lower compared to T. cruzi
TS with 4124 μM.
Kinetic studies with TS were also performed for the
acceptor substrate Gal-MU (Table 2) and the donor
substrate pNP-Neu5Ac. Almost similar KM and vmax-
values were found for both T. congolense TS1. The sub-
strate pNP-Neu5Ac was only weakly used as a donor
substrate by all three TS species. Therefore, no reliable
kinetic parameters could be determined.
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Figure 5 Time dependence of TS reactions. Reactions of 100 μg fetuin with 100 nmol lactose (A) or 100 nmol galactose (B) were started with
50 ng TS in 50 μL and incubated at 37°C. The amount of 3’SL produced was determined by HPAEC-PAD as described under Methods. Data
points are means ± standard deviations of three replicates.
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Figure 6 Concentration dependence of TS reactions. Reactions
of 100 μg fetuin with 100 nmol lactose were started with varying
amounts of TS in overall 50 μL 10 mM phosphate buffer, pH 7.4
and incubated at 37°C for 30 min. The amount of 3’SL produced
was determined by HPAEC-PAD as described under Methods. Data
points are means ± standard deviations of three determinations.
Table 1 Free Sia and 3’SL production at equilibrium of
the reaction
Neu5Ac [pmol] 3’SL [pmol]
0 ng TS 262 ± 46 0
50 ng T. cruzi TS 580 ± 8 12597 ± 115
250 ng T. cruzi TS 1820 ± 13 11199 ± 288
50 ng TS1b 415 ± 7 15378 ± 117
250 ng TS1b 1095 ± 129 14435 ± 2226
50 ng TS1 e-1 348 ± 83 12719 ± 3057
250 ng TS1 e-1 1186 ± 9 13655 ± 491
only fetuin 116 ± 8 0
Neu5Ac and 3’SL produced by TS after 20 h incubation under standard
conditions were determined as described under Material and Methods. Data
points are means ± standard deviations of three replicates.
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Sialylation pattern of glycopeptides
Structural differences between TS1 variants may influ-
ence the enzymes preference for glycans on glycopro-
teins, such as fetuin. This could possibly result in
different sialylation patterns on glycoproteins after incu-
bation with TS. Fetuin contains 3 N-glycosylation sites
and 3 O-glycans, which all can serve as Sia donors in
TS reactions [13]. To investigate the specificity of TS
towards different N-glycans on fetuin, we used MALDI-
TOF-MS to determine the sialylation pattern of glyco-
peptides (GPs) from trypsin-digested fetuin after incuba-
tion with TS and lactose (Figure 8).
The sialylation patterns of three glycopeptides, GP
127-141 (dibranched or tribranched), and GP 54-85
(tribranched) were determined. All 14 potential sialyla-
tion variants of these glycopeptides could be identified
unambiguously and quantified from the MALDI-TOF-
MS spectra. In untreated fetuin most branches on the
three N-glycans investigated were sialylated, whereas
upon treatment with TS and lactose after 30 minutes a
clear shift towards incompletely sialylated glycans was
observed. After 24 h TS incubation the relative
amounts of unsialylated glycans was further increased
and monosialylated glycans represented the most pro-
minent species on both, di- and tribranched glycans
(Figure 9).
Sialylation of glycoproteins
As described above, T. congolense TS1b and TS1 e-1
readily used fetuin as donor substrate for the production
of 3’SL. However, long-term TS reactions or experi-
ments with higher amounts of TS had suggested that
the reverse reaction also takes place. Therefore, we
investigated whether T. congolense TS1b and TS1 e-1
can restore sialylated glycans on Vibrio cholerae siali-
dase-treated fetuin (ASF) as model glycoprotein. Resialy-
lation experiments were performed with 100 μg ASF as
acceptor and 100 nmol 3’SL as donor substrate as well
as 50 ng TS1 in 50 μL to start the TS reaction and were
incubated up to 24 h. This resialylation partially
reversed the shift in electrophoretic mobility in SDS-
PAGE observed for sialidase-treated fetuin (Figure 10).
Also by MALDI-MS of glycopeptides, the sialylation of
unsialylated glycans was confirmed (data not shown).
Furthermore, we addressed the question of whether
through this reaction recognition sites for siglecs can be
restored. For this purpose, TS-treated ASF was immobi-
lized to a microtitre plate and used as target for Siglec-
4, which preferentially binds a2,3-linked Sia. Under
these conditions robust Siglec-4 binding was observed
of ASF that had been treated with TS for 4 h. A pro-
longed (up to 24 h) TS reaction only led to little further
increase reaching 40% of binding levels observed with
native fetuin (Figure 11).
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Figure 7 Michaelis-Menten kinetics of TS reactions. All reactions
were started with 50 ng TS in a final volume of 50 μL and
incubated for 30 min at 37°C. (A) 600 μM fetuin-bound Sia was
used as donor substrate with varying concentrations of lactose as
acceptor substrate. (B) Varying concentrations of fetuin-bound Sia
were used as donor substrate with 2 mM lactose as acceptor
substrate. (C) Varying amounts Gal-MU were used as acceptor
substrate and 50 nmol 3’SL as donor substrate. The amount of 3’SL
(in the case of (A) and (B)) or 3’Sia-Gal-MU (in the case of (C))
produced was determined by HPAEC-PAD as described under
Methods. Data points are means ± standard deviations of three
replicates.
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Discussion
In 2003 Tiralongo et al. published a partial sequence for
T. congolense TS1 [9]. Our approach to obtain the full
length sequence of TS1 led to the discovery of 11 var-
iants of this gene with an overall sequence identity of
96.3% in the genome of this parasite. The previously
published partial TS1 sequence, which had been
assembled from 47 independent PCR reactions, turned
out to represent a mixture of fragments from the 11
TS1 forms identified in this study. Therefore, it is likely
that that sequence doesn’t exist in nature.
Similar TS-like gene families occur also in other trypa-
nosomes. In T. brucei the situation appears to be less
complex, since only 8 TS closely related genes have
been identified [3] and these differences lead to 6 amino
acid mutations. The largest TS gene family has been
found in T. cruzi. Its 140 members fall into three differ-
ent groups [14]. Blood stream trypomastigotes express
two of these groups, one with TS activity and the other
only with lectin activity. A third group has TS activity
and is expressed by epimastigotes. At present it is
unknown whether the expression of the different TS
genes in African trypanosomes is also stage-dependent.
T. congolense TS1 shares about 57% identical amino
acids with T. brucei TS and 48% sequence identity with
T. cruzi TS. By comparison, the American T. rangeli SA
and T. cruzi TS are more closely related with approxi-
mately 70% sequence identity [15].
The homology model for T. congolense TS1 based on
crystal structures from T.cruzi TS and T. rangeli SA
provided (I) insight in differences in the active site and
its surrounding between TS from these parasites and
(II) revealed the spatial distribution of the amino acid
differences between the TS1 variants.
Compared to T. cruzi TS only three amino acids are
changed in TS1 (A325, S407 and Y408). At position 325
a proline at the corresponding position of T. cruzi TS
appears to be relevant for full TS activity [11]. However,
in both, T. brucei TS and in T. congolense TS1, position
325 is an alanine. Tiralongo et al., (2003) postulated
A325 might be common to African trypanosomes and
does not seem to have an effect on enzymatic activity
[9]. Our data have demonstrated that an alanine at this
position is well compatible with TS activity, since all
active TS1 variants have A325. The exchanges at 407
and 408 may be relevant for the different substrate
Table 2 Kinetic parameters of T. cruzi TS, T. congolense TS1b and TS1 e-1
Acceptor substrates Donor substrates
Lactose Gal-MU Fetuin-bound Siax
vmax
(μmol/(min × mg TS))
KM
(μM)
vmax
(μmol/(min × mg TS))
KM
(μM)
vmax
(μmol/(min × mg TS))
KM
(μM)
TS1b 4.3 ± 0.1 1683 ± 101 0.77 ± 0.03 57 ± 14 7.9 ± 0.3 359 ± 45
TS1 e-1 2.1 ± 0.1 727 ± 48 0.72 ± 0.03 74 ± 17 7.6 ± 0.5 1617 ± 223
T. cruzi TS 8.4 ± 0.3 327 ± 31 n.d. n.d. 37.9 ± 6.0 4124 ± 985
KM and vmax were calculated from Michaelis-Menten kinetics (Figure 7) by SigmaPlot. Data points are means ± standard deviations of three replicates. ×
Approximately 30 nmol Sia per 100 μg fetuin. Abbr.: n.d.: not determined.
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Figure 8 MALDI-TOF-MS of glycopeptide 127-141 sialylation variants. 100 μg fetuin were treated with trypsin and analyzed by MALDI-TOF-
MS as described under Methods. The symbols code for the monosaccharide units is according to the nomenclature of the Consortium for
Functional Glycomics (http://www.functionalglycomics.org): GlcNAc (blue squares), Man (green circles, Gal (yellow circles), Neu5Ac (purple
diamonds).
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specificities of TS species, since this area possibly parti-
cipates in the interaction with the underlying galactose.
With the full length coding sequence of TS1 available,
the enzymes were expressed and characterized as
recombinant proteins to address the question of
whether TS1 accounts for the TS activity in the two
preparations (TS-form 1 and TS-form 2) from procyclic
parasite cultures [6]. The amino acid sequences of the
eleven TS1 variants described here contain the peptide
VVDPTVVAK present in TS-form 1. Furthermore, all
recombinant TS1 variants reacted with the anti-T. con-
golense TS antibody (mAb 7/23) [6]. Based on this
information, it is now clear that TS1 was present in
both, TS-form1 and TS-form 2. However, two
observations made with recombinant TS1 suggest that
the native enzyme preparations of TS-form 1 and even
more for TS-form 2 contained additional TS1-like pro-
teins. (I) The reaction velocities with the synthetic sub-
strates pNP-Neu5Ac (as donor) and Gal-MU (as
acceptor) were much lower than with fetuin and lactose
for all three TS. Tiralongo et al., 2003 [6] determined a
KM of 500 μM for Gal-MU, which is approximately 10-
fold higher than for TS1b (57 μM) and TS1 e-1 (74
μM). These differences could be due to the presence of
other TS1-like enzymes in the preparations of TS-form
1 and TS-form 2. (II) Using the substrate Neu5Ac-MU
no SA or TS activity could be detected for the T. congo-
lense TS1 variants investigated here, whereas cleavage of
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Figure 9 Relative changes of the sialylation pattern of fetuin N-glycans. Shown are the sialylation patterns of the glycopeptides GP 127-141
with dibranched (GP 127-141 di) or tribranched (GP 127-141 tri) glycans and of the glycopeptide GP 54-85 with tribranched glycans (GP 54-85
tri) relative to the non-sialylated GP 1 -32. 100 μg fetuin was incubated with 50 ng TS1b, TS1 e-1 or T. cruzi TS and 100 nmol lactose for the
times indicated, trypsinized and glycopeptides analyzed by MALDI-MS as described under Methods. Data points are averages ± standard
deviations of three to ten replicates.
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this substrate indicated SA activity in preparations of
TS-form 1 and TS-form 2 [6], as well as TS activity in
procyclic parasites [16]. Also this apparent discrepancy
can easily be explained by the presence of other TS1-
like enzymes accepting Neu5Ac-MU as TS or SA
substrate.
Ten of the eleven recombinant TS1 variants revealed
TS activity, which is in agreement with the TS-form 1
purified by Tiralongo et al. [6]. Only TS1g, which carries
a cysteine at position 144 instead of an arginine, showed
very low TS but clear SA activity. This suggests that
R144 is important but not essential for the transfer reac-
tion and hinders SA activity in T. congolense TS1. In a
previous study on T. rangeli SA [17] R144 has been pos-
tulated to form a hydrogen bond to the O4 of Sia. How-
ever, it remains unclear how this could relate to TS
activity. Furthermore, the homology model of TS1 does
not provide evidence for such a hydrogen bond for the
binding site of T. congolense TS1.
The TS1 homology model (Figure 4B) displays also
the position of amino acid exchanges in the eleven
TS1 forms identified. It could be speculated that
these positions are relevant determinants of antigenic
sites and that these variations help to escape recogni-
tion by the immune system. However, if TS1 is
expressed in the procyclic form in the insect vector,
this is unlikely to be relevant. Interestingly, these
exchanges are located on the same side of the protein
where substrate binding occurs, which opens the pos-
sibility that these changes influence the binding speci-
ficities. The cluster of changes from position 599 to
602 and 643 could be involved in recognition of lar-
ger substrate molecules, such as glycoproteins. Posi-
tions, 407 and 408 (Figure 4B), as well as positions
375, 377 and 404 (Figure 4A) are closer to the active
site in the catalytic domain, possibly contributing to
interactions with substrates. It should be noted that
the six amino acid differences occurring in T. brucei
TS are not found in clusters like in T. congolense
TS1, and furthermore, they are not even on the same
side of the protein.
For a more detailed characterization of their differ-
ences in activity, we choose two TS1 variants, TS1b and
TS1 e-1. The two amino acid sequences of TS1b and
TS1 e-1 differ mainly in the lectin domain (Figure 4),
whereby the exchange from E600 in TS1b to K600 in
TS1 e-1 represents the most drastic change.
The observation that lactose is a much better acceptor
substrate than Gal is in agreement with previously
reported relative transfer activity data for the prepara-
tions TS-form 1 and TS-form 2 [9]. Interestingly, with
fetuin as donor substrate T. cruzi TS, T. congolense
TS1b and TS1 e-1 produced different amounts of 3’SL
in 30 minutes under identical conditions. It is likely that
these differences are due to distinct substrate specifici-
ties for the sialoglycans of fetuin. However, after 20 h,
equilibriums for the reactions were attained and the
three TS applied produced almost the same amounts of
3’SL. Most likely this reflects a similar equilibrium for
these three TS.
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Figure 10 SDS-PAGE of resialylated fetuin. ASF (45 to 58 kDa):
Vibrio cholera sialidase-treated fetuin (58 to 65 kDa). For resialylation
ASF was treated with TS1 e-1 and 3’SL for 24 h. 2 μg protein per
lane were run on a 12% polyacrylamide gel. Abbr.: MW: molecular
weight
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Figure 11 Binding of Siglec-4 to resialylated fetuin. Vibrio
cholera sialidase-treated fetuin (ASF) was treated with TS1 e-1 and
3’-SL for the times indicated as described under Material and
Methods. Siglec-4 binding relative to untreated fetuin is shown.
Data points are means ± standard deviations of three independent
determinations.
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Clear differences were found in the kinetic parameters
of TS1b and TS1 e-1 for lactose and fetuin. Reliable
kinetic parameter for 3’SL as donor substrate could not
be determined, because of the inaccurate quantification
of the high concentrations of 3’SL as donor substrate.
Whereas TS1b has a slightly higher KM (1683 μM) for
lactose compared to TS1 e-1 (727 μM), the opposite
and more pronounced difference was observed for
fetuin-bound Sia, where TS1 e-1 has approximately five-
fold higher KM (81 μM) compared to TS1b (17 μM). In
combination, this implies that the ratio of KM for lac-
tose/KM for fetuin-bound Sia is approximately 100 for
TS1b, whereas it is only 10 for TS1 e-1. By comparison,
for T. cruzi TS the KM for both substrates is quite simi-
lar (326 over 206 μM) and its vmax was fourfold higher
than for the TS1 isoforms. The differences in the kinetic
parameters for fetuin observed for TS1b and TS1 e-1
are possibly related to altered affinities resulting from
amino acid divergences in the lectin domain of TS1b
and TS1 e-1. This would suggest a mechanism linking
the lectin domain to the enzymatic properties of TS.
No release of free Sia could be detected after 30 min-
utes of TS reactions with fetuin as donor and lactose as
acceptor substrates, demonstrating the absence of SA
activity. However, after 20 h incubation, free Sia was
detected clearly indicating SA activity. This activity cor-
related with the TS amount present, implying SA activ-
ity to be a side reaction observable only in extended
reactions. Interestingly, in the reverse TS reactions with
3’SL as donor substrate for sialylation of galactose resi-
dues of ASF, free Sia is detected very early in the reac-
tion (data not shown). This suggests that the free Sia
detected in extended TS reactions times with fetuin as
donor substrate is mainly the product of a SA side activ-
ity of the reaction using 3’SL as substrate. Therefore, the
amount of free Sia could provide indirect information
on the velocity of the reverse reaction. This assumption
is further supported by the fact that lower amounts of
TS can led to the same amount of final 3’SL but pro-
duce less free Sia as side product (Table 1). In this con-
text it should be noted, that TS from T. cruzi clearly
produced more free Sia than T. congolense TS1b or TS1
e-1. The structural basis for this phenomenon is unclear
but may be related to the kinetics of the reaction. TS
have been reported to follow ping-pong bi bi kinetics
[12,18,19]. It will be interesting to investigate the struc-
ture-function relationship of this phenomenon and
whether this is related to the SA activity of TS1g.
The TS substrate specificities for the glycans of the
donor substrate fetuin were investigated by a MALDI-
TOF analysis of TS treated glycopeptides from trypsin
digested fetuin, since the glycosylation of fetuin is well
established [13,20-23]. Three glycopeptides coming from
two of the three N-glycosylation sites (di- and
tribranched GP 127-141, and tribranched GP 54-85)
could be analyzed reliably. The predicted masses of GP
142-169 di could not be identified in any spectra. GP
54-85 di and GP 142-169 tri differed only in one Da,
which were not resolved by the equipment available and
were excluded from the analysis. The peptide containing
the three O-glycosylation sites could not be detected
due to its high mass. But it is important to note, that
TS1 clearly utilizes sialylated O-glycans as donor sub-
strates as indicated by a rapid unmasking of peanut
agglutinin recognition sites (data not shown).
Only minor differences in the sialylation pattern of
fetuin GPs were observed using the different TS species.
In summary, these were too small to draw a conclusion
that these TS differ in their substrate specificities for
fetuin glycans. In general, the TS applied cleaved Sia
from N-glycans of glycopeptides investigated, but also
transferred Sia back to these N-glycans. N-glycans that
carried three and four Sia molecules in the case of the
tribranched N-glycans as well as N-glycans that carried
two Sia molecules in the case of dibranched N-glycans
before TS incubation, were reduced to predominantly 0-
2 Sia molecules in the case of tribranched and 0-1 Sia
molecule in the case of dibranched N-glycans after 24 h
TS incubation.
Whereas in the reactions discussed above Sia was
transferred from fetuin to synthesize 3’SL, we could also
show that T. congolense TS1 as well as T. cruzi TS
transfer Sia in the reverse direction from 3’SL to glyco-
proteins. Furthermore, the TS reaction restores binding
of Sia-binding proteins, such as Siglec-4. Due to the
reversibility of the reaction, a complete resialylation of
an acceptor substrate applying TS cannot be expected
under these conditions. Nevertheless, differences in the
kinetic parameters as shown for two of the eleven T.
congolense TS1 variants could be used in kinetically con-
trolled reactions to optimize the TS reaction to one or
the other product, making the TS1 variants interesting
tools for biotechnological applications. Thus, TS1 can
be utilized to transfer Sia in a2,3-linkage on biologically
relevant glycoproteins containing terminal galactose as
Sia acceptor.
Conclusions
For the first time, full length TS from the African para-
site T. congolense has been cloned and sequenced, open-
ing new perspectives for investigations on the biological
role of these enzymes in the pursuit of a cure for
Nagana and sleeping sickness. Eleven T. congolense TS1
variants were identified and expressed as recombinant
proteins. The eleven TS1 differ in 25 of 702 amino acid
positions and a structural model revealed that these var-
iations occur in three clusters on the side of the protein
that is open to substrate binding. Ten of these TS1
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variants share predominantly TS and little SA activity.
Only one, TS1g, has much lower TS but increased SA
activity, probably due to an exchange of an arginine to
a cysteine at position 144. Interestingly, the kinetic
parameters of two characterized TS1 variants reveal
subtle differences in substrate specificities. However,
these did not lead to major differences in the sialylation
pattern of N-glycans on fetuin after treatment with dif-
ferent TS variants. Finally a proof of principle has been
provided that these TS can be used to sialylate glyco-
conjugates to create binding sites for Sia-binding pro-
teins like Siglec-4.
It will be interesting to investigate the expression pat-
terns of TS1 variants in the parasite’s life cycle in future
investigations addressing their importance for the mani-
festation of midgut colonization and maturation in the
tsetse vector with possible implications for the transmis-
sion to the mammalian host.
Methods
Materials
Complete Mini, EDTA free protease-inhibitor tablets
and Vibrio cholerae sialidase were purchased from
Roche Diagnostics, Mannheim, Germany. Pfu DNA
polymerase and restriction enzymes BamHI and SpeI,
isopropyl b-D-1-thiogalacto-pyranoside (IPTG), Page-
Blue and molecular weight marker (PageRuler) were
from Fermentas, St. Leon-Rot, Germany. Trypsin was
from Promega, Mannheim, Germany, 2,5-Dihydroxyben-
zoic acid from Bruker Daltonics, Billerica, USA. Ultrafil-
tration units Vivaspin6 and VivaCell250 were from
Sartorius, Göttingen, Germany. BCA Protein Assay Kit
was purchased from Thermo Scientific Pierce, Rockford,
USA. Anti-SNAP-tag rabbit polyclonal antibody was
from GenScript, Piscataway, USA. Anti-Strep-tag rabbit
polyclonal antibody, StrepTactin beads and buffers were
purchased from IBA, Göttingen, Germany and hygromy-
cin from PAA, Pasching, Austria. 2’-(4-Methylumbelli-
feryl)-a-D-N-acetylneuraminic acid sodium salt hydrate
(MU-Neu5Ac), 4-methylumbelliferyl ß-D-galactoside
(MU-Gal), 4-methylumbelliferone (MU), glucoronic
acid, Ex-cell® CD CHO media, fetuin and PEI transfec-
tion reagent were purchased from Sigma-Aldrich,
Munich, Germany. X-ray film, enhanced chemilumines-
cence system, Ni-NTA and Q-Sepharose FF were pur-
chased from GE Healthcare, Munich, polyvinylidene
difluoride membranes and ZipTips from Millipore,
Schwalbach, Germany.
Cloning and expression of recombinant TS1
The published partial sequences of Trypanosoma congo-
lense TS1 [Genebank: AJ535487.1] [6,9] was used as
starting query for searching the T. congolense genomic
database for pathogen genomics at the WTSI (http://
www.sanger.ac.uk/). Based on the obtained sequence
fragments, an open reading frame encoding TS1 was
assembled. Based on this, primers were designed to
amplify TS1 from T. congolense (strain STIB 249) geno-
mic DNA [9] using Pfu DNA polymerase in a nested
PCR reaction leaving out the N-terminal signal peptide
sequence and the C-terminal GPI anchor attachment
site. Both outside primers (forward ATG CGG CCG
GTG AAT TGT TAN and reverse CAT CAG CAC
ATG CAC GAG CAN) were degenerate at the 3’ end,
whereas the internal primers (forward CGA CTA GTC
AGT GCT GCG ACC ACA TGC AN and reverse CGG
GAT CCG TCG CTC CCA GGC ACA CGA AN) were
designed to introduce Spe1 and BamHI restriction sites,
respectively. These restriction sites were used to ligate
the PCR-products in frame into a modified pDEF [24]
vector (pDEF-T3C/SNAPstrep) providing in frame a
Transin cleavable signal peptide [25], a 3C-protease
cleavage site [26] followed by SNAP (Covalys, Witters-
wil, Switzerland) and Strep (IBA, Göttingen, Germany)
tags. The pDEF-T3C/SNAPstrep was obtained as fol-
lows: The coding sequence for the Transin signal pep-
tide has been introduced into pcDNA 3 Amp Strep-tag
[27] using the HindIII/BamHI-digested linker obtained
by hybridization of the following oligonucleotides: sense
5’-CGAAGCTTATGAAAGGGCTCCCAGTCCTGC
TGTGGCTGTGTACGGCTGTGTGCTC
ATCCTACCCATTGCATGGCAGTGAAGAAGAT
GCTGGCATGGAGACTAGTGGATCCCG
and antisense primer 5’-
CGGGATCCACTAGTCTCCATGCCAGCATCTT
CTTCACTGCCATGCAATGGGTAGG
ATGAGCACACACAGCCGTACACAGCCACAGCA
GGACTGGGAGCCCTTTCATAAGCTTCG.
This Transin linker introduced a unique SpeI restric-
tion site. The coding sequence of the hAGT protein
(SNAP) was amplified using the pSNAP-tag® (T7) vec-
tor (NEB, Ipswich, MA, USA) as a template and sub-
cloned in frame into BamHI/EcoRI digested pcDNA3
Amp Transin Strep-tag providing pcDNA3-T3C/SNAP-
strep. The primers used for amplification were: sense 5’-
CGGGATCCCTGGAGGTGCTGTTCCAGGGCCC-
CATGGACAAAGACTGCGAAATGAAGCG-3’ includ-
ing the coding sequence for the 3C protease recognition
site of the human rhinovirus HRV 3C (LEVLFQGP,
underlined) and antisense 5’- CGGAATTCACCCAGC
CCAGGCTTGCCCAGA.
CHOLec1 cells were used for TS1 expression due to
their ability to express only high-mannose glycans, since
these cells are lacking N-acetyl glucosaminyltransferase I
[28]. Transfection of CHOLec1 cells grown in aMEM
supplemented with 10% fetal calf serum at 37°C, 5%
CO2 was accomplished with polyethylenimine (PEI)
transfection reagent following the manufacturer’s
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instructions. 24 h after transfection, cells were passaged
into 96-well plates in a selection media of aMEM con-
taining varying amounts of hygromycin, ranging from
400 μg/mL to 1000 μg/mL. Expression of recombinant
TS1 (120 kDa including SNAP and Strep tags) was
tested by analyzing cell culture supernatant using Wes-
tern blots with anti TS1 monoclonal antibody (mAb 7/
23) as primary antibody [9]. The presence of SNAP and
Strep tags was confirmed using anti-SNAP-tag rabbit
polyclonal antibody and anti-Strep-tag rabbit polyclonal
antibody respectively in Western blots analysis. Selected
cells were then adapted to Ex-cell® CD CHO media
supplemented with 8 mM L-glutamine.
Purification of Trypanosoma congolense trans-sialidase
The harvested tissue culture supernatant was supple-
mented with 10 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1
mM DTT and 0.02% sodium azide (all final concentra-
tions) and centrifuged at 125,000 × g for 1 h. The
cleared supernatant was then concentrated 100-fold by
ultrafiltration (100 kDa cut off). Buffer was exchanged
twice using 250 mL 100 mM Tris-Cl, pH 8.0, 150 mM
NaCl, 1 mM EDTA (buffer A) in the same ultrafiltration
unit and concentrated to a total volume of 10 mL for 1
L tissue culture supernatant. This was further clarified
by centrifugation at 21,000 × g for 30 minutes before
applying on a column of 1 mL StrepTactin® beads equi-
librated with buffer A. After loading the column was
washed with 5 column volumes wash buffer (100 mM
Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA) and TS1
was eluted with 3 column volumes of elution buffer
(100 mM Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA,
2.5 mM desthiobiotin) in fractions of 0.5 mL. The affi-
nity purified TS1 was dialyzed (10 kDa cut off) against
10 mM phosphate, pH 7.4. Purification products were
analyzed by SDS-PAGE and quantified by BCA assay
with bovine serum albumin as standard.
Expression and purification of Trypanosoma cruzi trans-
sialidase
Recombinant T. cruzi TS was produced in E. coli M15
(pREP4) according to Agusti et al., 2004 and Neubacher
et al., 2005 [29,30]. In brief, cells were grown in 1 L
“terrific broth” medium overnight at 18°C. Protein
expression was initiated with 0.5 mM IPTG. The cells
were dissolved in 40 mL lysis buffer (50 mM phosphate,
300 mM NaCl, pH 8.0 and 0.05% Lubrol), 1 tablet pro-
tease-inhibitor (Complete Mini, EDTA free) and 1 spa-
tula tip of lysozyme were before incubation of 30
minutes at 4°C. The cells were disrupted by 5 cycles of
sonification on ice. Cells debris was removed by centri-
fugation at 40,000 × g for 60 minutes at 4°C and the
supernatant was filtered using a 0.2 μm pore size filter.
20 mM imidazol was added before application on 0.5
mL Ni-NTA beads. Target proteins were eluted in the
same buffer and 250 mM imidazole. The eluted protein
was dialyzed against 20 mM Tris, 30 mM NaCl, pH 8.0
and further purified using a Q-Sepharose FF column in
the same buffer with a linear gradient up to 1 M NaCl.
The activity of the purified protein was tested by a siali-
dase activity assay using MU-Neu5Ac as donor substrate
and lactose as acceptor substrate as described below.
Vibrio cholerae sialidase treatment of fetuin
Asialofetuin (ASF) was prepared from fetuin by Vibrio
cholerae sialidase (VCS) treatment as described [31]. In
brief, fetuin was digested with VCS in 50 mM sodium
acetate, 9 mM CaCl2, pH 5.5 overnight at 37°C in a dia-
lysis bag against the same buffer and afterwards against
distilled water. Sialylated fetuin and sialidase was sepa-
rated from ASF by anion exchange chromatography
using Q-Sepharose. The proteins were eluted by a linear
gradient from 0 to 1 M NaCl in 10 mM Tris, pH 7.4.
Collected fractions were assayed for protein at 280 nm
and for SA activity with MU-Neu5Ac acid as substrate
as described below. The fractions containing ASF but
no SA activity were pooled and the buffer was
exchanged against 10 mM phosphate, pH 7.4 using
VivaSpin6 ultrafiltration units (10 kDa cut off).
Sialidase activity assay
Sialidase activity (+/- lactose) was determined by apply-
ing a microtitre plate assay detecting free 4-methylum-
belliferone (MU) released from Neu5Ac-MU [6]. In
brief, 50 μL sample were incubated with 1 mM
Neu5Ac-MU (final concentration) in a black 96-well
microtitre plate. To determine T. cruzi TS 1 mM lactose
was added as acceptor substrate. The plate was centri-
fuged for 1 minute at 1,000 × g and incubated for 30
minutes at room temperature in the dark. The reactions
were stopped with 200 μL 100 mM glycine, pH 10 and
the fluorescence intensities were measured at 355 nm
excitation and 460 nm emission using a fluorimeter
(Ascent Fluoroscan).
Trans-sialidase reactions
The principle of this assay is based on the quantification
of sialylated oligosaccharides by high performance
anion-exchange chromatography with pulsed ampero-
metric detection (HPAEC-PAD) as described below. In
these reactions either fetuin is used as donor substrate,
e.g. lactose as acceptor or 3’-sialyllactose (3’SL) is used
as donor substrate with ASF as acceptor. A final volume
of 50 μL 10 mM phosphate buffer were used for all TS
reactions. Stock solutions of donor and acceptor sub-
strate were mixed in 40 μL buffer (10 mM Tris/HCl, pH
7.5) and the reactions were started with 10 μL TS (50
ng in standard reactions) and incubated at 37°C. The
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reactions were stopped with 200 μL ice-cold acetone
containing 28 μM glucuronic acid and incubated over-
night at -20°C. After centrifugation for 15 minutes at
20,000 × g and 4°C, 225 μL supernatant were removed
and both, protein pellets and supernatants were
lyophilized.
The dried supernatant of the acetone precipitation was
dissolved in 125 μL H2O for HPAEC-PAD, which was
carried out by using a DX600 system (Dionex, Sunny-
vale, CA, USA) with an electrochemical detector (ED50),
a gradient pump (GP50) and an autosampler (AS50).
Carbohydrates were separated by HPAEC on a Carbo-
PAC PA1 (4 × 250 mm) analytical column (Dionex)
together with a guard column (4 × 50 mm) using a con-
stant flow rate of 1 mL/min. Sample volumes of 25 μL
were injected and the chromatography was performed
as follows: 100 mM NaOH for 2 min, followed by 100
mM NaOH/100 mM NaOAc for 22 min. The column
was regenerated by washing for 5 min with 100 mM
NaOH/500 mM NaOAc, followed by 5 min with 100
mM NaOH. For PAD the typical quadruple waveform
was used as described previously [32]. The Dionex soft-
ware Chromeleon 6.40 SP8 was used for data acquisition
and data evaluation.
Calculation of kinetic parameters
Vmax and KM were calculated using the curve fit module
of SigmaPlot 11 employing the Michaelis-Menten equa-
tion v = vmax ×cs/(cs + KM).
Siglec-4 binding assay
Murine Siglec-4d1-3-Fc was purified by protein-A affinity
chromatography from tissue culture supernatants of sta-
bly transfected CHO Lec3.2.8.1 as described before [33].
The protein solution was dialyzed against 10 mM phos-
phate buffer pH 7.4, sterile filtered and stored at 4°C.
Binding assays with Siglec-4 were performed as
described previously [33]. In brief, 4 μg/mL fetuin, ASF
or TS-treated fetuin were immobilized in microtitre
plates and binding of serially diluted Siglec-4d1-3-Fc (8
dilutions starting with 16 μg/mL) was determined using
alkaline phosphatase-labeled anti-Fc antibodies. The
concentrations sufficient for 50% binding (relative to
Siglec-4d1-3-Fc binding to fetuin) were determined from
corresponding binding curves. At least three indepen-
dent titrations were performed.
SDS-PAGE and Western Blot analysis
Samples were separated by SDS-PAGE (MiniProtean III;
Bio-Rad, München, Germany) according to Laemmli
[34] and stained with PageBlue.
For Western blot analysis, samples were transferred onto
polyvinylidene difluoride membranes after SDS-PAGE.
The membranes were blocked with 5% BSA in Tris-
buffered saline (TBS) buffer containing 0.15% Tween20
(TBS-T) for 1 h. Washing of the membrane was done five
times for 5 minutes each using TBS-T. Immunodetection
was performed by incubating membranes with a primary
antibody diluted in blocking buffer overnight at 4°C. The
following antibodies were used: anti-T. congolense TS
mAb 7/23 (1:1000) and rabbit anti-Strep-tag (1:1000). Fol-
lowing four washes with TBS-T of 10 minutes each, the
membranes were incubated with a secondary antibody
conjugated to horseradish peroxidase for 2 h at room tem-
perature. After washing four times with TBS-T, blots were
developed with the enhanced chemiluminescence system
using X-ray film.
Matrix-assisted laser desorption ionisation-time of flight
mass spectrometry (MALDI-TOF-MS)
TS reactions were carried out with 50 ng TS, 100 nmol
lactose and 100 μg fetuin as described above. The dried
protein pellets after TS reaction were dissolved in 200 μL
50 mM ammonium hydrogen carbonate, pH 7.8 and 1.6
μL 45 mM DTT were added. After 30 minutes incubation
at 50°C, 1.6 μL 100 mM IAA were added and further incu-
bated for 30 minutes at 37°C. The tryptic digestion was
started with 2 μg trypsin dissolved in 1 μL 50 mM acetic
acid and incubated overnight at 37°C and stored at -20°C.
5 μL of the tryptic digest were mixed with 5 μL H2O
and 1 μL 1% trifluoroacetic acid and were directly
mixed with matrix and 1 μL was applied to the MALDI-
TOF-MS target plate. The remaining 9 μL were desalted
using C18-reversed phase pipette tips (ZipTip). Peptides
were eluted with 3 × 100 μL 12% and 30% acetonitrile
in H2O and lyophilized. 2,5-Dihydroxybenzoic acid in
0.1% trifluoroacetic acid was used as MALDI matrix.
The dried peptides were directly dissolved in 10 μL
DHB solution and 1 μL of the mixture were spotted to
the target plate for crystallization.
The mass spectrometry was performed using a Voya-
ger DE Pro MALDI-TOF N2-Laser with a wavelength of
337 nm (Applied Biosystems, Foster City, USA). All
spectra were measured in the linear detector mode.
Laser intensities and the number of records per spec-
trum were varied manually.
Voyager software was used for data acquisition and
peak detection. For quantification the peak intensity of
each peptide was determined relative to the non-sialy-
lated glycopeptide 1-32 (3459.66 Da) as internal stan-
dard. This peptide is detected in all spectra of the
sialylation variants of the glycopeptides and is not chan-
ged by TS reaction (Figure 8). All measurements were
repeated for at least three times.
Homology Modeling
A homology model of T. congolense TS1 e-1 was calcu-
lated using the software Yasara 10.11.8 [35-40]. The
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crystal structure of T. cruzi TS (UniProt: Q26964; PDB
entry: 3B69), previously reported by Buschiazzo et al.,
2002 [12] was used as the template structure. A benzoy-
lated N-acetylneuraminic acid derivative used as a ligand
for T. cruzi TS in the template structure was kept in the
binding site during the calculation of the homology
model.
The following parameters of the Yasara homology
modeling module were modified manually from the
default settings of the program: Modeling speed: slow,
PsiBLASTs: 6, EValue Max: 0.5, Templates total: 1,
Templates SameSeq: 1, OligoState: 4, alignments: 10,
LoopSamples: 50, TermExtension:10.
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Abstract
Trans-sialidases are key enzymes in the life cycle of African trypanosomes in both, mammalian host and insect vector and
have been associated with the disease trypanosomiasis, namely sleeping sickness and nagana. Besides the previously
reported TconTS1, we have identified three additional active trans-sialidases, TconTS2, TconTS3 and TconTS4, and three
trans-sialidase like genes in Trypanosoma congolense. At least TconTS1, TconTS2 and TconTS4 are found in the bloodstream
of infected animals. We have characterised the enzymatic properties of recombinant proteins expressed in eukaryotic
fibroblasts using fetuin as model blood glycoprotein donor substrate. One of the recombinant trans-sialidases, TconTS2, had
the highest specific activity reported thus far with very low sialidase activity. The active trans-sialidases share all the amino
acids critical for the catalytic reaction with few variations in the predicted binding site for the leaving or acceptor glycan.
However, these differences cannot explain the orders of magnitudes between their transfer activities, which must be due to
other unidentified structural features of the proteins or substrates selectivity. Interestingly, the phylogenetic relationships
between the lectin domains correlate with their specific trans-sialylation activities. This raises the question whether and how
the lectin domains regulate the trans-sialidase reaction. The identification and enzymatic characterisation of the trans-
sialidase family in T. congolense will contribute significantly towards the understanding of the roles of these enzymes in the
pathogenesis of Animal African Trypanosomiasis.
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Introduction
Trypanosoma congolense (subgenus: Nannomonas) is a major causative
agent of the Animal African Trypanosomiasis (AAT) otherwise
known as nagana. Other parasites implicated in nagana include T.
vivax (subgenus: Duttonella) and T. brucei brucei (subgenus: Trypano-
zoon). These protozoan parasites are transmitted by several species
of hematophagous biting flies of the genus Glossina. Nagana
exhibits a severe negative impact on stock farming, milk and meat
production [1]. The impact of the disease is thought to be
underestimated as most affected areas are remote, limiting access
and hence accurate data acquisition. The need for an alternative
arsenal against AAT is heightened as existing drugs are either toxic
or rapidly becoming ineffective due to drug resistance [2].
The role of TS in Chaga’s disease caused by the South American
T. cruzi has been extensively studied [3]. On the other hand, studies
on the trans-sialidases from African trypanosomes responsible for the
Human African Trypanosomiasis (HAT) as well as AAT are scanty.
In T. brucei, TS has been implicated in the cyclical survival of the
parasite as evidence supports enhanced survival of parasite in
midgut of the insect host [4]. No data exist on T. congolense in this
regard. Though scanty, the role of blood stream TS and sialidase in
anaemia in animals suffering trypanosomiasis caused by T. congolense
[5] [6] and T. vivax [7] has been established.
Multiple copies of TS-like genes exist in Trypanosoma genomes.
The highest number occurs in T. cruzi, but most of the over 1000
genes encod enzymatically inactive proteins [8]. In African
trypanosomes, the TS-like gene families are much smaller. For
example, 9 members have been identified in T. brucei [9] [10] [11].
In T. congolense, at least 17 TS-like genes have been identified [12]
[13] [14] [6]. Eleven of these, forming the TconTS1 family, are
closely related and share over 95% sequence identity [14]. The key
element mediating the functions of TS has been ascribed to the N-
terminal catalytic domain (CD) harbouring the active site with
characteristic conserved amino acids [15] [16] [17] [9] [18],
whereas hardly anything is known about possible functions of the
lectin-like domain (LD) at the C-terminus of these enzymes.
Here we report that besides TconTS1, three additional
members of the T. congolense TS gene family transfer sialic acids
between glycoconjugates, but have much lower sialidase activities.
The identification and biochemical characterisation of T. congolense
TS genes will enable new studies investigating the role of these
genes in nagana disease.
Methods
Unless where stated, all chemicals and reagents used were cell
culture and analytical grade. Vibrio cholerae sialidase was purchased
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from Roche Diagnostics (Mannheim, Germany). Pfu DNA
polymerase, HindIII, XbaI, SpeI, EcoRI and DpnI, PageBlue,
molecular weight marker (PageRuler), BCA assay protein kit were
all purchased from Thermo Scientific (St. Leon-Rot, Germany).
VivaSpin 6 and VivaCell250 ultracentrifugation units were from
Sartorius (Go¨ttingen, Germany). Anti-SNAP-tag rabbit polyclonal
antibody was from GeneScript (Piscataway, USA) while anti-Strep-
tag rabbit polyclonal antibody, Strep-Tactin resin beads and buffers
were from IBA (Go¨ttingen, Germany). Hygromycin and Genta-
mycin were purchased from PAA, (Pasching, Austria). Polyethy-
lenimin transfection reagent, glucuronic acid, N-acetyl-neuraminic
acid (Neu5Ac), 3’sialyllactose (3’SL) and lactose were purchased
from Sigma-Aldrich (Steinheim, Germany). Ex-cell CD CHO
media from SAFC, USA, X-ray film, Enhanced Chemilumines-
cence system, and recProtein-A Sepharose Fast Flow were
purchased from GE Healthcare (Uppsala, Sweden). Polyvinylidene
difluoride membrane was from Millipore (Schwabach, Germany).
Cloning, sequencing, expression and purification of
trans-sialidase genes
The Basic Local Alignment Search Tool (BLAST) was used to
search the shot-gun sequences of T. congolense at the WSTI (http://
www.sanger.ac.uk). Using the BLASTN algorithm, the ‘‘T.
congolense reads’’ were queried with the partial nucleotide sequences
(Genbank Accession numbers TS1: AJ535487 and TS2:
AJ535488) previously described [13]. Perfect BLAST hits (smallest
sum probability P(N),10-10) were arranged into contiguous
sequences using Contig Express (Invitrogen, Carlsbad, USA). By
searching the database with ends of the contiguous sequences, the
assembled contigs were expanded until open reading frames
(ORF) were obtained. On the basis of the obtained ORFs, primers
(Supporting Information, Table S1) were designed to amplify by
nested PCR the ORF including flanking regions encoding for
TconTS2, TconTS3 and TconTS4 using genomic DNA of T.
congolense strain STIB249 [13]. The resulting products were cloned
into the pBlueScript KS- vector (Stratagene, Santa Clara, Ca,
USA) via SpeI and BamHI (TconTS2) or via EcoRI and SmaI
(TconTS4) or into the mammalian expression vector pcDNAIII
Amp (Invitrogen, Carlsbad, USA) via HindIII and XbaI (TconTS3)
and sequenced (Supporting Information, Table S2).
Cloning and sequencing of T. brucei TS genes followed a similar
strategy as described for T. congolense above except that genes were
cloned in pJET1.2/blunt vector (Thermo Scientific) following
instructions of the manufacturer (for primers see Supporting
Information, Table S1).
For the expression of secreted TconTS proteins in mammalian
fibroblasts, corresponding DNA sequences without those encoding
the signal peptides and GPI anchors were subcloned into a
modified pDEF vector providing a 3C protease recognition site,
SNAP and Strep tags using SpeI and BamHI restriction sites [14].
For this purpose, the BamHI site in TconTS3 as well as the SpeI
and BamHI sites in TconTS4 were removed by site directed
mutagenesis without changing the amino acid sequence encoded
(for primers see Supporting Information, Table S1). All sequences
and mutations were confirmed by Sanger dideoxy DNA sequenc-
ing at the Max Planck Institute for Marine Microbiology, Bremen,
Germany.
Recombinant TconTS proteins were purified as described [14].
Briefly, CHOLec1 cells (ATCC CRL-1735) were transfected with
polyethylenimine, transfection reagent (Sigma, Steinheim, Ger-
many) and stably expressing cell lines selected with hygromycin.
Expression of recombinant protein was tested from cell culture
supernatant by SDS-PAGE and Western blots methods using
rabbit anti-Strep and anti-SNAP antibodies. CHOLec1 cells
producing TconTS proteins were subsequently adapted to
chemically defined Excel CD CHO media.
Purification of anti-TS1 monoclonal antibody
The 7/23 hybridoma cells [12] were grown for 3 days in RPMI
media supplemented with IgG depleted 10% FCS. The tissue
culture supernatant was cleared by ultracentrifugation at 1056g
for 60 min and anti-TconTS antibody was purified using
recProtein-A Sepharose Fast Flow and eluted with 0.1 M
glycine/HCl pH 3.0. Antibody containing fractions were neutral-
ised with 1M Tris pH 8.0 and dialysed against 10 mM phosphate
buffer. Purified antibodies were used in the detection of TconTS
proteins in SDS-PAGE and Western Blot analysis as described
[14].
Trans-sialidase and sialidase reactions
Purified recombinant proteins were assayed for sialidase and TS
activities using Neu5Ac-MU and fetuin as sialic acid donor
substrates and lactose as acceptor substrate as described before
[14]. In brief, reactions of 50 mL containing substrates and
enzymes were incubated at 37uC for the times indicated. Sialidase
activity was determined as free sialic acids released from Neu5Ac-
MU, 3’SL or fetuin in the absence and/or presence of an acceptor
substrate. TS activity on the other hand was determined as 3’SL
produced in the presence of lactose. Both, free Neu5Ac and 3’SL
were quantified using high performance anion exchange chroma-
tography with pulsed amperometric detection (HPAEC-PAD)
using the Dionex system, DX600 (Dionex Sunnyvale, CA, USA)
[14]. The curve fit module of SigmapPlot 11 was used to calculate
vmax and KM employing the Michaelis-Menten equation v=
vmax6Cs/(Cs+KM).
Phylogenetic analysis
For the phylogenetic analysis TconTS1b, TconTS2, TconTS3
and TconTS4 were aligned with TS and sialidase sequences from
T. brucei, T. vivax, T. cruzi and T. rangeli. As outgroup the sialidase
from Vibrio cholerae was used (genes listed in Supporting Informa-
tion Table S2). Full length protein sequences were first aligned
using ClustalW in Geneious and then truncated at the N-terminus.
CDs started from the FRIP region to the N-terminus of the
conserved a-helix (HL) linking the CD to the LD. The LDs were
taken immediately after the a-helix linkage to the C-terminus
Author Summary
Trypanosomiasis is a disease also known as sleeping
sickness in humans (Human African Trypanosomiasis) and
nagana in animals (Animal African Trypanosomiasis). This
disease is caused by protozoan parasites of the genus
Trypanosoma. Tsetse flies are responsible for the transmis-
sion of these parasites. Trypanosoma congolense is the
main causative agent of nagana in cattle. The clinical signs
of the disease have been linked to the presence of an
enzyme called trans-sialidase. Interestingly, the enzyme
alternates in different forms in the mammalian and the
insect vector. Previous knowledge had shown that the
parasite requires the enzyme for survival in the fly vector.
Our current work has revealed other forms of the enzyme
that could be essential for the persistence of the disease in
mammalian and vector hosts. These enzymes, though
similar in structural architecture, show differences in their
activities that could be key in delineating their individual
roles in the pathophysiology of the disease.
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without the stop codon. DNA sequences encoding either full
length proteins, the CDs or the LDs were aligned based on the
alignment obtained for the amino acid sequences by T-Coffee
algorithm in RevTrans, version 2.0 (http://www.cbs.dtu.dk/
services/RevTrans-2.0/web/). DNA sequences used in the
phylogenetic calculations are shown in Supporting Information
Files S1, S2 and S3. Best parameters (HKY substitution model
with 6 gamma rate categories) for phylogenetic constructions were
determined using MEGA5 and applied in the phylogenetic
calculations using the ‘‘MrBayes’’ plug-in of Geneious.
Results
T. congolense sialidase/trans-sialidase genes
Partial coding sequences of TconTS1 and TconTS2 genes had
been described [13]. From ‘‘reads’’ of the WTSI T. congolense
genome sequencing project (http://www.sanger.ac.uk), we assem-
bled the full length sequences coding TconTS1 and TconTS2.
Further BLAST hits with smallest sum probabilities (P(N),1–10)
were identified and arranged into contiguous sequences leading to
further five genes with sequence similarities. Two of the putative
gene products shared over 40% sequence identity with TconTS1
and TconTS2 and contained all the conserved amino acids
required for transfer reactions [17] [18] [10]. Consistent with the
naming of TconTS1 and TconTS2 [13], we refer to them as
TconTS3 and TconTS4. The other three genes were distantly
related with 20–30% amino acid identity (Table 1) and lack several
of the conserved amino acid residues. We assume that these set of
genes are likely without sialidase or TS activity and were named
TconTS-Like1, TconTS-Like2, and TconTS-Like3.
In order to compare sequence similarities between TconTS
genes, we cloned and sequenced full lengths TconTS2, TconTS3
and TconTS4. In an earlier study, we amplified eleven highly
similar (about 96% identical amino acids) but clearly different
sequences of TconTS1 from T. congolense genomic DNA [14].
Sequencing several clones of TconTS2, TconTS3 and TconTS4
provided no evidence for such heterogeneity of these genes. The
alignment of these genes is given in Figure 1.
Amaya et al. [18] identified amino acids in T. cruzi TS involved
in the catalytic and substrate binding. Whereas these amino acids
are not conserved in the three TconTS-like gene products, they
are almost completely conserved in TconTS1, TconTS2,
TconTS3 and TconTS4 (Table 2). Most of these are conservative
changes, with the exception of position 293 (numbering in the
consensus sequence), where a Tyr is replaced by Pro in TconTS2.
Furthermore, based on mutagenesis experiments [19] [17] with
T. cruzi TS, two proline residues corresponding to positions 411
and 465 appear to be required for full TS activity. Whereas at
position 465 Pro is conserved across the TconTS, it is not found
in the TconTS-like gene products (Table 2). However, at position
411 the Pro is not conserved in TconTS, but replaced by Ala or
Ser.
TS orthologues occur in T. congolense and T. brucei but
not in T. vivax
To decipher the phylogenetic relationship between TS and TS-
like genes of African trypanosomes, we compared the four
TconTS and three TconTS-Like sequences together with seven
sequences from T. brucei and five from T. vivax (Supporting
Information Table S2) using the alignment of DNA sequences
reverse transcribed from the protein alignment (see Supporting
Information Files S1, S2 and S3 for DNA sequences used). As
shown in Figure 2A, for each TconTS and TconTS-Like gene a
corresponding orthologue was identified in T. brucei, whereas T.
vivax gene products cluster separately from TS of the other African
trypanosomes. TconTS-Like2 and TconTS-Like3 form a branch
together with their T. brucei orthologues separate from all South
American TS genes. In contrast, TconTS-Like1 and its T. brucei
orthologue appear to be more closely related with the more distant
South American branch than the African genes.
Trypanosomal TS contain an N-terminal CD followed by a C-
terminal LD. Besides the phylogenetic analysis with the entire
ORFs, analysis were performed using sequences coding for each
domain separately. The phylogenetic tree obtained for the CDs
resembles that for complete ORFs (not shown). Surprisingly, a
different situation was observed for the LDs of TconTS1,
TconTS2, TconTS3 and TconTS4 and the T. brucei TS genes
(Figure 2B). First, within the TconTS genes, the LD of TconTS2 is
most closely related to that of TconTS1, whereas the CD of
TconTS3 is more closely related to TconTS2. Second, it should be
noted that not the same T. congolense and T. brucei genes group as
orthologous pairs, if LDs are compared. Amplification and
sequencing ORF of T. brucei TS genes confirmed that the
combination of the CDs and LDs were as predicted from the
contigs in the databases.
Monclonal anti-TS1 antibody cross-reacts with TconTS2,
recognising an epitope on the lectin domain
To biochemically characterise TconTS genes, recombinant
proteins were made for TconTS2, TconTS3 and TconTS4 as
previously described for TconTS1 [14]. Recombinant TconTS
proteins were expressed in CHOLec1 [20] and purified by affinity
chromatography to obtain pure protein from eukaryotic cells with
high mannose-type N-glycans. The apparent molecular masses of
the recombinant TconTS proteins including the SNAP and Strep
tags are between 110 and 125 kDA as resolved on SDS-PAGE.
The generic Strep tag fused to the proteins is recognised by anti-
Strep polyclonal Ab in all the recombinant TconTS proteins as
shown in Figure 3 (upper panel). Surprisingly, the monoclonal
anti-TS antibody [12] reacted with both TconTS1 and TconTS2,
Table 1. Trypanosoma congolense trans-sialidase sequence similarities expressed as percentage of identical amino acids in pair-
wise alignments.
Trans-sialidase TconTS2 TconTS3 TconTS4 TconTS-Like1 TconTS-Like2 TconTS-Like3
TconTS1 42.2% 43.6% 46.2% 21.1% 26.3% 29.8%
TconTS2 - 48.3% 42.8% 20.8% 26.2% 29.3%
TconTS3 - 48.9% 21.1% 25.1% 29.9%
TconTS4 - 21.3% 27.8% 29.8%
Tcon= Trypanosoma congolense
doi:10.1371/journal.pntd.0002549.t001
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but not TconTS3 and TconTS4 (Figure 3; lower panel). This
result points to a similar epitope being present in both TconTS1
and TconTS2. Further experiments provided evidence that the
epitope is located in the LDs.
TconTS2, TconTS3 and TconTS4 are trans-sialidases
In order to investigate the enzymatic activities we used the
glycoprotein fetuin as donor and lactose as acceptor substrates.
Free sialic acid (the product of sialidase activity) and 3’SL (the
product of TS activity) could be quantified simultaneously from
HPAEC-PAD chromatograms of the reactions. Under standard
conditions 25 ng TconTS2 produced about 330 pmol/min 3’SL
leading to 200 mM 3’SL in the reaction mix within 30 minutes
(Figure 4A). Product formation by TconTS2 was linear for up to
50 ng enzyme under these conditions. The reaction catalysed by
TconTS3 was slower than that of TconTS2, since 500 ng of
enzyme generated only 4.2 pmol/min 3’SL corresponding to
10 mM 3’SL after 4 h (Figure 4B). 3’SL formation by TconTS3
was almost linear for 4 h. TS activity was also detected for
TconTS4. However, the activity was even lower than that of
TconTS3 and 500 ng of TconTS4 produced less than 0.1 pmol/
min 3’SL (Figure 4C). Therefore, 24 h incubations were routinely
used to determine TconTS4 activity.
To determine kinetic parameters (Table 3) reactions were
conducted under standard conditions for 30, 120 and 1440 min-
utes for TconTS2, TconTS3 and TconTS4, respectively.
TconTS2 exhibited the lowest KM for fetuin (299 mM), similar
to that reported for TconTS1b (395 mM) [14], whereas those
determined for Tcon TS3 (6090 mM) and TconTS4 (949 mM)
were higher. The lowest KM for lactose was found for TconTS2
(602 mM), followed by TconTS3 (1104 mM) and TS4 (1806 mM).
Comparing the results with those obtained for two variants of
TconTS1 [14], TconTS2 has a KM value for lactose similar to
TconTS1e-1 but about 3-fold less than TconTS1b. For both
substrates, TconTS2 showed about 2-, 200- and 2000-fold
higher vmax values than TconTS1, TconTS3 and TconTS4,
respectively.
Sialidase activities
Sialidase activity has been shown for TconTS purified from
T.congolense axenic culture [12] and for T. congolense infected
animals [5] [7]. Therefore, we investigated the sialidase activities
of TconTS using fetuin as a model glycoprotein. Whereas no
release of free Neu5Ac was observed for TconTS1, TconTS2 and
TconTS3 under standard conditions of TS assays, TconTS4
clearly showed sialidase activity producing 0.76 pmol/min
Neu5Ac up to 48 h (Figure 5A). Indeed, the sialidase activity of
TconTS4 is relatively stable and retained a residual sialidase
activity of 40% even after incubation at 37oC for 120 days.
We also investigated the effect of lactose on TconTS4 sialidase
activity. At lactose concentrations above 3 mM, release of Neu5Ac
dropped to undetectable levels (Figure 5B). This result indicates
the existence of a competition between lactose and water for the
cleaved Neu5Ac from the donor fetuin. This is confirmed by the
increased amount of 3’SL produced with increasing lactose
concentration.
When we incubated TconTS2 or TconTS3 with fetuin and
lactose for extended periods, it was observed that increasing
amounts of Neu5Ac were released, similar to TconTS1 [14].
Interestingly, free Neu5Ac appeared only after 3’SL has
accumulated as a product of transialylation. For example, in
TconTS2 reactions, Neu5Ac was detectable (0.68 mM, 27 pmol)
when the 3’SL concentration had reached almost 600 mM, the
maximum 3’SL concentration reached. Whereas further incuba-
tion did not result in higher 3’SL concentrations, the amount of
free Neu5Ac continuously increased. This observation suggests
that TconTS2releases free Neu5Ac from 3’SL but not from
fetuin. Similar observations were made for TconTS1, but the
highest 3’SL concentration reached was about 300 mM. These
data indicated that for TconTS1 and TconTS2 at 300 mM and
600 mM 3’SL, respectively, the transfer of Neu5Ac between fetuin
and 3’SL has reached an equilibrium. For TconTS3, we could
not reach such equilibrium; probably since the maximum 3’SL
concentration obtained was 50 mM due to the low specific activity
of this enzyme. Nevertheless, small amounts of free Neu5Ac were
detected in prolonged TconTS3 reactions leading to 50 mM 3’SL.
Also in this case, Sia appears to be released from 3’SL only, since
in the absence of lactose no release of free Neu5Ac could be
observed.
These observations suggest that TconTS1, TconTS2 and
TconTS3 can release free Neu5Ac from glycoconjugates, but the
level of product released is too low to be detected under standard
TS assay conditions. To address this, higher amounts (500 ng) of
TconTS1, TconTS2, TconTS3 and TconTS4 were incubated
with 600 mM fetuin-bound Neu5Ac without lactose for 2 h. Under
these conditions sialidase activities could also be detected for
TconTS1 and TconTS2, but not for TconTS3 (Table 4).
However, compared to the corresponding TS activities, the
sialidase activities were very low.
Discussion
The enzymatic properties of four TconTS were compared using
fetuin as a model for a blood glycoprotein donor substrate. Two of
these enzymes, TconTS1 and TconTS2, exhibit about 100- or
1000-fold higher specific TS activities than TconTS3 and
TconTS4, respectively. The KM values for lactose were around
1 mM (0.6 to 1.8 mM) for all four TconTS and did not correlate
with their specific activities. The KM values for the donor fetuin
were more different ranging from 0.4 to 6 mM glycoprotein
bound sialic acids. The KM for fetuin also did not correlate with
the specific activity, since the highest KM was determined for
TconTS3, one of the enzymes with low activity, and TconTS4 has
a similar KM as TconTS1, but is 1000-fold less active. Since the
KM values are lower than the substrate concentrations used,
especially for TconTS4, the specific activities given in Table 3 are
lower than those to be expected, if the acceptor substrate lactose
would be at saturating concentrations.
Figure 1. Primary amino acid sequence alignment of TconTS and TconTS-Like genes. Amino acid sequences of TconTS1b
(EMBL:HE583284), TconTS2, TconTS3 and TconTS4 were obtained by sequencing of cloned genes. Those of TconTS-Like 1, TconTS-Like 2 and
TconTS-Like 3 were obtained from the WSTI database. CluwstalW alignment plugin of the Geneious software was used employing BLOSUM12 with
gap openings and extension penalties of 10 and 0.1, respectively. Increasing darkness of background indicates increasing numbers of identical amino
acids at each position. The numbers on top of the sequences indicate the positions in the consensus sequence. Amino acid residues postulated to be
critical for catalysis, substrate binding and structure as given in Table 2 are boxed.
doi:10.1371/journal.pntd.0002549.g001
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Table 2. Amino acids in the catalytic domains of TS and TS-Like genes from T. congolense involved in enzymatic activities*.
Consensus Tcon TS1 Tcon TS2 Tcon TS3 Tcon TS4 Tcon TS-Like1 Tcon TS-Like2 Tcon TS-Like3
catalysis
212 D150 D135 D142 D207 D110 E85 K86
410 E324 E309 E316 E381 N291 Y257 S262
532 Y438 Y423 Y430 Y493 F404 L375 H382
substrate binding
188 R126 R111 R118 R183 E86 H61 R62
425 R339 R324 R331 R396 A306 Q272 S277
496 R410 R395 R402 R465 N375 L339 D346
206 R144 R129 R136 R201 R104 R79 W80
270 D188 D173 D180 D245 G160 L122 P132
293 Y211 P196 Y203 Y268 A183 G145 S155
294 W212 W197 W204 W269 L184 T146 L156
374 Q289 Q274 Q281 Q364 V255 E222 V227
494 Y408 W393 W400 Y463 A373 E337 D344
structure
411 A325 A310 S317 A382 P292 C258 S263
465 P379 P364 P371 P434 V344 G308 G315
*The indicated amino acids have been selected based on structural [18] and mutation [19] [23] studies with T. cruzi TS and on the sequence alignment of TconTS1b with
T. cruzi [14]. Amino acid positions have been numbered based on the consensus of alignment (Figure 1) or starting methionine of each ORF.
doi:10.1371/journal.pntd.0002549.t002
Figure 2. Phylogenetic analysis TS genes. Phylogenetic analyses of DNA sequences were performed as described under Methods using
‘‘MrBayes’’ plug-in of Geneious. Trees are midpoint rooted and nodes supported by posterior probability values and non-parametric bootstraps
generated by maximum likelihood analysis in ‘‘MrBayes’’ as described under Methods. TS genes from T. congolense and T. brucei are marked by blue
frames, TS genes from T. vivax by red frames. A: Phylogenetic tree for full ORFs, the ‘‘African TS-branch’’ is marked by a grey frame; B: Phylogenetic
tree for LDs, the most active TconTS and their orthologues from T. brucei are highlighted by a grey box.
doi:10.1371/journal.pntd.0002549.g002
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Tiralongo et al. [12] purified two TconTS forms with different
TS/sialidase activity ratios from procyclic T. congolense cultures.
Peptide sequences from these preparations have demonstrated that
they contained at least TconTS1 [12] [14]. Recombinant
TconTS1 variants expressed in eukaryotic cells had lower specific
activities for synthetic substrates than described for the purified
enzyme [12] suggesting that these TconTS preparations also
contained other enzymes and/or factors influencing the TS/
sialidase activities [14]. For example, in those preparations,
Glutamic Acid-Rich Protein, GARP, a natural substrate for
TconTS was co-purified with one of the TS forms [12]. Although
it is unclear what role GARP might have played, its presence, as
well as other TS enzymes, might have been responsible for the
reported higher specific activities of these TS preparations for
synthetic substrates. In summary, it appears that TconTS1 and
TconTS2 are responsible for most of the TS activity of T.
congolense. However, it may well be that TconTS3 and TconTS4
are more active on other donor substrates, such as glycoproteins
and/or glycolipids from blood components, the natural substrates
for trypanosomal TS.
It has been established that procyclic forms of African
trypanosomes express TS [21] and emerging evidences point to
expression also in the blood stream forms [6] [7]. So far, no
information is available on which TS genes are expressed at what
stage of the parasite’s life cycle. Recently, we have identified
mRNAs for TconTS1, TconTS2 and TconTS4 in the blood of
infected goats (data not shown). Also the stability and persistence
of shed enzymes in the blood stream has to be taken into account.
In vitro TconTS1 and TconTS3 are the most stable of the four
enzymes investigated, retaining full TS activities even after four
months at 37uC. Under these conditions TconTS2 lost its activity
completely, while TconTS4 retained 40% residual sialidase but no
transfer activity (data not shown). It would be interesting to
investigate whether this long-term stability correlates with a
sustained persistence of enzyme activity in the blood stream.
Lactose was found to suppress the sialidase activity of TconTS4.
In vitro, lactose appears to be a better acceptor than water
(Figure 5B). Therefore, in presence of lactose, the transfer activity
of TconTS4 is more efficient than its hydrolytic activity. Anaemia
in animals suffering African Trypanosoma infections has been
attributed to the effects of sialidases [22] [5] [7]. Desialylation of
erythrocytes by sialidases exposes underlying galactose residues
and their subsequent degradation. The presence of lactose in
mammalian blood would lead to lowered efficiency of parasites
sialylation and eventual clearance by the immune system.
However, desialylation of parasites is equally possible in presence
of lactose due to the action of TS. Along this line it is interesting to
note that infusion of lactose in the blood of sheep suffering
experimental anaemia from T. congolense suppressed anaemia
(unpublished observation).
All amino acid residues shown to be involved in the catalytic
reaction or interaction with the substrate for T. cruzi TS are
conserved in the TconTS enzymes (Table 2). Only the two
residues interacting with the methylumbelliferyl aglycon or the
lactose part of 3’SL in the T. cruzi TS [18], positions 293 and 494
in consensus sequence (Figure 1), are different in the two most
active TconTS1 and TconTS2. This could explain why these
enzymes do not use Neu5Ac-MU as substrate (data not shown).
Furthermore, these changes could lead to a weaker interaction
with the leaving groups and thus facilitate their release during
catalysis. In this context it is interesting to note that the most
drastic change, Tyr to Pro at position 293, occurs as P196 in
TconTS2, the most active enzyme with the highest TS/sialidase
ratio (Table 4). Certainly, this modification will reduce the
interaction with hydrophobic aglycons or the leaving galactose
residue of the donor substrate.
Amaya et al. [18] also provided evidence that in T. cruzi TS
Y119 (position 293 in the consensus sequence) also contributes to
hydrogen bonding with O9 of the covalently bound Sia following a
conformational change induced by the reaction. Such an
interaction would not be possible in TconTS2, but could be
compensated by hydrogen bonding with the conserved side chains
W197 and Q274 of TconTS2 corresponding to W120 and Q195
in T. cruzi TS, two amino acids contributing to the hydrogen
bonding network of O9 in the covalently bound Sia [18].
Similarly, although to a lesser degree, the replacement of a Trp
at position 494 (corresponding to W312 in T. cruzi TS) with a Tyr,
as found in TconTS1, is expected to reduce the hydrophobicity of
this site leading to a reduced affinity for the leaving group. In T.
cruzi TS substitution of this Trp (W312) by Ala basically abolished
Neu5Ac transfer but only slightly decreased hydrolytic activity for
3’SL [23]. Interestingly, in contrast to the wild type T. cruzi TS,
this mutant was not able to hydrolyse Neu5Ac-MU, similar to
TconTS1, which also does not accept Neu5Ac-MU as a substrate
[14].
It appears that TS activity depends on well controlled
conformational changes [17] influenced by specific proline
residues. This is supported by the potential of the T. rangeli
sialidase to acquire transfer ability due to a change of Gln to Pro at
position 284 [24] and the loss of enzymatic activity in T. cruzi TS
by the reverse mutation [16]. At the corresponding position 465
Pro is found in all active TconTS (Table 2). The relevance of
conformational changes in the enzyme rather than a direct specific
interaction of the amino acid were also indicated by mutation of
Pro231 to Ala in T. cruzi TS [19], corresponding to position 411 in
the consensus sequence. Although this mutation led to a significant
decrease in T. cruzi TS activity, all active TconTS have an Ala or
Ser at this position. It would be interesting to see, if higher TS
activities can be obtained by introducing a Pro at this position,
particularly in TconTS3 or TconTS4, the two enzymes with low
TS activities.
Besides these critical amino acids listed in Table 2, other
structural features obviously control the ratio of TS versus sialidase
activities, since TconTS2 and TconTS4 share identical amino
acids at all these positions. Yet, TconTS4 has the highest sialidase
to TS ratio amongst the TconTS enzymes, whereas TconTS2 has
the lowest ratio (Table 4). Koliwer-Brandl et al. [14] observed for
TconTS1 that a natural mutation that replaced R144 (206 in
Figure 3. Recognition of TconTS proteins by antibodies. 100 ng
of affinity purified TconTS proteins were analysed by Western blot as
described under Methods. Blots were probed either with polyclonal
rabbit anti-Strep (upper pane) or with monoclonal mouse anti-TS1
antibody, which shows cross reactivity with TconTS2 (lower pane).
doi:10.1371/journal.pntd.0002549.g003
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consensus) sequence with Cys in the variants TconTS1g (EMBL:
HE582290) did not terminate but only reduced TS activity, while
increasing relative hydrolytic activity. It can be assumed that a
weaker interaction with the hydroxyl group at C4 of sialic acid is
responsible for the catalytic properties of TS1g, since the Arg (R53
in T. cruzi TS) is in close contact with the bound sialic acid and
probably supports the stabilisation of the enzyme-substrate
complex [18].
Conservation and/or substitution of amino acids in the active
centre of the catalytic domain did not give clear indications of
activity differences between the TconTS enzymes. In this context,
an interesting aspect is how the different specific activities of
TconTS enzymes correlate with those of related gene products
from other African trypanosomes. Phylogenetic analyses have
allowed the clear assignment of orthologues for T. brucei, but not
for T. vivax, where TS genes clustered exclusively together and
away from the TS genes of T. congolense and T. brucei (Figure 2) [7]
[25]. A direct comparison of the TS activities between T.
congolense and T. brucei is difficult, since limited comparable data
for enzymatic activities is available. In T. brucei TbTS and TbSA
C2 have been identified as active TS [9] [10] [11]. This is
consistent with the observation that their orthologues (TconTS1
and TconTS2, respectively) are the most active TS in T.
congolense. RNAi based experiments provided evidence that in T.
brucei TS and sialidase activities are encoded by different genes,
TbTS and TbSA C [10], whereas assays with purified
recombinant proteins demonstrated both enzyme activities for
TbTS and TbSA C2 [11]. Noticeably, the diversity of TS-related
genes in T. vivax is lower than what was obtained for T. congolense
and T. brucei. Equally, T. vivax is distinctively different from T.
congolense and T. brucei in terms of development in the insect host.
While the later two develop in the insect midgut and proboscis or
salivary glands respectively, T. vivax develops exclusively in
mouthparts of the tsetse. Moloo and Gray [26] showed that T.
vivax ingested with blood meal to the midgut is disintegrated. TS-
like genes from T. vivax share all but two (consensus sequence
positions 411 and 494) of the conserved amino acids listed in
Table 2 with the active TconTS. Recently Guegan et al. [7]
reported that TvivTS2 has TS activity. Furthermore, they
obtained evidence for the presence of at least TvivTS1, TvivTS3
and TvivTS5 in the bloodstream form and none in epimastigotes
and the possible involvement of these proteins in anaemia in
infected mice. In summary, it may be possible that T. vivax is
missing a suitable TS to survive and colonise the fly vector
midgut. To this end, it would be interesting to see the survival
ability of transgenic T. vivax expressing a TS, which is expressed
by T. congolense in the midgut of tsetse flies.
The presence of multiple highly similar TS genes, as described
for TconTS1 [14], suggests that these genes undergo active
rearrangements, which could lead to strain specific differences. For
example, Coustou et al. [6] referred to two highly related TconTS3
genes in the IL3000 strain identified in GeneDB and TrytrypDB
databases. However, we could not find evidence for their existence
in the STIB294 strain used in this study. Similarly, closely related
genes with over 80% sequence identity have been identified for
TbSA B and TbSA C in T. brucei [11].
TS and sialidase genes of African trypanosomes are organised in
two major domains; the CD and the LD. The LDs of TconTS are
more varied (40% pairwise identity) when compared with the CDs
(58% pairwise identity). Surprisingly, the phylogenetic relation-
ships between the TS are clearly different, if only the LDs are
included in the analysis (Figure 2). Furthermore, the LDs of the
two most active enzymes TconTS1 and TconTS2 are more closely
related than the CDs, where TconTS2 is most closely related to
TconTS3. Interestingly, the monoclonal anti-TS1 antibody also
binds TconTS2, recognising an epitope in the LD. First
preliminary experiments obtained with recombinant proteins, in
which the LDs have been swapped between TconTS, provided
supporting evidence that the LD influences TS and sialidase
activities of the enzymes (data not shown). However, the specific
activities of these proteins expressed in bacteria is much lower than
those of the proteins expressed in fibroblasts described here,
Figure 4. Concentration dependency of TS activity. The indicated amounts of recombinant TconTS proteins were incubated with 100 mg fetuin
(600 mM bound Sia) and 2 mM lactose for 30 (TconTS2), 240 (TconTS3), or 1440 (TconTS4) minutes. 3’SL produced was determined by HPAEC-PAD as
described under Methods. Data points are means 6 standard deviations of three independent experiments, each as triplicates. A: TconTS2, B:
TconTS3, C: TconTS4.
doi:10.1371/journal.pntd.0002549.g004
Table 3. Kinetic parameters of TconTS.
Donor substrate (fetuin-bound Sia)* Acceptor (lactose)**
vmax*** (mmol/(min6mg TS)) KM*** (mM) vmax*** (mmol/(min6mg TS)) KM*** (mM)
TS1b**** 7.960.3 359645 4.360.1 16836101
TS1e-1**** 7.660.5 16176223 2.160.1 727648
TconTS2 17.6260.13 299.0067.0 17.8560.13 602616
TconTS3 0.1760.02 6090.0061267 0.056760.0014 1104679
TconTS4 0.006760.0002 949650 0.007560.0002 18066112
*Approximately 30 nmol Sia per 100 mg fetuin; 2 mM lactose was used as acceptor substrate.
**600 mM fetuin-bound Sia was used as donor substrate.
***KM and vmax were calculated from Michaelis-Menten kinetics (see Supplementary Information, Figure S1) by SigmaPlot. Data points are mean 6 standard deviations
of three independent experiments, each replicated thrice.
****values from Koliwer-Brandl et al. [14].
doi:10.1371/journal.pntd.0002549.t003
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suggesting that for conclusive interpretation the domain swapped
TconTS have to be expressed in eukaryotic cells and that further
studies are necessary to optimise the fusion of the two domains. In
summary, these data indicate a more significant role for the LD for
the TS activities of TS1 and TS2 and thus possibly in the
pathogenesis of African trypanosomiasis.
Figure 5. Sialidase activity of TconTS4. A: Recombinant TconTS4 was incubated with 100 mg fetuin (600 mM bound Sia) for the times indicated
(see insert for long term reactions) and free Sia determined by HPAEC-PAD as described under Methods. Data points are means 6 standard
deviations of 3 independent reactions each triplicated. B: Recombinant TconTS4 was incubated for 1440 min with 100 mg fetuin (600 mM bound Sia)
in the presence of the lactose concentrations indicated and free Sia determined by HPAEC-PAD as described under Methods. Data points are means
6 standard deviations of 3 independent reactions each as triplicates.
doi:10.1371/journal.pntd.0002549.g005
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Supporting Information
Figure S1 Trans-sialidase reaction velocities depending
on substrate concentrations. Product (39-sialyl-lactose)
amounts were determined as described under Methods. vmax and
KM for lactose shown in Table 3 were calculated from these data.
Data points are mean 6 standard deviations of three independent
experiments, each replicated thrice. A) TconTS2 with different
donor substrate concentrations. 50 ng TconTS2 were
incubated for 30 minutes with 2 mM lactose and the indicated
concentrations of fetuin-bound Sia. B) TconTS2 with different
acceptor substrate concentrations. 50 ng TconTS2 were
incubated for 30 minutes with 600 mM fetuin-bound Sia and the
indicated lactose concentrations. C) TconTS3 with different
donor substrate concentrations. 250 ng TconTS3 were
incubated for 120 minutes with 2 mM lactose and the indicated
concentrations of fetuin-bound Sia. D) TconTS3 with different
acceptor substrate concentrations. 500 ng TconTS3 were
incubated for 120 minutes with 600 mM fetuin-bound Sia and the
indicated lactose concentrations. E) TconTS4 with different
donor substrate concentrations. 500 ng TconTS4 were
incubated for 1440 minutes with 2 mM lactose and the indicated
concentrations of fetuin-bound Sia. F) TconTS4 with different
acceptor substrate concentrations. 500 ng TconTS4 were
incubated for 1440 minutes with 600 mM fetuin-bound Sia and the
indicated lactose concentrations.
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File S1 Nucleotide sequences of the sialidase and trans-
sialidase genes used in the phylogenetic comparison of
‘‘full length open reading frames’’ (catalytic plus lectin
domains). The gaps inserted for the alignment as described
under Methods are indicated by dashes. The file is a text file in
FASTA format with the gene names (see Table S2) in the first line
for each gene.
(TXT)
File S2 Nucleotide sequences of the sialidase and trans-
sialidase genes used in the phylogenetic comparison of
‘‘catalytic domains’’. The gaps inserted for the alignment as
described under Methods are indicated by dashes. The file is a text
file in FASTA format with the gene names (see Table S2) in the
first line for each gene.
(TXT)
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Abstract
Nagana, the animal form of trypanosomiasis, caused by Trypanosoma species is a serious 
problem in Africa, the pathology of which trans-sialidases (TS) play a key role. Four active TS 
genes from T. congolense, TconTS1, TconTS2, TconTS3 and TconTS4 are expressed in the 
bloodstream of infected animals. We studied the enzymatic activities of these diverse gene 
products on blood glycoconjugates and report that all TconTS enzymes transfer sialic acids (Sia) 
with TconTS1 and TconTS2 exhibiting highest specific activities for transfer, with little sialidase 
activity. Sialidase activities of TconTS1, TconTS2 and TconTS4 were higher on serum 
glycoconjugates than on fetuin. A combination of recombinant proteins leads to cleavage of MU-
Neu5Ac, a sialoside not used by single recombinant proteins at detectable levels. The enzymes 
exhibit different pH optima with TconTS2 showing a wide pH range, being active even at alkaline 
pH above 9. 
Author Summary
Trans-sialidases (TS) have been established as virulent factors in the Animal African 
Trypanosomiasis (AAT). Clinical signs of nagana include but not limited to accumulation of free Sia 
in blood and serum, however, it has remained unclear where this free Sia comes from and which 
enzymes are involved. Our study revealed high sialidase activities of some of the TS on blood 
glycoconjugates, possibly accounting for the high free Sia observed in blood of infected animals. 
The discovery that one of these enzymes, TconTS2, has a wide pH range and can be active at 
alkaline pH is in contrast to other sialidases which show preferences to acidic pH. The implication 
is that TconTS2 would be active even in the tsetse midgut which has an alkaline pH of about 10. 
While single recombinant TS enzymes do not utilise MU-Neu5Ac in detectable amounts, when 
combined, recombinant TconTS accepts MU-Neu5Ac. This suggests that combining different TS 
would enhance the parasites' ability to handle a wide variety of natural substrates as occurs in the 
mammalian host.
Introduction
Trypanosoma congolense (subgenus: Nannomonas) is a major causative agent of the Animal 
African Trypanosomiasis (AAT) otherwise known as nagana. Nagana has profound negative 
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impact on stock farming, milk and meat production on the African continent (Steverding 2008). 
Other Trypanosoma spp. implicated in nagana include but not limited to T. vivax (sungenus: 
Duttonella) and T. brucei brucei (subgenus: Trypanozoon), which are transmitted by bites of 
Glossina spp. These protozoans express a unique enzyme called trans-sialidase (TS). Their role in 
establishing infection in the tsetse vector has been established for T. brucei (Nagamune et al. 
2004). While no such information is available for T. congolense, TS genes are likely to play a 
similar role, since T. congolense and T. brucei share several aspects of their biology, for e.g. they 
both establish infection first in the tsetse midgut where TS plays a role. Both T. brucei and T. 
congolense share TS orthologues, which are distinctively absent in T. vivax (Guegan et al. 2013, 
Jackson et al. 2013, Gbem et al. 2013). Though transmitted by tsetse as well, T. vivax exhibits a 
different mode of development in the fly vector only restricted to the mouth parts (Moloo and Gray, 
1989). 
In the mammalian host, TS/sialidase are shed in the serum of infected animals and have been 
identified as virulent factors in trypanosomiasis caused by T. congolense (Coustou et al. 2012) and
T. vivax (Guegan et al. 2013). A significant level of sialidase activities in the blood of T. congolense 
(Nok and Balogun 2003) as well as sialidase and TS in T. vivax (Guegan et al. 2013) of infected 
mice have been reported. Similarly, the mechanism of anaemia induction has been established. It 
has been shown that removal of Sia from erythrocytes' major surface sialoglycoproteins, the 
glycophorins leads to erythrophagocytosis in the course of T. vivax (Guegan et al. 2013) and T. 
congolense (Coustou et al. 2012) infections.
Serum contains a wide array of glycoproteins and glycolipids that are heavily sialylated. For a 
detailed list of serum components, refer to the serum metabolomics where a comprehensive list of 
serum components has been compiled (Psychogios et al. 2011) and can be assessed at SMDB: 
http://www.serummetablome.ca/http://www.serummetablome.ca. Pathogens can alter the chemical 
and physiological composition of serum and blood plasma. For example, the intracellular 
Trypanosoma parasite T. cruzi is poorly sialylated when released from cells but becomes densely 
sialylated upon contact with serum (Schenkman et al. 1991). In investigating the role of TS and 
sialidases in trypanosomosis however, attention has focussed mainly on whole blood (Esievo et al. 
1982, Nok and Balogun 2003, Coustou et al. 2012, Guegan et al. 2013), but it has remained 
unclear where the free Sia come from; the blood cells, soluble glycoproteins, glycolipids or a 
combination thereof. On these glycoconjugates, Sia occur linked as ?2,3, ?2,6 or ?2,8 to a variety 
of glycan structures. Further diversity comes from the different naturally occurring Sia modifications 
(Kelm and Schauer 1997). Bulai et al. (2003) reported that 96% Sia on human erythrocytes are 
glycoprotein-associated comprising 9 other Sia besides Neu5Ac, the main Sia. These diverse 
sialylated glycoconjugates on RBC surfaces and on serum components represent potential 
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substrates for TS and could be removed by these enzymes. While a proportion is transferred to the 
parasites, as described for T. cruzi (Zingales et al. 1987, Schenkman et al. 1991), a certain 
proportion is lost becoming free Sia in the serum. The desialylated blood glycoconjugates products
are rapidly cleared via galactose specific mechanisms (Kelm and Schauer 1997), a mechanism 
which is most likely an important reason for pathological effects of nagana, such as anaemia and 
impaired immune response.
T. congolense expresses several TS, which are also expressed in the bloodstream of infected 
animals (Coustou et al. 2012, Gbem et al. 2013), but the biological relevance for this diversity has 
not been addressed. Previously, we expressed recombinant TconTS1, TconTS2, TconTS3 and 
TconTS4 proteins and studied their kinetic activities on single natural substrates. We showed that 
they are all able to trans-sialylate, but with distinct enzyme kinetics and levels of sialidase 
activities. Investigating the effects of TconTS activities on biologically relevant substrates is 
necessary for a better understanding of their possible role in the pathology of nagana. Here, we 
investigated the activities of TconTS genes on serum, a biologically relevant substrate and 
conclude that expressing more than one enzyme at a stage may be beneficial to the parasite.
Materials and Methods
Methods
All chemicals and reagents used were cell culture and analytical grade. Anti-SNAP-tag rabbit 
polyclonal antibody was from GeneScript (Piscataway, USA) while anti-Strep tag rabbit polyclonal 
antibody, Strep-Tactin resin beads and buffers were from IBA (Göttingen, Germany). Vibrio 
cholerae sialidase was purchased from Roche Diagnostics (Mannheim, Germany). Pfu DNA 
polymerase, HindIII, XbaI, SpeI, EcoRI and DpnI, PageBlue, molecular weight marker (PageRuler), 
BCA assay protein kit were all purchased from Thermo Scientific (St. Leon-Rot, Germany). X-ray 
film, Enhanced Chemiluminescence system, and recProtein-A Sepharose Fast Flow were 
purchased from GE Healthcare (Uppsala, Sweden). Polyvinylidene difluoride membrane was from 
Millipore (Schwabach, Germany). VivaSpin 6 and VivaCell250 ultracentrifugation units were from 
Sartorius (Göttingen, Germany). Hygromycin and gentamycin were purchased from PAA, 
(Pasching, Austria). Polyethylenimin transfection reagent, glucoronic acid, N-acetyl-neuraminic 
acid (Neu5Ac), 3'sialyllactose (3'SL), Neu5Ac-MU, MU-Gal and lactose, HCl and orcinol were 
purchased from Sigma-Aldrich (Steinheim, Germany). Ex-cell CD CHO media from SAFC, USA, 
and 96-well plates were from Sarstedt (Hamburg, Germany). Asialofetuin (ASF) was prepared 
using Vibrio cholerae sialidase as previously described (Koliwer-Brandl et al. 2011).
Recombinant trans-sialidases
Cell lines derived from CHOLec 1 cells (Kumar and Stanley 1989) expressing recombinant TconTS1 
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through TconTS4 with a SNAP and a Strep tag and the purification of these proteins has been 
described (Koliwer-Brandl et al. 2011, Gbem et al. 2013).
Serum preparations
To obtain serum, human blood was collected without anticoagulant and and was allowed to clot at 
room temperature for at least 30 minutes. The clotted components were separated from serum by 
centrifugation at 1500 min-1 for between 10 minutes at 4oC. To quantify Sia content, serum was 
serially diluted in 40 ?L amounts per well and total sialic acid determined using the resorcinol/Fe3+ 
reagent as described (Reuter and Schauer 1994).
Trans-sialidase and sialidase reactions
Enzymes used in control assays were heat inactivated. All reactions were incubated at 37oC in 10 
mM phosphate buffer, pH 7.4. Fetuin, human serum and synthetic substrates including Neu5Ac-
MU, 3'SL, pNP-Neu5Ac served as Sia donor substrates while lactose, Gal-MU and ASF served as 
acceptor substrates. Except for the experiments involving different mixtures of TconTS on Neu5Ac-
MU and that involving determination of pH optima, all other tests were carried out as described 
(Koliwer-Brandl et al. 2011, Gbem et al. 2013). For determination of pH optima for TconTS 
enzymes, pH was adjusted to the required pH of 6, 7, 8, 9 and 10, while reactions in which pH 7.4 
was maintained served as controls. The reactions involving Neu5Ac-MU were done by combining 
250 ng individual TS enzymes into different enzyme mixtures in a total reaction volume of 50 ?L 
with 1 mM Neu5Ac-MU as Sia donor and 2 mM lactose as acceptor. Quantification of Neu5Ac, 
3'SL and Neu5Ac-GalMU were carried out using the HPAEC-PAD system described (Koliwer-
Brandl et al. 2011, Gbem et al. 2013).
In order to establish kinetic parameters, the ligand binding (single site saturation) curve fit module 
of SigmapPlot 11 was used to calculate vmax and KM employing the Michaelis-Menten equation v = 
vmax Cs/(Cs+ KM).
Results
Sialidase activities on fetuin
Sialidase activities of TconTS genes have been implicated in anaemia in animals suffering 
Trypanosoma infections (Nok and Balogun 2003, Coustou et al. 2012, Guegan et al. 2013). 
Desialylation of erythrocytes by Trypanosoma TS enzymes subsequently leading to their clearance 
from the host circulatory system has been linked to causes of anaemia. Serum is a complex 
substrate with different sialylated glycolipids, and glycoproteins. We needed to have a comparative
basis by using a single substrate. We firstly characterised sialidase activities of TconTS enzymes 
on the blood glycoprotein fetuin for the following reasons; (i) it has been extensively employed to 
62
biochemically characterize the transfer activities of these genes (Koliwer-Brandl et al. 2011, Gbem 
et al. 2013), (ii) it is a single and less complex substrate allowing easy comparison and inferences 
and (iii) though found in only foetal serum and may be less relevant in this respect, substrates like 
acute-phase proteins (APPs) e.g. the Alpha-1-acid glycoprotein (AGP) present in serum are highly 
sialylated and thought to play a role in modulating immune and inflammatory responses (Logdberg 
and Wester 2000) may be cleared. 
Gbem et al. (2013) reported that TconTS enzymes exhibited low sialidase activities with TconTS4 
showing the highest activity when fetuin was used as donor in TS reactions with sialidase activities 
of TconTS1, TconTS2 and TconTS3 detected only when 3'SL accumulated in the reaction. This 
indicated the desialylation of the 3'SL product but not the donor fetuin. Similarly, we reported that in 
the absence of lactose, except for TconTS4, sialidase activity were observed for TconTS1 and 
TconTS2 when 10-fold (500ng) enzyme amount were incubated with fetuin for 2 h. TconTS3 did not 
show sialidase activity even under these conditions. However, the study did not give vmax and KM 
values for sialidase activities of these enzymes. Equally, enzyme amounts higher than 50 ng were 
not incubated with fetuin for longer times and therefore, no definite statement could be made as to 
wether or not lower enzyme amounts exhibited sialidase activities.
In the present study, sialidase reactions contained approximately 600 ?M fetuin-bound Sia without 
an acceptor substrate. Reaction velocities were measured at indicated time points (Figure 1a, 
Table 3). 200 ng TconTS1 released 0.82 nmol Sia in 8 h (1.7 pmol/min). Incubations over extended 
periods up to 24 h released 2 nmol Sia (40 ?M), showing reduced reaction velocity. TconTS2 
showed a similar pattern but higher Sia release. 200 ng TconTS2 released 1 nmol Sia in 8 h (2.2 
pmol/min) with the velocity of free Sia release decreasing with a total of 2.5 nmol free Sia (50 ?M) 
within 24 h. 250 ng TconTS3 released 0.14 nmol Sia in 4 h (0.75 pmol/min). Velocity decreased as 
prolonged incubations released a total of 0.6 nmol Sia (12 ?M) after 24 h. 250 ng TconTS4 
released 0.15 nmol Sia in 2 h (1.25 pmol/min). At prolonged incubations up to 24 h, reactions 
velocities decreased until a total of 1.1 nmol Sia (22 ?M). Since fetuin-bound Sia contained 600 ?M 
Sia, the amount of Sia available could not be responsible for the decrease in the velocity of Sia 
release. However, in typical bacteria sialidases, free Sia has been shown to inhibit sialidase activity 
(Garcia Sastre et al. 1991). Varied enzyme amounts up to 1000 ng were incubated for 24 h to 
monitor if Sia release from fetuin depended on the amount of enzyme (Figure 1b). Under these 
conditions, Sia release from fetuin by TconTS1 and TconTS2 was concentration dependent. 500 ng 
enzyme released 6 nmol Sia (4.2 pmol /min) and 1000 ng released 12 nmol (8.3 pmol Sia/min) for 
both TconTS1 and TconTS2. At below 500 ng enzyme amounts, differences exist in the amount of 
Sia released by the two TconTS enzymes. At 200 ng enzyme amounts, TconTS1 released 2 pmol 
Sia/min while TconTS2 released 2.4 pmol Sia/min, indicating faster Sia release by TconTS2. The 
amount of Sia released by TconTS3 followed a similar pattern with those of TconTS1 and TconTS2 
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but with lower Sia amounts released as 500 ng released 2.1 nmol (40 ?M) while 1000 ng released 
4.2 nmol Sia (80 ?M) after 24 h. Increasing Sia release was observed with increasing TconTS 
amounts. 500 ng TconTS4 enzyme released 4.5 nmol while 1000 ng released 6.5 nmol in 24 h. 
Kinetics parameters were determined for sialidase activities of TconTS enzymes on fetuin (Tables 
1, Figure S1a-d). To achieve this, we used 200 ng each for TconTS1 and TconTS2, and 250 ng 
each for TconTS3 and TconTS4 were incubated with 600 ?M fetuin-bound Sia for 2 h for both 
TconTS1 and TconTS2, and 24h for both TconTS3 and TconTS4. TconTS1 and TconTS2 exhibited 
similar magnitudes of specific activity on fetuin (about 0.1 μmol/(min x mg TS)). This is 13- and 33-
fold higher than that exhibited by TconTS4 and TconTS3 respectively on the same substrate. KM 
values were also similar for TconTS1 (20 ?M) and TconTS2 (30 ?M). The KM values for TconTS3 
(137 ?M) and TconTS4 (441 ?M) were higher than those of TconTS1 and TconTS2.
Serum glycoconjugates as substrates for TconTS enzymes
Sia transfer was determined from 3'SL production in reactions containing serum as donor and 
lactose as acceptor substrates, respectively. Sialidase activity was monitored by Neu5Ac release 
from serum either in the absence or presence of lactose. A summary of these results is presented 
in Table 4. 200 ng TconTS1 produced 42 pmol 3'SL/min during the first 2 h (Figure 2a). At longer 
incubation times, the reaction velocity decreased until a maximum of 6 nmol 3'SL was reached. 
This did not appear to be due to donor substrate exhaustion, since this amount corresponds to 120 
?M 3'SL, which is only 20% of the 600 ?M serum-bound Sia available in the reaction. Even at 
prolonged incubations for up to 24 h with up to 1000 ng TconTS1 no more 3'SL was obtained 
(Figure 2b) suggesting that at 120 ?M 3'SL, an equilibrium has been attained or the residual 
serum-bound Sia is not available for transfer by TconTS1, for example due to sialidase activity. 
However, free Sia could only be detected after longer incubations or with high amounts of TconTS1 
and the maximum Sia released was 1.5 nmol after 24 h or with 1000 ng enzyme, representing less 
than 3 % of total serum-bound Sia added. In the absence of lactose, higher sialidase activity was 
detected and 200 ng TconTS1 released 8 pmol Sia/min for up to 4 h, after which the velocity 
started to decrease, attaining 5 nmol free Sia after 24 h (Figure 2a). Even 1000 ng TconTS1 
hydrolysed only slightly more Sia (6.5 nmol). Interestingly, this is similar to the 6 nmol 3'SL formed 
by the same amount of enzyme.
A similar pattern of 3'SL formation was observed for TconTS2. 200 ng TconTS2 produced 75 pmol 
3'SL/min for the first 2 h (Figure 2c). Reaction velocity decreased at longer incubation times until a 
maximum of 8 nmol 3'SL was reached. Increasing the enzyme to 1000 ng TconTS2 did not lead to 
higher amounts of 3'SL (Figure 2d) corresponding to 160 ?M 3'SL, which represents 27% of the 
total serum-bound Sia available in the reaction. In the presence of 2 mM lactose, free Sia could 
only be detected after longer incubation times and reached a maximum of 0.25 nmol free Sia, less 
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than 1% total serum-bound Sia available in the reaction (Figure 2c and 2d). Higher sialidase 
activities were observed in the absence of lactose, where 200 ng TconTS2 released 13 pmol free 
Sia/min in the first 2 h (Figure 2c). Reaction velocity decreased at longer incubation times. The 
maximum free Sia obtained was 5 nmol and did not increase, even if 1000 ng TconTS2 was 
incubated for 24 h.
Sia transfer from serum donor substrate by TconTS3 was almost two orders of magnitude slower 
than with TconTS2, since 250 ng TconTS3 produced 0.83 pmol 3'SL/min. This reaction velocity 
was linear during the first 8 h (Figure 2e) before it decreased and a total of 0.65 nmol 3'SL was 
reached after 24 h. Increasing the enzyme to 1000 ng TconTS3, 1 nmol 3'SL could be obtained 
(Figure 2f). This corresponds to 20 ?M representing 3 % of the total 600 ?M serum-bound Sia 
available in the reaction. Under these conditions, free Sia was not detected in TconTS3 reactions 
containing the acceptor lactose, even at longer incubation times and higher enzyme amounts. In 
absence of lactose however, sialidase activity was detected and 1000 ng enzyme released 0.3 
nmol free Sia in 24 h.
TconTS4 showed faster Sia transfer from serum donor than TconTS3 with 250 ng enzyme 
producing 4 pmol 3'SL/min in 1 h (Figure 2g). Reaction velocity decreased over extended 
incubation times leading to 0. 8 nmol 3'SL in 24 h. Incubation with 1000 ng TconTS4 for 24 h 
produced 1.1 nmol (Figure 2h). In the presence of lactose, 1000 ng TconTS4 released 0.21 nmol 
free Sia in 24 h and the amount increased to 4.5 nmol in absence of lactose (Figure 2h).
Kinetic parameters of serum-bound Sia as substrate for sialidase and trans-sialidase activities 
were determined in the presence of 2000 ?M lactose as acceptor substrate for trans-sialidase 
(Table 2, Figure S2a-d). Similarly, KM and vmax values of lactose as acceptor substrate for trans-
sialidase was determined in the presence of 600 ?M serum-bound Sia (Table 2, Figure S3a-d). In 
summary, TconTS1 and TconTS2 have higher specific activities than TconTS3 and TconTS4. 
TconTS1 and TconTS2 have lower KM values for the acceptor substrate lactose, whereas TconTS3 
and TconTS4 have lower KM for serum-bound Sia.
Kinetic parameters were also established for sialidase activities by incubating reactions at standard 
conditions without lactose (Table 1, Figure S4a-c). Since 250 ng TconTS3 did not show sialidase 
activity within a 24 h incubation, no further reaction was set up for this enzyme. TconTS1 had the 
lowest KM (0.16 mM) followed by TconTS2 (0.41 mM). TconTS4 had the highest KM (1.28 mM) but 
lowest free Sia release from serum-bound Sia. Free Sia release by TconTS4 is about 50- and 80-
fold less than that released by TconTS1 and TconTS2, respectively.
TconTS show poor catalytic activities on synthetic donor substrates 
(Tiralongo et al. 2003b) reported higher specific activities for synthetic substrates by two TconTS 
forms purified from procyclic T. congolense cultures. One of those preparations was co-purified 
with Glutamate and Alanine Rich Protein (GARP), the natural substrate for TconTS. Expressed as 
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recombinant TconTS1 variants in eukaryotic fibroblasts, lower specific activities on synthetic 
substrates were reported for TconTS1 variants, which were equally unable to release Neu5Ac from 
Neu5Ac-MU (Koliwer-Brandl et al. 2011). While GARP might have played a role in the higher 
specific activities observed by Tiralongo et al. (2003a) evidence was provided (Koliwer-Brandl et al.
2011, Gbem et al. 2013) that other TconTS enzymes were probably present in the TconTS forms 
purified from polycyclic cultures.
We tested individual recombinant TconTS2, TconTS3 and TconTS4 on different synthetic 
substrates. Like TconTS1 (Koliwer-Brandl et al. 2011), TconTS2, TconTS3 and TconTS4 enzymes 
were poor at utilising synthetic donor substrates (results not shown). Neu5Ac-MU has been widely 
used in establishing TconTS enzyme activities (Schrader et al. 2003, Schrader et al. 2006). Apart 
from the activities of TconTS enzymes of polycyclic origin (Engstler et al. 1993, Engstler et al. 
1995, Tiralongo et al. 2003b, Nok and Balogun 2003, Coustou et al. 2012) reported activities of 
TS/sialidases from blood of T. congolense infected animals on Neu5Ac-MU. However, for 
recombinant TconTS1, TconTS2, TconTS3 and TconTS4 hardly any TS or sialidase activities on 
Neu5AcMU were detected, even after 24 h incubation (Koliwer-Brandl et al. 2011, Gbem et al. 
2013). Bearing in mind that the procyclic TconTS forms most likely contained other TconTS forms, 
we tested different combinations of TconTS gene products on Neu5Ac-MU. Interestingly, a mixture 
of TconTS1 and that of TconTS2 with any other TconTS transferred Sia from Neu5Ac-MU, while 
TconTS3 mixed with TconTS4 did not. No free Sia was detected in the reactions (Figure 3). 
Serum presents different donor and acceptor substrates possibilities for TconTS enzymes
We had earlier established that among the TconTS enzymes, TconTS1 and TconTS2 have the 
highest specific activities on the donor blood glycoprotein fetuin and lactose as acceptor (Gbem et 
al. 2013). We speculated on the basis of that finding the possibility of substrate selectivity detecting 
differences in specific activities of the enzymes; for example, TconTS3 and TconTS4 exhibiting 
higher specific activities on other donor substrates, possibly blood glycoproteins and/or glycolipids.
The HPAEC-PAD methods used in quantification of products made it possible to quantify different 
sialylated as well as desialylated products (shown by reduced peak areas) from chromatograms of 
single reactions. If TconTS3 was used as enzyme with human serum as substrate, at least one 
additional product was observed, which was eluted after 3'SL. Quantification of this unknown 
product ( tR of 8 mins) revealed higher peak areas when compared with the 3'SL peak (Figure 4a). 
Interestingly, when serum-bound Sia was varied and lactose kept constant, the unidentified product 
was favoured at low serum-Sia concentrations, whereas 3'SL was formed with higher priority at 
high serum-Sia concentrations (Figure 4b). Control serum samples usually contained inherent 
compound peaks that are detected by the HPAEC-PAD method used. We observed that when 
TconTS2 was used, three of these inherent peaks were desialylated (Figure 5a). No desialylated 
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peak was observed for TconTS1 (Figure 5b) as well as for TconTS3 and TconTS4 (not shown). 
This indicates a preference for different donor substrates in serum between TconTS2 and the other 
TconTS enzymes.
TconTS activities exhibit different pH optima
The pH in the midgut of the tsetse vector is between 9 and 10 (Dyer et al. 2013). In the mammal, 
the parasite encounters a pH of 7.4. pH optimum may give a likely indication of which TconTS gene 
product operate better in the different host systems. Using fetuin as a model blood glycoprotein 
donor and lactose as acceptor substrates, we measured enzyme activities at different pH as 
indicated (Figure 6a-d). Extended incubation periods were required to asses hydrolytic activities for 
TconTS1 and TconTS2 given their poor sialidase activities compared to the high TS activities 
(Gbem et al. 2013). Therefore TS activities were run for 30 minutes, while sialidase activities 
without the acceptor lactose, incubated for 24h. Whereas TconTS1, TconTS3 and TconTS4 had pH 
optima at around 7 and only low TS activities between pH 9 to 10, the transfer activity of TconTS2 
was basically pH-independent between pH 6 and 10. Interestingly, while the TS activity of TconTS4 
is highest at pH 7, its sialidase activity has its optimum at pH 9. 
Discussion
Two forms of TconTS enzymes purified from polycyclic T. congolense cultures showed higher 
specific activities on synthetic substrates (Tiralongo et al. 2003b) when compared to recombinant 
TconTS proteins that were expressed in fibroblasts (Koliwer-Brandl et al. 2011). Convincing 
evidence was provided indicating that the purified proteins from T. congolense procyclic cultures 
possibly contained products from other TconTS genes (Koliwer-Brandl et al. 2011, Gbem et al. 
2013). The current study using recombinant proteins showed lack and/or poor activity on synthetic 
substrates (not shown). We observed that individually TconTS recombinant proteins do not cleave 
Neu5Ac-MU, the commonly employed substrate in sialidase and trans-sialidase assays. Cleavage 
of Neu5Ac-MU has been reported in assays involving these enzymes (Engstler et al. 1995, 
Tiralongo et al. 2003b, Nok and Balogun 2003, Schrader et al. 2003, Schrader et al. 2006, Coustou 
et al. 2012). These assays were either done with TconTS purified from polycyclic cultures or using 
blood/serum of infected animals. A mixture of either TconTS1 or TconTS2 with other TconTS 
resulted in Neu5Ac transfer to acceptor lactose (Figure 3) resulting in formation of 3'SL. This would 
point to the availability of other forms of TconTS enzymes in the previous reports. More importantly, 
it illustrates the synergistic effects of these enzymes and an enhanced virulence in infected 
animals where more than one enzyme is expressed. Secondly, it presents the possibility that when 
expressed in combination, the repertoire of potential donor substrates available to the parasite is 
increased possibly supporting a better survival in the host system. cDNA and Western blots 
analysis on tissues and blood of infected insects and goats respectively have confirmed the 
expression of more than one TconTS gene (Gbem et al. 2013). 
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Amino acid composition in the catalytic pockets of TonTS enzymes were reported in the partial 
sequences of TconTS form 1 and form 2 (Tiralongo et al. 2003a, Tiralongo et al. 2003b) and in 
TconTS1 variants (Koliwer-Brandl et al. 2011). Recently we reported on the amino acid 
composition in the catalytic pockets of active TconTS genes; TconTS2, TconTS3 and TconTS4 
(Gbem et al. 2013). When TconTS ORFs were aligned with the reference T. cruzi TS (Amaya et al. 
2004), two residues at consensus positions 293 and 494 were found substituted in TconTS1 and 
TconTS2, the most active TconTS genes. These residues are conserved in TconTS3 and TconTS4, 
the TconTS enzymes with low specific activities (Gbem et al. 2013). Structural and catalysis 
studies (Amaya et al. 2004) showed the residues in question to be essential in interacting with the 
methylumbelliferyl aglycon or the lactose part of 3'SL. Interactions of the enzymes may lead to 
formation of heterodimers or heterooligomers making it possible for Neu5Ac-MU to become a 
substrate. It is possible that other unidentified structural features of the proteins may be 
responsible for the differences in activity. It has been suggested recently that the lectin domain 
may play a more significant role in TS activities than previously thought (Gbem et al. 2013). It is 
also possible that the activity of TconTS enzymes on Neu5Ac-MU may be enhanced by suitable 
acceptor substrate since TS form 1 purified from polycyclic cultures contained GARP (Tiralongo et 
al. 2003b). In this vain, it would be interesting to see the effect of individual TconTS gene products 
on Neu5Ac-MU in the presence of GARP.
In previous studies (Koliwer-Brandl et al. 2011, Gbem et al. 2013), the enzymatic activities of four 
TconTS gene products using fetuin as a model blood glycoprotein donor substrate were compared. 
While the use of fetuin as a substrate provided important insights into the biochemical diversity of 
these enzymes, it was considered nevertheless important to look at a natural medium in which 
these enzymes operate. For this purpose, serum was employed. Specific activity patterns are 
similar for both fetuin (Gbem et al. 2013) and serum glycoconjugates in presence of lactose as 
common acceptor. TconTS2 showed the highest specific activity, followed by TconTS1, TconTS3 
and TconTS4 in that order (Table 2, Figure S2 and S3). Except for TconTS4, 3'SL production for the 
remaining TconTS enzymes is at least 10-fold higher in reactions involving fetuin-bound Sia 
(Koliwer-Brandl et al. 2011, Gbem et al. 2013) than those in which serum glycoconjugates is the 
donor substrate. The vmax obtained for TconTS1 and TconTS2 from assays with varying lactose 
concentrations are lower than the specific activities determined by varying the donor substrate, 
since for technical reasons the donor substrate concentration was non-saturating (0.3- and 0.8-fold 
of the KM values for the serum-bound Sia for TconTS1 and TconTS2, respectively).
TconTS1 and TconTS2 have the highest specific activities of the TconTS genes on the substrates 
considered so far. This however does not preclude the possibility of TconTS3 and TconTS4 being 
more active on other substrates. Generally, TconTS genes showed lower transfer activities on 
serum samples (Table 2) when compared to those obtained for fetuin (Gbem et al. 2013), both 
using as common acceptor. Serum contains a wide array of glycoproteins and/or glycolipids with 
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different Sia types (Bulai et al. 2002) in addition to other components (Psychogios et al. 2011). The 
possibility of a complex pattern of sialylation and desialylation is therefore enhanced as well as a 
more diverse source of Sia. TconTS2 desialylated peaks that are not desialylated by other TconTS 
enzymes (Figure 5), yet there is 3'SL formation in TconTS1, TconTS3 and TconTS4. This indicates 
different Sia source from those utilized by TconTS2. Peak desialylation was already pronounced 
after a 2-hour incubation of serum and lactose with TconTS2 (Figure 5b). Interestingly, no free Sia 
was detected in the TconTS2 reaction medium up to 8 h (Figure 2c) indicating an efficient Sia 
transfer to lactose and possibly other acceptors present in serum. 
TconTS3 showed an additional product peak (Figure 4a), in addition to the 3'SL peak. The 
formation of this additional product ,eluting at 8 minutes was favoured. This collaborates our earlier 
postulations on activities differing on the basis of substrates. Further, when lactose concentration 
was kept constant and Sia concentration varied, 3'SL formation was only favoured at higher Sia 
concentration compared to the additional product peak whose formation was favoured at lower 
serum-Sia concentrations (Figure 4b). It is possible that TconTS3 transfers Sia to different 
acceptors under differing Sia concentrations and may be employed at different stages of infection 
in the mammalian life stage; early disease state when Sia concentration is high and late disease 
stage or advanced anaemia when Sia availability might be low. 
TS from T. cruzi (Agusti et al. 2007) and T. congolense (Engstler et al. 1995) have been shown to 
transfer hydroxylated sialic acids, N-glycolylneuraminic acid, Neu5Gc on to surface acceptors. 
While Neu5Gc is widely distributed in the animal kingdom, it is absent in the normal tissues of 
humans (Varki, 2001, Angata and Varki 2002, Sprenger and Duncan, 2012). TconTS transfer both 
Neu5Ac and Neu5Gc with similar efficiencies (Engstler et al. 1995). 
TconTS3 did not show sialidase activity on human serum glycoconjugates. TconTS1 and TconTS2 
showed highest specific activities with similar magnitude of Sia release from both substrates. The 
KM values for fetuin-bound Sia were similar for TconTS1 and TconTS2, (Table 1). Gbem et al. 
(2011) reported that in absence of lactose, Sia cleavage from fetuin by TconTS1 and TconTS2 
could only be observed at high enzyme concentrations and extended incubation periods with free 
Sia detected only when 3'SL formation attained 300 ?M and 600 ?M for TconTS1 and TconTS2, 
respectively. Similarly, in presence of lactose, free Sia was detected in serum incubated with 
TconTS1 and TconTS2 only after 3'SL accumulated in the reaction medium and at high enzyme 
concentrations (Figure 2a-d). However, in absence of an external acceptor, e.g. lactose, sialidase 
activity for TconTS1 and TconTS2 increased (Table 5). This raises the question of the high amounts 
of Sia in the blood and serum (Nok and Balogun 2003, Coustou et al. 2012) of animals suffering 
anaemia from T. congolense infections. Koliwer-Brandl et al. (2011) found only partial resialylataion 
of asialofetuin by TconTS1 variants. Erythrocytes and serum components bearing Sia have 
evolved to be naturally glycosylated via cellular processing of Sia. These cells and mammalian 
gylcoconjugates may be poor acceptors of Sias after they have been desialylated. Once parasites 
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surfaces are sialylated, TS may continue to remove Sia but within an environment of poor 
acceptors, transfer becomes low.
Trypanosoma are digenetic parasites with life cycles that alternate between two different host 
systems; the tsetse vector and the mammalian host. Profound differences exist between these two 
systems, not least the pH as sialidases have rather acid pH optima and are inactive at pH between
9 and 10 (Reuter et al. 1987). The pH at which each enzyme show highest activity was established 
for TconTS enzymes. Considering the pH optimum for TconTS enzymes, TconTS2 can be expected 
to transfer Sia efficiently in the fly midgut. It would be interesting to see the impact of a TconTS2 
whose activity has been genetically modified to act as a sialidase in the gut of tsetse carrying 
Trpanosoma parasites. Interestingly, the sialidase activity of TconTS4 has a pH optimum around 
pH 9, in contrast to that for TS activity at pH 7. Nagana is accompanied by severe anaemia, which 
has been linked to trypanosomal sialidase (Nok and Balogoun 2003). We found that TconTS1 and 
TconTS3 did not loose their activity even after four weeks at 37ºC (Gbem et al. 2013). As TconS1 
activity tends to persist over long periods, this low activity could be compensated over time. This 
could explain why anaemia persists even at low levels of parasitaemia.
In conclusion, serum glycoconjugates serve as good sources with variable types of Sia, which 
could be transferred to the Trypanosoma parasite surfaces. Interestingly, when lactose acceptor 
was absented from reaction medium, free Sia accumulated. 
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Figure legends
Figure 1. Concentration and time dependency of Sia release from fetuin. TconTS enzymes 
were incubated at 37oC with 600 ?M fetuin-bound Sia. Free Neu5Ac indicating sialidase activity 
was determined by HPAEC-PAD. A: 200 ng enzyme was used for both TconTS1 and TconTS2 
while 250 ng enzymes were used for TconTS3 and TconTS4 and incubated at 37oC over indicated 
times and 24 h values are given in Table 3. B: Varying amounts of TconTS enzymes incubated for 
24 h. In all cases, values are means ± standard deviations of at least 3 independent experiments 
replicated trice.
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Figure 2. Concentration and time dependency of TconTS enzymes on human serum 
glycoconjugates. For concentration dependencies, indicated amounts of recombinant TconTS 
proteins were incubated with 600 ?M serum-bound Sia in presence and absence of 2 mM lactose 
for 24 h. In the time dependency studies, 200 ng each of TconTS1 and TconTS2, and 250 ng each 
of TconTS3 and TconTS4 were incubated at 37 °C for the indicated times. Detection of 3'SL 
represents transfer activity while the presence of Neu5Ac represents sialidase activity. Both were 
determined using HPAEC-PAD. A-D: TconTS1 and TconTS2. E-H: TconTS3 and TconTS4. Data 
points are means ± standard deviations of at least 3 independent experiments, each as triplicates.
Figure 3. TconTS activity on Neu5Ac-MU. TS reactions were setup with 1 mM Neu5Ac-MU and 
2 mM lactose as donor and acceptor substrates, respectively, and incubated either as single 
enzymes or as a mixture (250 ng of each enzyme) and incubated for 24 h at 37 °C as indicated . 
Neu5Ac and 3'SL was measured using HPAEC-PAD . Bars represent means ± standard deviations 
of triplicates of 3 independent experiments.
Figure 4. Additional product peak by TconTS3. An additional product peak that elutes at 8 is 
formed in addition to 3'SL by TconTS3 when incubated with serum-bound Sia in presence of 
lactose. 250 ng recombinant TconTS3 protein was used against a fixed concentration of one 
substrate and reactions incubated for 720 mins. A: Lactose variation against 600 ?M serum-bound 
Sia. B: Serum-bound Sia variation against 2 mM lactose. In all cases, HPAEC-PAD was employed 
in quantification as described in the Methods section. Data points are means ± standard deviations 
of at least 3 independent experiments, each as triplicates.
Figure 5. Effects of TconTS1 and tconTS2 on human serum glycoconjugates. 200 ng 
TconTS1 and TconTS2 protein were incubated with 600 ?M serum-bound in presence of 2 mM 
lactose Sia for 24 h. Letters a, b, c and d represent unidentified glycoconjugates peaks while 
GlcAc represent glucoronic acid, used as internal standard. A: TconTS2 showing desialylated 
peaks. B: TconTS1 showing 3'SL formation without desialylation of peaks. Colours represent 
different incubation times: black, blue, pink, brown and green indicate chromatograms of products 
obtained after 0, 4, 8, 12, 16 and 24 hours respectively.
Figure 6. pH optima for TconTS enzymes. Reactions to determine pH optima were carried out at 
indicated pH points as described under Methods using 100 ?g fetuin (600 ?M fetuin-bound Sia) in 
presence and absence of lactose. A: TconTS1 and B: TconTS2: 50 ng TconTS incubated for 30 
min to measure transfer activity indicated by 3'SL formation, while 250 ng TconTS incubated with 
600 ?M fetuin-bound Sia in absence of lactose for 24 hours. C: TconTS3 and D: TconTS4: 250 ng 
TconTS incubated for 24 hours in presence and absence of lactose for 1440 mins. All other 
experimental conditions are as stated in methods. Neu5Ac and 3'SL were measured using 
HPAEC-PAD as described under Methods. Data points are means ± standard deviations of 3 
independent experiments, each as triplicates.
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Legends to Supporting Information
Figure S1. Sialidase reaction velocities depending on fetuin-bound Sia concentration. 
Neu5Ac amounts were determined as described in Methods. vmax and KM shown in Table 1 were 
calculated from these set of data. A: 200 ng TconTS1 and B: 200ng TconTS2, both incubated for 2 
h with varied fetuin-bound Sia up to 200 mM. C: 250 ng TconTS3 incubated for 12 h with varied 
fetuin-bound Sia up to 200 mM, and D: 500ng TconTS4 incubated for 24h with varied fetuin-bound 
Sia up to 1500 mM. Data points are means ± standard deviations of 3 independent experiments, 
each as triplicates.
Figure S2. Trans-sialidase reaction velocities depending on serum glycoconjugates 
concentrations. 3'SL amounts were determined as described in Methods. vmax and KM as shown in 
Table 2 were calculated from these set of data. A: 200 ng TconTS1 incubated with 2 mM lactose 
and varying serum-bound glycoconjugates for 2 hours. B: 200ng TconTS2 incubated with 2 mM 
lactose and varying serum-bound glycoconjugates for 1 hour. C. 250 ng TconTS3 incubated with 2 
mM lactose and varying serum-bound glycoconjugates for 12 hours. D: 250 ng TconTS4 incubated 
with 2 mM lactose and varying serum-bound glycoconjugates for 24 hr. Data points are means ± 
standard deviations of 3 independent experiments, each as triplicates.
Figure S3. Trans-sialidase reaction velocities depending on lactose concentrations. 3'sialyl-
lactose amounts were determined as described in methods. vmax and KM as shown in Table 2 were 
calculated from these set of data. A: 200ng TconTS1 was incubated with 600 ?M serum 
glycoconjugates and varying amounts of lactose as indicated for 2 hour. B: 200 ng TconTS2 was 
incubated with 600 ?M serum glycoconjugates and varying concentrations of lactose as indicated 
for 1 hour. C: 250 ng TconTS3 was incubated with 600 ?M serum glycoconjugates and varying 
concentrations of lactose as indicated for 12 hours. D: 250 ng TconTS4 was incubated with 600 ?M 
serum glycoconjugates and varying concentrations of lactose as indicated for 24 hours. Data 
points are means ± standard deviations of at least 3 independent experiments, each as triplicates.
Figure S4. Sialidase reaction velocities depending on serum glycoconjugates 
concentrations. Neu5Ac amounts were determined as described in methods. vmax and KM shown 
in Table 1 were calculated from these set of data. A: 200 ng TconTS1 and B: 200ng TconTS2, both 
incubated for 2 and 1 hour, respectively, with varied serum glycoconjugates concentration without 
the acceptor lactose. C: 250 ng TconTS4 incubated for 24 hour with varied concentrations of 
serum-bound Sia. Data points are means ± standard deviations of 3 independent experiments, 
each as triplicates.
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Table 1. Kinetic parameters for sialidase activities of TconTS enzymes on fetuin- and serum-
bound Sia
TconTS Fetuin-bound Sia* Serum-bound Sia*
vmax**
(μmol/(min x mg TS))
KM **
(μM)
vmax**
(μmol/(min x mg TS))   
KM **
(μM)
TconTS1f 85±1.6 20±1.5 63±0.6 155±7.1
TconTS2 99±1.7 30±1.7 105±3.5 412±40
TconTS3 3.2±0.6 137±7.5 - -
TconTS4 8.1±0.3 441±16 1.3±0.0 1281±146
* 600?M was used as substrate for both fetuin-bound Sia and serum-bound Sia.
**KM and vmax were calculated from Michaelis-Menten kinetics (Figure S1 and S4) by SigmaPlot. 
Data points are mean ± standard deviations of three independent experiments, each replicated 
thrice
-= no hydrolytic activity on serum
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Table 2. Kinetic parameters of TconTS on sialic acid transfer from serum-bound Sia
Transfer
TconTS  Acceptor (lactose)* Donor substrate (serum-bound Sia)**
vmax***
(nmol/(min x mg TS))
KM***
(μM)
vmax***
(nmol/(min x mg TS))
KM***
(μM) 
TconTS1f 181±1.5 203±16 315±16 669±83
TconTS2 486±9.3  79±7.1 1005±60 750±104
TconTS3 4.2±1.0 1165±91 5.1±0.1 339±25
TconTS4 2.2±0.1 1321±156 3.2±0.1 259±26
* 600?M serum-bound Sia was used as donor substrate.
**2mM lactose was used as acceptor substrate.
***KM and vmax were calculated from Michaelis-Menten kinetics (Figure S2 and S3) by SigmaPlot. 
Data points are mean ± standard deviations of three independent experiments, each as triplicates.
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Table 5. Relationship between sialidase and trans-sialidase activities of TconTS enzymes on 
serum glycoconjugates
TconTS Trans-sialidase*
(nmol/(min x mg TS)
Sialidase (nmol/(min x mg TS)
- lactose**    + lactose***
TS/sialidase
 - lactose****    + lactose
TconTS1f 315±16 63±0.6 1.04±0.001 5 303
TconTS2 1005±60 105±3.5 0.17±0.0 10 5912
TconTS3 5.1±0.1 n.d.***** n.d.***** >5 >5
TconTS4 3.2±0.1 1.3±0.0 0.31±0.0001 2.5 10
* TS activity values are given in Table 1
** Sialidase activity values in absence of lactose are given in Table 1 
*** Sialidase activities in presence of 2 mM lactose were determined by incubating 1000 ng of 
indicated TconTS enzymes for 24 h with 600 ?M serum-bound Sia. Data points are mean ± 
standard deviations of 3 independent reactions, each in 3 replicates.
**** sialidase activity values in absence of lactose acceptor.
*****n.d. not determined, below 0.1 nmol Sia
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5.0. General
Trans-sialidases (TS) are expressed by parasitic trypanosomes and this special group of enzymes 
transfer Sialic acids (Sia) in a regio- and stereo-specific manner resulting in ?2-3 linkages to 
underlying Gal or GalNAc. In this work, TS gene products from the animal African parasite, 
Trypanosoma congolense were biochemically characterised. Three distantly related genes with  
less than 40% similarity to the ones whose products are active were also identified form data 
bases. Gene products from this group are presumably inactive. 
TS was first described in T. cruzi and implicated in the pathology of the bloodstream form of the 
same parasite (Schenkman et al. 1991). It was subsequently described in the procyclic insect 
forms of the African trypanosomes (Engstler et al. 1993), where it was for long thought to be only 
stage specifically expressed. In the African trypanosomes, TS has also been linked to the 
pathogenesis of trypanosomosis. First, it has been shown to be required for establishment of 
infection in the fly midgut (Nagamune et al. 2004) as transgenic parasites without the ability to 
express TS showed reduced survival and colonisation rates in the Glossina midgut. Of critical 
importance to survival of the parasite and disease is the establishment of infection in the midgut as 
fly innate immune responses clear most infections in fly gut (Hu and Aksoy 2006). Recent 
evidences showed the expression of TconTS4 (TcoTS-D2) and TconTS-Like 2 (TcoTS-like2) genes 
by the BSFs of infected mice (Coustou et al. 2012). Studies on Trypanosoma congolense (Nok and 
Balogun 2003, Coustou et al. 2012) and T. vivax (Guegan et al. 2013) have implicated TS as 
virulence factors in anaemia in animals suffering those infections. Of note is the fact that TS 
orthologues are not found in mammals. TS therefore could be a 'weak spot' in the life of the 
parasite that could be targeted for the fight against trypanosomiasis.
The current study set out with the aim to biochemically characterise TS genes from the most 
prevalent animal Trypanosoma parasite, T. congolese. Data mining with partial sequences of TS-
forms 1 and 2 (Tiralongo et al. 2003b) as queries on WTSI resulted to full ORFs for the two TS 
forms. Further searches using complete ORFs resulted in two other related genes and the 
existence of 3 distantly related members. We classified the former group into TconTS1, TconTS2, 
TconTS3, TconTS4. The latter distantly related members are collectively referred to as TconTS-like 
genes and have been named TconTS-like1, TconTS-like2 and TconTS-like3. To make 
comparisons, we cloned and sequenced genes from from another parasitic African relative, T. 
brucei. Cloned TconTS genes were expressed in mammalian fibroblasts and enzyme activities 
assayed in order to establish kinetic parameters using different substrates. The findings of the 
study are presented in the thesis as individual chapters. Each of these chapters contain specific 
discussions of results presented therein. 
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5.1. TconTS genes from African trypanosomes
TS genes have a different and diverse occurrence in all known pathogenic trypanosomes (Tables 
5.1 and 5.2). TS genes would therefore have evolved as multi-gene family and maintained in the 
parasites before the split of the continental plates separating for instance the African and American 
parasites. However, different environmental pressures probably led to the varying degrees of 
complexity exhibited across trypanosomes. T. cruzi has over 1400 TS-like genes (Cazzulo and 
Frasch 1992, De Pablos and Osuna 2012). Out of these large number, only 12 encode 
enzymatically active T. cruzi trans-sialidase (TcTS) proteins. About half encode for inactive gene 
products while the remaining half are pseudogenes (Kim et al. 2005). In the African trypanosomes, 
the TS gene families show up in several copies but with fewer numbers than occur in T. cruzi. 
T. congolense remains to date the only African trypanosome from which TS genes have been 
studied in detail (Tiralongo et al. 2003a, Tiralongo et al. 2003b, Koliwer-Brandl et al. 2011, Coustou 
et al. 2012, Chapters 3 and 4). Of all the TS genes so far identified in African trypanosomes, T. 
congolense (STIB 249) has the highest number with at least 14 active members. In addition, T. 
congolense has 3 other genes (TconTS-like genes) which are considered inactive as they lack 
most of the critical amino acids required in transfer and hydrolysis activity, though no activity 
studies have been undertaken. The active genes have been classified into TconTS1, TconTS2, 
TconTS3 and TconTS4. TconTS1 is a multi-copy gene group with 11 members, all active and share 
over 96% similarity (Chapter 2). This number could have arisen from active gene rearrangement. 
In the STIB 249 strain used in this study, only one representative member has been identified for 
the other TconTS (Chapter 3) but there could be differences between strains as an extra copy, 
each for TconTS3 and TconTS4 in the IL3000 strain has been reported (Coustou et al. 2012).
So far, 9 TS gene members have been reported for T. brucei (Montagna et al. 2002, Montagna, 
Donelson and Frasch 2006, Nakatani et al. 2011). Two of these genes, TbTS (Montagna et al. 
2006, Nakatani et al. 2011) have been enzymatically characterised. In the current study, T. brucei 
TS genes from the genomic DNA of EATRO427 were cloned and sequenced. Validity of gene 
numbers as well as correct assembly from different reads into contigs listed in databases was 
confirmed. TbTS1, an orthologue of TconTS1 had at least 3 members. T. brucei also retains 
orthologues for the other groups of TS genes found in T. congolense as well as three other gene 
copies, TconTS like D1, TconTS like D2 and TconTS-like E (Montagna et al. 2006) whose 
products are presumably inactive due to the non-conservation of the critical amino acids acids. 
Data mining from TritrypDB, WSTI and GeneDB identified 6 TS representatives from T. vivax 
(Jackson et al. 2013). Though Guegan et al. (2013) confirmed the existence of these genes by 
PCR using genomic DNA, peptide evidence could only be obtained for only three of the genes, 
TvivTS1, TvivTS3 and TvivTS5 in the BSF parasites. Sequence comparison with known TS of 
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other trypanosomes showed the BSF-expressed genes retained the critical amino acids required 
for activity and hence presumed to be active (Table 5.1). 
Table 5.1. Amino acids in the catalytic domains of TS gene products of animal African 
trypanosomes involved in enzymatic activities*
T. congolense                            T. brucei                   T. vivax                                     T.evansi
Tcon
TS1
Tcon
TS2
Tcon
TS3
Tcon
TS4
TbTS TbSAC2 Tviv1 Tviv3 Tviv5 TevTS
1
TevTS
2
TevTS
3
TevTS
4
catalysis
D150 D135 D142 D207 D157 D108 D197 D192 D207 D157 D163 D108 D163
E324 E309 E316 E381 E311 E283 E399 E395 E409 E331 E337 E283 E336
Y438 Y423 Y430 Y493 Y457 Y402 Y510 Y506 Y520 Y457 Y451 Y402 Y450
substrate binding
R126 R111 R118 R183 R133 R84 R173 R168 R183 R133 R139 R84 R139
R339 R324 R331 R396 R346 R298 R414 R410 R424 R346 R352 R298 R351
R410 R395 R402 R465 R429 L381 R482 R478 R492 R429 R423 R374 R422
R144 R129 R136 R201 R151 R102 R191 R186 R201 R151 R157 R102 R157
D188 D173 D180 D245 D195 D146 D235 D230 D245 D195 D201 D146 D201
Y211 P196 Y203 Y268 Y218 W169 Y258 Y253 Y268 Y218 Y224 W169 Y224
W212 W197 W204 W269 W219 W170 W259 W254 W269 W219 W225 W170 W225
Q289 Q274 Q281 Q364 Q296 Q248 Q364 Q360 Q374 Q296 Q302 Q248 Q301
Y408 W393 W400 Y463 W427 W372 H480 Y476 H490 W427 F421 W372 F420
 structure
A325 A310 S317 A382 A332 S284 S400 S396 S410 A332 S338 S284 S337
P379 P364 P371 P434 P229 I350 P451 P447 P461 P398 P392 P343 P391
 *The indicated amino acids have been selected based on structural (Amaya et al. 2004) and 
mutation (Cremona et al. 1995,  Paris et al. 2001) studies with T. cruzi TS and on the sequence 
alignment of TconTS1b with T. cruzi (Koliwer-Brandl et al. 2011). T. vivax and T. evansi genes are 
mined from WSTI, GeneDB and TritrypDB (Taken from Gbem et al. 2013 with modification by 
inclusion of the T. evansi genes). Colours indicate drastic changes in amino acids.
Using phylogenetic analysis, T. vivax genes clustered distinctively away with no orthologues 
shared among T. cruzi, T. brucei and T. congolense (Chapter 3). This is consistent with a different 
form of selection pressure operating on T. vivax TS genes. T. vivax has a different pattern of 
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development in the tsetse vector, confined only in the cibarium and the mouth parts without 
extending to the midgut (Moloo and Gray 1989). Evolutionary pressures operating at the level of 
the vector host may likely be more significant in shaping the development of TS genes.
TS from T. evansi (TevTS) have not been studied. There is a report of TS from this parasite 
(Yakubu et al. 2011) with an NCBI accession number FJ597949. Unfortunately, the PCR primers 
used in this case were identical to those previously used in amplifying TS from T. brucei (Montagna 
et al. 2002). Equally, the method of species identification is questionable, coupled with the fact that 
T. brucei and T. evansi are closely related possibly due to a recent divergence (Gibson et al. 2001) 
and share between 85 and 99.6% identity in TS genes. Recently, TritrypDB® released the genome 
sequence of T. evansi (Schnaufer et al. unpublished). Taking advantage of this data, T. evansi TS 
genes were mined by using both T. congolense and T. brucei TS genes as starting queries. A total 
of 8 genes have been identified without an exact match for FJ597949. Five of these genes 
conserve the critical amino acids required for activity while the remaining three do not. This later 
group is presumed inactive and therefore termed TevTS-likes. Phylogenetic analysis showed that 
except for TconTS-like1, TevTS genes share orthologues with TconTS genes (see Table 5.2). 
TevTS1 showed two copies, one long (TevSTIB805.7.7540) one short (TevSTIB805.7.7510). Since 
these share over 98% identity with difference only concentrated at the end of the C-terminal in the 
short form, it is possible this may be due to wrong assembly of “reads”. Experimental confirmation 
is required in order to make definite conclusions. However, it if turns out that this indeed is a true 
gene copy, it would satisfy our previous observations on TS1 gene orthologues possessing 
multiple copy numbers across the animal African trypanosomes. Interestingly, a short form of TS1 
has been reported in T. brucei (Montagna et al. 2002). The other TevTS genes, TevTS2, TevTS3 
and TevTS4 all showed no evidence for multiple copy numbers from database. Cloning and 
sequencing would ascertain copy numbers for these genes. T. evansi occurs in South America 
apart from the African continent and this is attributed to the movement of cattle from Africa to South 
America in the early 19th century (Jones and Davila 2001). Adapting a mechanical mode of 
transmission as a response to the absence of tsetse flies in South America ensures its survival and 
transmission. Comparing TS sequences of strains from both continents would offer more insights 
into the diversity of TS gene from T. evansi. 
A key question would arise concerning the observation of multiple gene copies in TS1: why the 
apparent diversity in this family? Recent mass spectrometry and immunoprecipitation with specific 
anti-sialidase IgG evidences (Coustou et al. 2012) points to the expression of TconTS1 both in the 
PCF and BSF stages of parasites in mice. Gbem et al. (2013) confirmed the expression of 
TconTS1 and/or TconTS2 in both the metacyclics forms in insects proboscis as well as BSFs of T. 
congolense experimentally infected goats. TconTS2 has a wide pH optimum (Chapter 3), indicating 
it could be active both in the insects gut (pH of up to 10) (Dyer et al. 2013) and in mammalian 
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blood system (pH 7.4). Information on the pH optima of TbTS1 enzyme activity is not available for 
any of the other African parasites and though TvivTS1 have been identified in the blood of infected 
mice (Guegan et al. 2013), TviTS genes share no orthologues with any other Trypanosoma to 
warrant meaningful inferences. More studies are needed on TbTS and the recently sequenced 
TevTS genes. If indeed it turns out that the TbTS and TevTS1 are expressed both in the blood and 
insects forms, the diversity seen in this orthologue group could be attributed to it being central to 
the survival of the parasites in both hosts, and certainly would deserve more attention.
5.2. Amino acid residue variations in TS
Mutation studies on TcTS revealed the identity of amino acids required for transfer and hydrolysis 
activities (Paris et al. 2001), (Amaya et al. 2004), (Paris et al. 2005). While most of these amino 
acids are conserved across the trypanosomes (Table 5.1), it is nevertheless difficult to make direct 
comparison of enzyme activities across TS families of African trypanosomes. This is because there 
are no comprehensive enzyme activity studies for trans-sialidases from T. brucei, T. evansi and T. 
vivax. Such comparison is only available for T. congolense, whose active TS genes have been 
biochemically characterised (Chapter 2, 3 and 4). 
TconTS1 and TconTS2 show higher specific transfer activities than TconTS3 and TconTS4 on 
fetuin and serum glycoconjugates donor substrates. Comparison of the amino acid sequences of 
these TconTS genes with that of T. cruzi revealed two variations each in the critical amino acid 
residues involved in substrate binding. These are Y211, Y408 and P192, W393 for TconTS1 and 
TconTS2, respectively. In T. cruzi, these residues are Y199 and W312 and together they form the 
binding pocket for the acceptor substrate (Amaya et al. 2004, Mitchell et al. 2013). Interestingly, the 
change in TconTS2 at position 192 where Pro replaces Tyr (Table 5.1) is drastic and yet, TconTS2 
exhibited the highest specific transfer activity among all enzymes from T. congolense. Phylogenetic 
analysis have assigned orthologues for TconTS and TbTS genes, using separately the catalytic 
domain (CD) and lectin domain(LD). Due to high similarity between T. brucei and T. evansi, 
phylogenetic analysis unsurprisingly assigned orthologues in a similar way as for T. brucei except 
for TbTS-Like E, where no orthologue is found in T. evansi (Table 5.2). The LD grouped the most 
active TconTS gene together. Identification of orthologues from the other trypanosomes and their 
subsequent grouping with TconTS genes could be an indication of the activity status of such 
orthologues. It is important to note here that these genes grouped differently when CD was used 
(Chapter 3).
It was observed that singly, TconTS genes could not cleave the chromogenic substrate Neu5Ac-
MU. However, if either TconTS1 or TconTS2 were mixed with any other TconTS enzyme, these 
synthetic sialosides were hydrolysed. A synergistic effect has been envisaged. Other unidentified 
structural features of the proteins may be responsible for this effect. 
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The observation that TconTS1 and TconTS2 grouped together when LD domains were used in 
phylogenetic analysis led to the the suggestion that the lectin domain may play a more significant  
role in TS activities than previously thought. Preliminary results from experiments with swapped 
domains lend credence to this observation (Chapter 3). Equally, a mouse monoclonal antibody 
raised against purified native TconTS protein (Tiralongo et al. 2003b) binds to both TconTS1 and 
TconTS2. Epitope mapping identified the epitope as been located in the lectin domain of both 
enzymes (Chapter 3). In the past, emphasis on TS enzyme activities have been on the catalytic  
domain that harbours amino acid residues involved in substrate binding, conformational changes 
and catalysis. The lectin domain hardly attracted any attention. Detailed experiments will be 
necessary to fully ascertain this observation, but, if finally proven, the impact of this finding on 
rational drug design and other avenues in the fight against the pathogenesis of African 
trypanosomosis would be enhanced.
5.3. Substrates could led to variation in enzyme activity
Expression of TconTS genes in the mammalian fibroblasts CHOLec1 cells represents the first time 
TS genes were expressed in fibroblasts. Comparing with reports from literature, specific activities 
have been observed to be much lower for proteins expressed in bacteria than those expressed in 
fibroblasts (Chapter 3). Poor specific activities were observed when fibroblasts-expressed proteins 
were incubated with synthetic substrates, compared to natural substrates (Chapter 2 & 3). Specific 
activities were highest for TconTS1 and TconTS2 when fetuin and serum glycoconjugates were 
used as donor and lactose as acceptor. In both cases, free Neu5Ac became detectable only when 
3'SL accumulated in the reaction. In absence of lactose however, sialidase activity was observed 
for TconTS1, TconTS2, TconTS4 but none for TconTS3 on serum samples. Lactose has been 
shown to be a suitable acceptor for the transferred Sia (Chapters 2 & 3,). Similar observations 
have been made with TbTS enzymes (Engstler et al. 1993). 
Specific activities for TconTS enzymes on natural substrates were higher for fetuin-bound Sia than 
serum glycoconjugates with lactose as acceptor substrate (Table 5.3). Serum presents several 
donor and acceptor possibilities. A complex pattern of Sia removal and transfer is possible. 
This means lactose may not be the only acceptor present as opposed to a single substrate like 
fetuin. This could lead to an underestimation of sialylation by such a method as used in the study. 
TconTS1 and TconTS2 transferred between 50 and 60% Sia from fetuin (Chapter 3), and between 
20 and 27% from serum glycoconjugates (Chapter 4). More Sia is therefore transferred from fetuin 
than from serum by the two enzymes, with TconTS2 transferring higher Sia in both cases. For both 
enzymes, maximum free Sia released in presence of lactose was not more than 1.5 nmol. Sia 
release by TconTS1 in absence of lactose is comparable to amounts of 3'SL formed when lactose 
is present while TconS2 released slightly less Sia than 3'SL formed (Chapter 4). While this 
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difference may not be relevant, it is possible that these TconTS enzymes access different Sia on 
serum glycoconjugates thereby giving the parasite access to a variety of Sia in the host and hence 
better survival. BSF parasites require Sia in order to escape lysis by trypanolytic factors present in 
serum (Vanhamme et al. 2003). Incubating serum glycoconjugates with a mixture of the two 
enzymes would reveal whether or not they use one or different Sia types. 
Sialidase activity of TconTS4 on fetuin was suppressed when increasing concentrations of lactose 
were used (Chapter 3). The presence of lactose, for instance by direct infusion, could lower 
parasites sialylation, with lactose as the preferred acceptor. Loss of Sia from parasites' surfaces 
could also occur. The sum total effect of these processes is clearance of parasites from the host 
body system. Indeed, infusion of lactose in sheep suffering experimental T. congolense infections 
suppressed anaemia (Chapter 3, personal communication). More studies are required for a 
detailed understanding of acceptor binding towards inhibition of TconTS by use of acceptors. 
The finding that individual TconTS genes do not cleave the widely used Neu5Ac-MU substrate 
except when mixed with other TconTS (section 5.2 above) is significant, even towards 
standardising activity tests. Although this may be due to absence of a suitable acceptor substrate 
as reports supporting cleavage of Neu5Ac-MU by TS enzymes possibly contained natural 
acceptors like GARP (Tiralongo et al. 2003b, Schrader et al. 2003, Schrader et al. 2006), further 
studies are needed for example in presence of GARP to make conclusive statements on this 
finding. Use of Neu5Ac-MU is wide spread and seems to be the preferred method, but may not be 
the most suitable method at least in testing for activities of recombinant TconTS genes.
There is no obvious link between trypanosomiasis and synthetic substrates' cleavage by TS 
enzymes. By extrapolation however, one could assume a sort of synergy that might arise from 
combined expression of these gene products in mammalian blood. In this vain, cleavage of Sia 
from hitherto difficult linkages or donors could be achieved, with enhanced virulence as a result. It 
is also reasonable to assume that combined expression of different TS genes provides the broader 
repertoire of potential Sia sources available to the parasite leading to a better survival of the 
parasites in the host. Serum and blood contain several glycoproteins and/or glycolipids. The 
possibility of a complex pattern of sialylation and desialylation is envisaged and has been observed 
for serum and equally revealed an interesting pattern of sialylation at varying serum-bound Sia 
concentrations (Chapter 4). The parasite is equipped with different acceptors on its surface. It is 
tempting to postulate that the parasites deploy specific set of acceptors with better efficiencies at 
given Sia concentration or stages of infection. 
5.4. TS as target in the fight against AAT
It has been established that SA /TS genes of T. congolense (Nok and Balogun 2003, Coustou et al. 
2012) and those of T. vivax (Guegan et al. 2013) are involved in anaemia, a major clinical sign for 
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trypanosomiasis caused by these parasites. mRNA evidence from insect vector tissue and blood of 
infected goats showed that apart from TconTS1, TconTS2 and TconTS4 are also expressed in the 
mammalian blood (Gbem et al. 2013). However, as monoclonal antibodies are not available for 
TconTS2, TconTS3 and TconTS4, presence of various gene products at protein levels could not be 
confirmed. No study to the best of our knowledge has reported on whether or not the BSF forms of 
T. brucei and T. evansi also express these genes. However, the expression of common 
orthologues shared among T. congolense, T. brucei and T. evansi in blood would have the same 
beneficial effect(s) to these parasites. In both T. congolese and T. vivax, the expressed enzymes 
have been implicated as virulence factors in anaemia resulting from Trypanosoma infections.
Apart from the active TS genes, TS-like genes are retained between T. congolense, T. brucei 
(Guegan et al. 2013, Jackson et al. 2013, Chapter 3) and T. evansi as common orthologues (Table 
5.2). The obvious question would be why retaining inactive genes? Interestingly, TconTS-like2 
(TcoTS-like 2 in Coustou et al. 2012) is reported to be expressed in the blood of infected mice and 
showed protection against T. congolense when used as a DNA vaccine (Coustou et al. 2012). 
Could the expression of the inactive TS-like genes in mammals be a “decoy” by the parasite to 
avoid immune responses such as complement lysis? In T. cruzi, the C-terminally located SAPA is a 
gene domain found both in the active and inactive TcTS (Pereira et al. 1991). SAPA increases the 
half-life of TS in the blood (Buscaglia et al. 1999) and is also thought to serve as a decoy by TS to 
evade the host immune system (Frasch, 1994). SAPA is unrelated to TS-like proteins and it is 
absent in TS and TS-like genes of African trypanosomes. The expression of TS-like genes may 
serve a similar purpose. In T. cruzi however, a T/C transition resulting in Tyr342-His replacement 
differentiates active from inactive trans-sialidase (Cremona et al. 1995). While enzymatically 
inactive, these genes retain the substrate binding, hence lectin-like ability (Cremona et al. 1995), 
(Todeschini et al. 2002a, Todeschini et al. 2004). Todeschini et al. (2002b) used an inactive TcTS 
and observed stimulation of host's T-lymphocytes. Recently, crystallographic and enzyme kinetics 
studies showed residual hydrolytic activities retained in inactive TcTS (Oppezzo et al. 2011). It 
would be interesting to study expression profiles of TS-like genes in the BSFs of African 
trypanosomes by quantitative RT-PCR experiments and their possible role in the pathogenesis of 
the African trypanosomes.
Several compounds have been used as inhibitors of TS mainly in T. cruzi (reviewed in Chapter 1). 
These have met with varying degrees of success but till date, no potent inhibitor has been 
reported. Gene knockout is obviously unattractive due to the presence of several TS copies/gene 
members. RNAi while suppressing activities in T. brucei did not lead to total inhibition of gene 
expression (Montagna et al. 2006). The reason for this is obvious as closely related genes with 
over 80% sequence identity have been identified for TbSA B and TbSA C (Nakatani et al. 2011). 
TS are shed in the blood of the mammalian hosts and elicit several antibody responses (Dc-Rubin 
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and Schenkman 2012). Recently, Buschiazzo et al. (2012) reported a mouse monoclonal Ab, 
mAb13G9 showing strong inhibition of parasite surface sialylation of T. cruzi. This finding is 
interesting especially in the African trypanosomes as fewer TS genes have been reported. 
Vaccination of animals with recombinant genes should lead to immune response studies and a 
possible screening and selection of a potent neutralising antibody against TS. 
There have been ongoing efforts to employ tsetse gut symbiont in the fight against 
trypanosomiasis. In line with this, naturally occurring tsetse symbionts like Wolbachia sp, Sodalis 
sp and Wiggleswortia sp thought to influence Trypanosoma infections in tsetse have been studied 
(Wamwiri et al. 2013). Does any of the naturally occurring midgut tsetse flora express sialidases 
which may act as a competitor to any TS expressed in fly midgut? Such a sialidase would 
essentially desialylate glycoconjugates from mammalian blood and parasites and prevent 
establishment of infection in vector gut. So far, there has been no such report. What however is 
known is that endosymbionts are not universally present (Wamwiri et al. 2013) in the over 30 
extant Glossina spp (Krafsur 2009) all capable of transmitting trypanosomes. In light of this, a 
transgenic endosymbiont carrying an active sialidase gene may be a more reasonable approach. 
However, such a sialidase should be highly active and at such pH conditions as prevalent in tsetse 
midgut (Dyer et al. 2013). TconTS2 is the TconTS with the highest specific activity. Moreover, its pH 
optima equally meet the pH conditions in the fly midgut (Chapter 4) and should be considered for 
genetic manipulation to enhance its sialidase activity.
In conclusion, this study characterised T. congolense TS by utilising recombinant gene products 
made from the genomic DNA of the organism. All TconTS genes transfer Sia with varying specific 
activities, TconTS1 and TconTS2 showing the highest specific activities. Activity studies on blood 
glycoconjugates reveal different preferences for Sia by TconTS enzymes with high sialidase activity 
for TconTS1 and TconTS2 in absence of preferred acceptors, possibly accounting for the high 
amount of free Sia observed in blood and serum of infected animals. TconTS2 gene shows a 
robust pH optima that could warrant it exhibit activity both in the vector and the mammalian host.  
Phylogenetic analysis employing different domains of TS genes from sequenced and mined data 
reveal orthologues across the Trypanosoma genus, clustering TconTS gene products with higher 
specific activities in together when lectin domain were used. The multi-copy nature of the TS1 gene 
group seems to be a common feature in parasitic trypanosomes. 
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Apart from infecting animals, atypical cases of human (a-HT) infections with animal trypanosomes 
(Truc et al. 2013) have been documented. This portends great worry with the spate of drug 
resistance coupled with the little or no possibility of new drugs on the horizon. TS clearly presents 
a weak-spot and should constitute an attractive target for alternative arsenals.
The role of the lectin domain in pathogenesis of trypanosomiasis needs further investigation. 
Domain exchanges, followed by enzyme activity studies of fibroblasts expressed 'chimera TconTS' 
should provide immediate insight into the role of lectin domain in activity. 
The multi-copy nature of TS1 gene group seems a common feature of the animal African 
trypanosomes. The variability in this gene group may be central in the survival of these parasites. 
Studies are required on the other parasitic animal African trypanosomes to decipher the true 
situation of this gene group. Equally, the inactive TconTS-like genes occur as orthologues in 
African trypanosomes that establish infections in the vector host. This suggests a role in the 
pathogenesis for these genes and needs further investigation. 
We have shown by mRNA experiments that TconTS genes are expressed in the blood of 
mammalian hosts. However, since monoclonal antibodies are not yet available for TconTS2, 
TconTS3 and TconTS4, difficulty still remains as as to which these TconTS gene products are 
present in the blood. While a mouse monoclonal Ab is available, this Ab reacts with TconTS2 
thereby making it impossible at the moment to say with certainty which of these TconTS proteins is 
expressed in the blood of infected animals. There is need to raise monoclonals which are specific 
for each TconTS protein.
Tsetse vector harbour endosymbionts. The idea of an endosymbiont expressing sialidase that 
could counter TS activities in the gut of the insect host has been muted. Unfortunately, the 
distribution of endosymbionts is not catholic in the tsetse gut, placing a limitation on such a 
potential approach. Transgenic endosymbiont carrying an active sialidase gene may be a more 
reasonable approach. TconTS2 is highly active even at pH conditions prevalent in tsetse midgut, 
and should therefore be considered for genetic manipulation to enhance its sialidase activity 
towards creating a common transgenic endosymbiont.
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